Primary Site >> Liver Cancer

Gene >> EPHB2

Journal: J Clin Invest. 1993 Nov;92(5):2419-26.
Title: Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.
Author: Imai, H|Chan, E K|Kiyosawa, K|Fu, X D|Tan, E M
PMID: 8227358
Journal: Hepatology. 1998 Apr;27(4):951-8.
Title: Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma.
Author: Ito, Y|Sasaki, Y|Horimoto, M|Wada, S|Tanaka, Y|Kasahara, A|Ueki, T|Hirano, T|Yamamoto, H|Fujimoto, J|Okamoto, E|Hayashi, N|Hori, M
PMID: 9537433
Journal: Hepatology. 2000 Nov;32(5):958-61.
Title: Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha.
Author: Hayashi, J|Aoki, H|Kajino, K|Moriyama, M|Arakawa, Y|Hino, O
PMID: 11050045
Journal: Arch Pharm Res. 2000 Dec;23(6):605-12.
Title: Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death.
Author: Chen, C|Yu, R|Owuor, E D|Kong, A N
PMID: 11156183
Journal: Int J Oncol. 2001 Jun;18(6):1271-8.
Title: Genetic and epigenetic events in human hepatocarcinogenesis.
Author: Kondoh, N|Wakatsuki, T|Hada, A|Shuda, M|Tanaka, K|Arai, M|Yamamoto, M
PMID: 11351262
Journal: Cancer Res. 2001 Jul 1;61(13):5016-23.
Title: Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
Author: Yang, S|Lin, H Z|Hwang, J|Chacko, V P|Diehl, A M
PMID: 11431335
Journal: Hum Mol Genet. 2001 Aug 15;10(17):1741-52.
Title: Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.
Author: Jorquera, R|Tanguay, R M
PMID: 11532983
Journal: J Biol Chem. 2001 Nov 2;276(44):40968-76.
Title: High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.
Author: Tsukada, Y|Miyazawa, K|Kitamura, N
PMID: 11533045
Journal: J Virol. 2001 Nov;75(21):10348-58.
Title: Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo.
Author: Nijhara, R|Jana, S S|Goswami, S K|Rana, A|Majumdar, S S|Kumar, V|Sarkar, D P
PMID: 11581403
Journal: Cancer. 2002 Feb 15;94(4):934-9.
Title: Coexpression of ephrin-Bs and their receptors in colon carcinoma.
Author: Liu, Wenbiao|Ahmad, Syed A|Jung, Young D|Reinmuth, Niels|Fan, Fan|Bucana, Corazon D|Ellis, Lee M
PMID: 11920461
Journal: Cancer. 2002 Aug 15;95(4):896-906.
Title: Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
Author: Zhang, Hao|Ozaki, Iwata|Mizuta, Toshihiko|Matsuhashi, Sachiko|Yoshimura, Tohru|Hisatomi, Akitaka|Tadano, Jutaro|Sakai, Takahiro|Yamamoto, Kyosuke
PMID: 12209735
Journal: Gut. 2003 May;52(5):706-12.
Title: Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.
Author: Tannapfel, A|Sommerer, F|Benicke, M|Katalinic, A|Uhlmann, D|Witzigmann, H|Hauss, J|Wittekind, C
PMID: 12692057
Journal: Biochem Biophys Res Commun. 2003 May 30;305(2):428-33.
Title: An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells.
Author: Hah, Nasun|Lee, Seung-Taek
PMID: 12745093
Journal: J Hepatol. 2003 Jun;38(6):803-10.
Title: Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor.
Author: Wiedmann, Marcus|Tamaki, Seishu|Silberman, Rebecca|de la Monte, Suzanne M|Cousens, Leslie|Wands, Jack R
PMID: 12763374
Journal: J Gastrointest Surg. 2003 Dec;7(8):1024-33.
Title: Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
Author: Schmidt, C Max|Wang, Yufang|Wiesenauer, Chad
PMID: 14675712
Journal: Clin Chem. 2004 Mar;50(3):490-9.
Title: Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers.
Author: Hafner, Christian|Schmitz, Gerd|Meyer, Stefanie|Bataille, Frauke|Hau, Peter|Langmann, Thomas|Dietmaier, Wolfgang|Landthaler, Michael|Vogt, Thomas
PMID: 14726470
Journal: J Am Coll Surg. 2004 Mar;198(3):410-21.
Title: Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Author: Wiesenauer, Chad A|Yip-Schneider, Michele T|Wang, Yufang|Schmidt, C Max
PMID: 14992744
Journal: FASEB J. 2004 May;18(7):914-6.
Title: Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
Author: Chen, Lixin|Zeng, Ying|Yang, Heping|Lee, Taunia D|French, Samuel W|Corrales, Fernando J|Garcia-Trevijano, Elena R|Avila, Matias A|Mato, Jose M|Lu, Shelly C
PMID: 15033934
Journal: Mol Cancer Res. 2004 Mar;2(3):159-69.
Title: Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway.
Author: Yun, Chawon|Cho, Hyeseon|Kim, Su-Jeong|Lee, Jae-Ho|Park, Sun Yi|Chan, Gordon K|Cho, Hyeseong
PMID: 15037655
Journal: FASEB J. 2004 Jul;18(10):1123-5.
Title: Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Author: Chung, Tae-Wook|Lee, Young-Choon|Kim, Cheorl-Ho
PMID: 15132991
Journal: Mol Immunol. 2004 Jul;41(9):847-54.
Title: Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells.
Author: Schauber, Jurgen|Iffland, Konrad|Frisch, Susanne|Kudlich, Theodor|Schmausser, Bernd|Eck, Matthias|Menzel, Thomas|Gostner, Andrea|Luhrs, Hardi|Scheppach, Wolfgang
PMID: 15261456
Journal: J Hepatol. 2004 Aug;41(2):274-83.
Title: Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion.
Author: Schmitt, Marcus|Horbach, Axel|Kubitz, Ralf|Frilling, Andrea|Haussinger, Dieter
PMID: 15288477
Journal: Cancer Sci. 2004 Aug;95(8):666-73.
Title: Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines.
Author: Cheng, Jidong|Imanishi, Hiroyasu|Liu, Weidong|Nakamura, Hideji|Morisaki, Takayuki|Higashino, Kazuya|Hada, Toshikazu
PMID: 15298730
Journal: Hepatology. 2004 Sep;40(3):618-28.
Title: Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1.
Author: Yan, He-Xin|Wang, Hong-Yang|Zhang, Rui|Chen, Lei|Li, Bao-An|Liu, Shu-Qin|Cao, Hui-Fang|Qiu, Xiu-Hua|Shan, Yun-Feng|Yan, Zhong-Hua|Wu, Hong-Ping|Tan, Ye-Xiong|Wu, Meng-Chao
PMID: 15349900
Journal: J Hepatol. 2004 Oct;41(4):538-44.
Title: Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells.
Author: Fernandez-Veledo, Sonia|Valdes, Raquel|Wallenius, Ville|Casado, F Javier|Pastor-Anglada, Marcal
PMID: 15464233
Journal: Liver Int. 2004 Oct;24(5):432-6.
Title: Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
Author: Tsuboi, Yasunori|Ichida, Takafumi|Sugitani, Soichi|Genda, Takuya|Inayoshi, Jun|Takamura, Masaaki|Matsuda, Yasunobu|Nomoto, Minoru|Aoyagi, Yutaka
PMID: 15482339
Journal: Int J Oncol. 2004 Dec;25(6):1839-47.
Title: Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma.
Author: Huynh, H|Do, P T|Nguyen, T H|Chow, P|Tan, P H|Quach, T H|Van, T|Soo, K C|Tran, E
PMID: 15547725
Journal: J Biochem. 2004 Nov;136(5):701-9.
Title: Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Author: Tsukada, Yu-ichi|Tanaka, Toshiaki|Miyazawa, Keiji|Kitamura, Naomi
PMID: 15632311
Journal: J Cell Physiol. 2005 Jun;203(3):510-9.
Title: Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
Author: Wang, Ziqiu|Wang, Meifang|Carr, Brian I
PMID: 15534860
Journal: J Clin Oncol. 2005 Feb 10;23(5):965-72.
Title: Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.
Author: Strumberg, Dirk|Richly, Heike|Hilger, Ralf A|Schleucher, Norbert|Korfee, Sonke|Tewes, Mitra|Faghih, Markus|Brendel, Erich|Voliotis, Dimitris|Haase, Claus G|Schwartz, Brian|Awada, Ahmad|Voigtmann, Rudolf|Scheulen, Max E|Seeber, Siegfried
PMID: 15613696
Journal: Carcinogenesis. 2005 Apr;26(4):753-61.
Title: Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells.
Author: Mayoral, Rafael|Fernandez-Martinez, Amalia|Bosca, Lisardo|Martin-Sanz, Paloma
PMID: 15661807
Journal: Arch Biochem Biophys. 2005 Apr 15;436(2):285-96.
Title: Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways.
Author: Guberman, Alejandra S|Scassa, Maria E|Canepa, Eduardo T
PMID: 15797241
Journal: Mol Cancer Ther. 2005 Apr;4(4):595-602.
Title: Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties.
Author: Peyregne, Vincent P|Kar, Siddhartha|Ham, Seung W|Wang, Meifang|Wang, Ziqiu|Carr, Brian I
PMID: 15827333
Journal: Life Sci. 2005 Jun 3;77(3):252-65.
Title: Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells.
Author: Li, Chyi-Hann|Chen, Pei-Yu|Chang, Ue-Min|Kan, Lou-Sing|Fang, Woei-Horng|Tsai, Keh-Sung|Lin, Shwu-Bin
PMID: 15878354
Journal: Arch Biochem Biophys. 2005 Jun 1;438(1):36-52.
Title: Transcriptional activation of the Egr-1 gene mediated by tetradecanoylphorbol acetate and extracellular signal-regulated protein kinase.
Author: Bauer, Inge|Hohl, Mathias|Al-Sarraj, Alia|Vinson, Charles|Thiel, Gerald
PMID: 15910736
Journal: J Biomed Sci. 2005;12(2):289-96.
Title: Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.
Author: Wen-Sheng, Wu|Jun-Ming, Huang
PMID: 15917995
Journal: Biochem Pharmacol. 2005 Jul 15;70(2):229-41.
Title: Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway.
Author: Su, Yu-Ting|Chang, Huei-Ling|Shyue, Song-Kun|Hsu, Shih-Lan
PMID: 15941563
Journal: J Biol Chem. 2005 Sep 9;280(36):31548-56.
Title: Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.
Author: Han, Junhong|Tsukada, Yu-ichi|Hara, Eiji|Kitamura, Naomi|Tanaka, Toshiaki
PMID: 16014626
Journal: Mol Cell. 2005 Jul 22;19(2):159-70.
Title: Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
Author: Ding, Qingqing|Xia, Weiya|Liu, Jaw-Ching|Yang, Jer-Yen|Lee, Dung-Fang|Xia, Jiahong|Bartholomeusz, Geoffrey|Li, Yan|Pan, Yong|Li, Zheng|Bargou, Ralf C|Qin, Jun|Lai, Chien-Chen|Tsai, Fuu-Jen|Tsai, Chang-Hai|Hung, Mien-Chie
PMID: 16039586
Journal: Cancer Biol Ther. 2005 Aug;4(8):874-82.
Title: PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Author: Tian, Fang|Zhang, Xiongwen|Tong, Yunguang|Yi, Yanghua|Zhang, Shilong|Li, Ling|Sun, Peng|Lin, Liping|Ding, Jian
PMID: 16082187
Journal: Ai Zheng. 2005 Aug;24(8):965-9.
Title: [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2].
Author: Xie, Yi|Tang, Cheng-Wei|Wang, Chun-Hui
PMID: 16086874
Journal: Cancer Lett. 2005 Dec 18;230(2):260-70.
Title: DNA damage and G2/M arrest in Syrian hamster embryo cells during Malachite green exposure are associated with elevated phosphorylation of ERK1 and JNK1.
Author: Bose, Bipasha|Motiwale, Leena|Rao, K V K
PMID: 16297712
Journal: Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):55-62.
Title: Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells.
Author: Kuo, Hsing-Chun|Lee, Herng-Jiun|Hu, Chao-Chin|Shun, Han-I|Tseng, Tsui-Hwa
PMID: 16051289
Journal: Food Chem Toxicol. 2006 Feb;44(2):227-35.
Title: Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Author: Liu, Tsan-Zon|Chen, Chung-Yi|Yiin, Shuenn-Jiun|Chen, Ching-Hsein|Cheng, Jiin-Tsuey|Shih, Ming-Kuei|Wang, Yu-Shan|Chern, Chi-Liang
PMID: 16112786
Journal: Cancer Lett. 2006 Jul 28;239(1):27-35.
Title: Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Author: Wen-Sheng, Wu
PMID: 16169661
Journal: Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G624-32.
Title: Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals.
Author: Sterpetti, Paola|Marucci, Luca|Candelaresi, Cinzia|Toksoz, Deniz|Alpini, Gianfranco|Ugili, Laura|Baroni, Gianluca Svegliati|Macarri, Giampiero|Benedetti, Antonio
PMID: 16322093
Journal: Int J Oncol. 2006 Jan;28(1):25-32.
Title: Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
Author: Fleischer, Binje|Schulze-Bergkamen, Henning|Schuchmann, Marcus|Weber, Achim|Biesterfeld, Stefan|Muller, Martina|Krammer, Peter H|Galle, Peter R
PMID: 16327976
Journal: Chem Biol Interact. 2006 Mar 25;160(2):123-33.
Title: Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
Author: Lee, Wei-Jiunn|Wu, Lan-Feng|Chen, Wen-Kang|Wang, Chau-Jong|Tseng, Tsui-Hwa
PMID: 16458870
Journal: Cancer Lett. 2006 Oct 28;242(2):141-50.
Title: Sprouty and cancer: the first terms report.
Author: Lo, Ting Ling|Fong, Chee Wai|Yusoff, Permeen|McKie, Arthur B|Chua, Mei-Sze|Leung, Hing Y|Guy, Graeme R
PMID: 16469433
Journal: Neoplasia. 2006 Jan;8(1):1-8.
Title: The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.
Author: Klein, Patrick J|Schmidt, C Max|Wiesenauer, Chad A|Choi, Jennifer N|Gage, Earl A|Yip-Schneider, Michele T|Wiebke, Eric A|Wang, Yufang|Omer, Charles|Sebolt-Leopold, Judith S
PMID: 16533420
Journal: J Hepatol. 2006 May;44(5):971-83.
Title: Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
Author: de la Monte, Suzanne M|Tamaki, Seishu|Cantarini, M Chiara|Ince, Nedim|Wiedmann, Marcus|Carter, Jade J|Lahousse, Stephanie A|Califano, Sophia|Maeda, Takashi|Ueno, Takato|D'Errico, Antonia|Trevisani, Franco|Wands, Jack R
PMID: 16564107
Journal: Gut. 2006 Dec;55(12):1801-8.
Title: Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Author: Sato, Y|Kato, J|Takimoto, R|Takada, K|Kawano, Y|Miyanishi, K|Kobune, M|Sato, Y|Takayama, T|Matunaga, T|Niitsu, Y
PMID: 16581947
Journal: Methods Enzymol. 2006;407:597-612.
Title: Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.
Author: Adnane, Lila|Trail, Pamela A|Taylor, Ian|Wilhelm, Scott M
PMID: 16757355
Journal: Gastroenterology. 2006 Jun;130(7):2130-44.
Title: SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Author: Lai, Jin-Ping|Yu, Chunrong|Moser, Catherine D|Aderca, Ileana|Han, Tao|Garvey, Thomas D|Murphy, Linda M|Garrity-Park, Megan M|Shridhar, Viji|Adjei, Alex A|Roberts, Lewis R
PMID: 16762634
Journal: Nihon Rinsho. 2006 Jun;64(6):1033-42.
Title: [Hepatocyte-specific Pten deficient mice].
Author: Horie, Yasuo|Ohshima, Shigetoshi|Sato, Wataru|Suzuki, Akira|Watanabe, Sumio
PMID: 16768106
Journal: Arch Biochem Biophys. 2006 Aug 15;452(2):138-48.
Title: The binding between p67 and eukaryotic initiation factor 2 plays important roles in the protection of eIF2alpha from phosphorylation by kinases.
Author: Datta, Bansidhar|Datta, Rekha|Ghosh, Arnab|Majumdar, Avijit
PMID: 16843428
Journal: Oncol Rep. 2006 Sep;16(3):451-6.
Title: Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
Author: Schuierer, Marion M|Bataille, Frauke|Weiss, Thomas S|Hellerbrand, Claus|Bosserhoff, Anja K
PMID: 16865242
Journal: Biochem Pharmacol. 2006 Nov 15;72(10):1217-27.
Title: Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
Author: Kar, Siddhartha|Wang, Meifang|Ham, Seung Wook|Carr, Brian I
PMID: 16930563
Journal: Gastroenterology. 2006 Oct;131(4):1208-17.
Title: Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
Author: Lee, Han Chu|Tian, Bo|Sedivy, John M|Wands, Jack R|Kim, Miran
PMID: 17030190
Journal: Mol Cells. 2006 Dec 31;22(3):291-9.
Title: Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells.
Author: Choi, Hwa Jung|Eun, Jae Soon|Kim, Bang Geul|Kim, Sun Yeou|Jeon, Hoon|Soh, Yunjo
PMID: 17202857
Journal: J Cell Physiol. 2007 Mar;210(3):766-73.
Title: Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
Author: Yang, Heping|Magilnick, Nathaniel|Noureddin, Mazen|Mato, Jose M|Lu, Shelly C
PMID: 17154373
Journal: Liver Int. 2007 Mar;27(2):155-62.
Title: Survival and apoptosis: a dysregulated balance in liver cancer.
Author: Fabregat, Isabel|Roncero, Cesar|Fernandez, Margarita
PMID: 17311609
Journal: J Cell Physiol. 2007 Jun;211(3):699-707.
Title: Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Author: Kaufmann, Roland|Rahn, Stephanie|Pollrich, Kristin|Hertel, Julia|Dittmar, Yves|Hommann, Merten|Henklein, Peter|Biskup, Christoph|Westermann, Martin|Hollenberg, Morley D|Settmacher, Utz
PMID: 17323377
Journal: J Cell Physiol. 2007 Aug;212(2):526-36.
Title: MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Author: Bessard, Anne|Fremin, Christophe|Ezan, Frederic|Coutant, Alexandre|Baffet, Georges
PMID: 17427199
Journal: Mol Cells. 2007 Feb 28;23(1):30-8.
Title: Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione.
Author: Fan, Yumei|Chen, Hui|Qiao, Bo|Luo, Lan|Ma, Hsiaoyen|Li, Heng|Jiang, Jihong|Niu, Dezhong|Yin, Zhimin
PMID: 17464209
Journal: J Hepatol. 2007 Sep;47(3):325-37.
Title: Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.
Author: Chin, Ruth|Earnest-Silveira, Linda|Koeberlein, Bernd|Franz, Susanne|Zentgraf, Hanswalter|Dong, Xuebin|Gowans, Eric|Bock, C-Thomas|Torresi, Joseph
PMID: 17512084
Journal: Cancer Biol Ther. 2007 Jul;6(7):1044-50.
Title: Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells.
Author: Xiao, Yu|Yang, Feng-Qing|Li, Shao-Ping|Gao, Jian-Li|Hu, Guang|Lao, Sin-Cheng|Conceicao, Emilia Leong|Fung, Kwok-Pui|Wangl, Yi-Tao|Lee, Simon Ming-Yuen
PMID: 17611410
Journal: Food Chem Toxicol. 2007 Dec;45(12):2446-53.
Title: MAPK inhibitors and pifithrin-alpha block cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells.
Author: Wu, Shu-Jing|Ng, Lean-Teik
PMID: 17673346
Journal: Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44.
Title: Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma.
Author: Ailawadhi, Sikander|Nagase, Hiroki|Khoury, Thaer|Yu, Jihnhee|Tan, Dongfeng|Black, Jennifer|Brattain, Michael|Javle, Milind
PMID: 17708250
Journal: J Clin Invest. 2007 Sep;117(9):2713-22.
Title: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
Author: Calvisi, Diego F|Ladu, Sara|Gorden, Alexis|Farina, Miriam|Lee, Ju-Seog|Conner, Elizabeth A|Schroeder, Insa|Factor, Valentina M|Thorgeirsson, Snorri S
PMID: 17717605
Journal: Hepatology. 2007 Dec;46(6):1801-9.
Title: Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins.
Author: Bergamini, Carlo|Sgarra, Concetta|Trerotoli, Paolo|Lupo, Luigi|Azzariti, Amalia|Antonaci, Salvatore|Giannelli, Gianluigi
PMID: 17948258
Journal: Zhonghua Wai Ke Za Zhi. 2007 Jul 1;45(13):917-20.
Title: [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Author: Zhu, Hong|Chen, Xiao-Ping|Luo, Shun-Feng|Guan, Jian|Zhang, Wan-Guang|Zhang, Bi-Xiang|Mao, Cai-Ping
PMID: 17953842
Journal: Arch Biochem Biophys. 2007 Dec 1;468(1):100-6.
Title: Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.
Author: Xue, Jing|Bi, Xinsheng|Wu, Guohao|Meng, Dan|Fang, Jing
PMID: 17961496
Journal: Curr Pharm Des. 2007;13(32):3279-87.
Title: Molecular pathways and related target therapies in liver carcinoma.
Author: Tommasi, S|Pinto, R|Pilato, B|Paradiso, A
PMID: 18045179
Journal: Cancer Biol Ther. 2007 Sep;6(9):1461-8. Epub 2007 Jun 26.
Title: Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Author: Cusimano, Antonella|Fodera, Daniela|D'Alessandro, Natale|Lampiasi, Nadia|Azzolina, Antonina|Montalto, Giuseppe|Cervello, Melchiorre
PMID: 18424914
Journal: J Surg Res. 2008 Jun 1;147(1):23-33.
Title: Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway.
Author: Moran, Dairmuid M|Mattocks, M Adrian|Cahill, Paul A|Koniaris, Leonidas G|McKillop, Iain H
PMID: 17574577
Journal: Oncogene. 2008 Jan 3;27(1):85-97.
Title: Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
Author: Desnoyers, L R|Pai, R|Ferrando, R E|Hotzel, K|Le, T|Ross, J|Carano, R|D'Souza, A|Qing, J|Mohtashemi, I|Ashkenazi, A|French, D M
PMID: 17599042
Journal: J Cancer Res Clin Oncol. 2008 Apr;134(4):503-13.
Title: siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells.
Author: Niu, Jian|Li, Xiang-Nong|Qian, Haixin|Han, Zeguang
PMID: 17901981
Journal: Virology. 2008 Feb 5;371(1):61-70.
Title: NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways.
Author: Lu, Lili|Wei, Liang|Peng, Guiqing|Mu, Yongxin|Wu, Kailang|Kang, Lei|Yan, Xiaohong|Zhu, Ying|Wu, Jianguo
PMID: 17964630
Journal: Drug Metab Dispos. 2008 Feb;36(2):217-22.
Title: Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Author: Le Vee, Marc|Gripon, Philippe|Stieger, Bruno|Fardel, Olivier
PMID: 17991769
Journal: Chem Biol Interact. 2008 Jan 10;171(1):1-14.
Title: Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines.
Author: Sa, Fei|Gao, Jian-Li|Fung, Kwok-Pui|Zheng, Ying|Lee, Simon Ming-Yuen|Wang, Yi-Tao
PMID: 17996228
Journal: J Hepatol. 2008 Jan;48(1):83-90.
Title: Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
Author: Schmitz, Klaus Juergen|Wohlschlaeger, Jeremias|Lang, Hauke|Sotiropoulos, Georgios Charalambos|Malago, Massimo|Steveling, Karen|Reis, Henning|Cicinnati, Vito Rosario|Schmid, Kurt Werner|Baba, Hideo Andreas
PMID: 17998146
Journal: J Cell Biochem. 2008 May 1;104(1):176-88.
Title: Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Author: Shirako, Erika|Hirayama, Naoki|Tsukada, Yu-ichi|Tanaka, Toshiaki|Kitamura, Naomi
PMID: 18004740
Journal: J Exp Med. 2008 Jan 21;205(1):91-103.
Title: Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
Author: Riehle, Kimberly J|Campbell, Jean S|McMahan, Ryan S|Johnson, Melissa M|Beyer, Richard P|Bammler, Theo K|Fausto, Nelson
PMID: 18158318
Journal: Cancer Lett. 2008 Apr 8;262(1):10-8.
Title: EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Author: Shimizu, Masahito|Shirakami, Yohei|Sakai, Hiroyasu|Tatebe, Hideharu|Nakagawa, Takayuki|Hara, Yukihiko|Weinstein, I Bernard|Moriwaki, Hisataka
PMID: 18164805
Journal: Langenbecks Arch Surg. 2008 May;393(3):333-41.
Title: Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model.
Author: Lang, Sven Arke|Brecht, Isabel|Moser, Christian|Obed, Aiman|Batt, David|Schlitt, Hans Juergen|Geissler, Edward Kenneth|Stoeltzing, Oliver
PMID: 18297306
Journal: Ann Hepatol. 2008 Jan-Mar;7(1):46-51.
Title: Sorafenib, a systemic therapy for hepatocellular carcinoma.
Author: Mendez-Sanchez, Nahum|Vasquez-Fernandez, Francisco|Zamora-Valdes, Daniel|Uribe, Misael
PMID: 18376365
Journal: Clin Cancer Res. 2008 May 1;14(9):2806-12.
Title: Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells.
Author: Tatebe, Hideharu|Shimizu, Masahito|Shirakami, Yohei|Tsurumi, Hisashi|Moriwaki, Hisataka
PMID: 18451248
Journal: J Surg Res. 2008 Dec;150(2):219-26.
Title: The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Author: Choi, Jennifer|Yip-Schneider, Michele|Albertin, Faith|Wiesenauer, Chad|Wang, Yufang|Schmidt, C Max
PMID: 18468633
Journal: Antivir Ther. 2008;13(2):221-30.
Title: Failure of lamivudine to reverse hepatitis B virus-associated changes in ERK, Akt and cell cycle regulatory proteins.
Author: Chin, Ruth|Earnest-Silveira, Linda|Koeberlein, Bernd|Franz, Susanne|Zentgraf, Hanswalter|Bowden, Scott|Bock, C-Thomas|Torresi, Joseph
PMID: 18505173
Journal: Apoptosis. 2008 Sep;13(9):1135-47.
Title: Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
Author: Tsang, Tsun Yee|Tang, Wan Yee|Tsang, Wing Pui|Co, Ngai Na|Kong, Siu Kai|Kwok, Tim Tak
PMID: 18651222
Journal: BMC Cancer. 2008 Jul 23;8:206.
Title: ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Author: Moser, Christian|Lang, Sven A|Mori, Akira|Hellerbrand, Claus|Schlitt, Hans J|Geissler, Edward K|Fogler, William E|Stoeltzing, Oliver
PMID: 18651980
Journal: Int J Cancer. 2008 Nov 1;123(9):2057-64.
Title: Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
Author: Calvisi, Diego F|Pinna, Federico|Pellegrino, Rossella|Sanna, Valeria|Sini, Marcella|Daino, Lucia|Simile, Maria M|De Miglio, Maria R|Frau, Maddalena|Tomasi, Maria L|Seddaiu, Maria A|Muroni, Maria R|Feo, Francesco|Pascale, Rosa M
PMID: 18697198
Journal: Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1269-77.
Title: Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
Author: Chaparro, M|Gonzalez Moreno, L|Trapero-Marugan, M|Medina, J|Moreno-Otero, R
PMID: 18808443
Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1684-7.
Title: [Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro].
Author: Chen, Feng-sheng|Cui, Yan-zhi|Luo, Rong-cheng|Wu, Jing|Zhang, Hua
PMID: 18819900
Journal: Tumori. 2008 Jul-Aug;94(4):523-30.
Title: Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma.
Author: Lee, Kyung Hee|Choi, Eun Young|Hyun, Myung Soo|Eun, Jong Ryul|Jang, Byung Ik|Kim, Tae Nyeun|Lee, Heon Ju|Lee, Dong Shik|Yun, Sung Su|Kim, Hong Jin|Kim, Jung Hye|Kim, Jae-Ryong
PMID: 18822689
Journal: Cancer Invest. 2008 Dec;26(10):977-83.
Title: Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Author: Jia, Li|Xu, Henggui|Zhao, Yongfu|Jiang, Lili|Yu, Jingda|Zhang, Jianing
PMID: 19093255
Journal: J Biol Chem. 2009 Jan 2;284(1):495-504.
Title: Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-alpha-induced hepatocyte survival.
Author: Haimerl, Florian|Erhardt, Annette|Sass, Gabriele|Tiegs, Gisa
PMID: 19001362
Journal: Mol Carcinog. 2009 Jun;48(6):553-62.
Title: Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.
Author: Huang, Xinqiang|Yang, Chaofeng|Jin, Chengliu|Luo, Yongde|Wang, Fen|McKeehan, Wallace L
PMID: 19009564
Journal: Int J Mol Med. 2009 Feb;23(2):189-96.
Title: Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line.
Author: Auyeung, Kathy Ka-wai|Law, Pui-ching|Ko, Joshua Ka-shun
PMID: 19148542
Journal: J Cell Mol Med. 2009 Aug;13(8B):2673-83.
Title: Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
Author: Huynh, Hung|Ngo, Van Chanh|Koong, Heng Nung|Poon, Donald|Choo, Su Pin|Thng, Choon Hua|Chow, Pierce|Ong, Hock Soo|Chung, Alexander|Soo, Khee Chee
PMID: 19220580
Journal: J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70.
Title: Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Author: Yip-Schneider, Michele T|Klein, Patrick J|Wentz, Sabrina C|Zeni, Amer|Menze, Alex|Schmidt, C Max
PMID: 19258520
Journal: Exp Mol Med. 2009 Mar 31;41(3):180-8.
Title: Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor.
Author: Lee, Kyung Hee|Kim, Jae Ryong
PMID: 19293637
Journal: J Hepatol. 2009 Jun;50(6):1112-21.
Title: Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.
Author: Lai, Jin-Ping|Sandhu, Dalbir S|Moser, Catherine D|Cazanave, Sophie C|Oseini, Abdul M|Shire, Abdirashid M|Shridhar, Viji|Sanderson, Schuyler O|Roberts, Lewis R
PMID: 19376607
Journal: World J Gastroenterol. 2009 Apr 28;15(16):1943-50.
Title: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
Author: Cui, Wei|Gu, Fan|Hu, Ke-Qin
PMID: 19399925
Journal: Nat Prod Res. 2009;23(8):704-18.
Title: Inhibitory effect of immature plum on PMA-induced MMP-9 expression in human hepatocellular carcinoma.
Author: Yu, Mi Hee|Gwon Im, Hyo|Gyu Lee, Sung|Kim, Dae-Ik|Jeong Seo, Hwa|Lee, In-Seon
PMID: 19418353
Journal: Int J Oncol. 2009 Jun;34(6):1749-57.
Title: Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells.
Author: Dai, Rongyang|Chen, Run|Li, Hong
PMID: 19424594
Journal: Exp Biol Med (Maywood). 2009 Jul;234(7):726-36.
Title: Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
Author: Feo, Francesco|Frau, Maddalena|Tomasi, Maria L|Brozzetti, Stefania|Pascale, Rosa M
PMID: 19429855
Journal: J Exp Clin Cancer Res. 2009 May 18;28:65.
Title: Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.
Author: Li, Qinglong|Yang, Zhulin
PMID: 19445727
Journal: IUBMB Life. 2009 Jun;61(6):685-92.
Title: Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathway.
Author: Song, Chunjiao|Wang, Weimin|Li, Meng|Liu, Yanxin|Zheng, Dexian
PMID: 19472191
Journal: J Proteome Res. 2009 Aug;8(8):3987-94.
Title: Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.
Author: Rignall, Benjamin|Ittrich, Carina|Krause, Eberhard|Appel, Klaus E|Buchmann, Albrecht|Schwarz, Michael
PMID: 19476384
Journal: Cancer Lett. 2009 Nov 28;285(2):210-7.
Title: Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
Author: Tatebe, Hideharu|Shimizu, Masahito|Shirakami, Yohei|Sakai, Hiroyasu|Yasuda, Yoichi|Tsurumi, Hisashi|Moriwaki, Hisataka
PMID: 19520494
Journal: Cancer Sci. 2009 Oct;100(10):1957-62.
Title: (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Author: Shirakami, Yohei|Shimizu, Masahito|Adachi, Seiji|Sakai, Hiroyasu|Nakagawa, Takayuki|Yasuda, Yoichi|Tsurumi, Hisashi|Hara, Yukihiko|Moriwaki, Hisataka
PMID: 19558547
Journal: Oncol Rep. 2009 Sep;22(3):599-604.
Title: Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.
Author: Ide, Yasushi|Zhang, Hao|Hamajima, Hiroshi|Kawaguchi, Yasunori|Eguchi, Yuichiro|Mizuta, Toshihiko|Yamamoto, Kyosuke|Fujimoto, Kazuma|Ozaki, Iwata
PMID: 19639210
Journal: BMC Med. 2009 Aug 24;7:41.
Title: Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study.
Author: Zhang, Zhe|Zhou, Xiaoyun|Shen, Hujia|Wang, Dexing|Wang, Yanhong
PMID: 19698189
Journal: Biomed Environ Sci. 2009 Jun;22(3):244-52.
Title: Role of prosurvival molecules in the action of lidamycin toward human tumor cells.
Author: Yang, A-Jing|Shi, Wei-Wei|Li, Yong|Wang, Zhen|Shao, Rong-Guang|Li, Dian-Dong|He, Qi-Yang
PMID: 19725468
Journal: Am J Chin Med. 2009;37(5):923-31.
Title: Rhein lysinate suppresses the growth of tumor cells and increases the anti-tumor activity of Taxol in mice.
Author: Lin, Ya-Jun|Zhen, Yong-Zhan|Shang, Bo-Yang|Zhen, Yong-Su
PMID: 19885952
Journal: Cancer Chemother Pharmacol. 2010 Apr;65(5):903-11.
Title: Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
Author: Roy, Karnati R|Reddy, Gorla V|Maitreyi, Leela|Agarwal, Smita|Achari, Chandrani|Vali, Shireen|Reddanna, Pallu
PMID: 19685055
Journal: Virus Res. 2010 Jan;147(1):7-16.
Title: Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus.
Author: Chin, Ruth|Nachbur, Ulrich|Earnest-Silveira, Linda|Bankovacki, Aleksandra|Koeberlein, Bernd|Zentgraf, Hanswalter|Bock, C-Thomas|Silke, John|Torresi, Joseph
PMID: 19786052
Journal: J Hepatol. 2010 Jan;52(1):79-87.
Title: AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
Author: Huynh, Hung|Ngo, Van Chanh|Koong, Heng Nung|Poon, Donald|Choo, Su Pin|Toh, Han Chong|Thng, Choon Hua|Chow, Pierce|Ong, Hock Soo|Chung, Alexander|Goh, Boon Cher|Smith, Paul D|Soo, Khee Chee
PMID: 19910069
Journal: Liver Int. 2010 Jan;30(1):31-41.
Title: Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.
Author: Sancho-Bru, Pau|Juez, Elena|Moreno, Montserrat|Khurdayan, Valeria|Morales-Ruiz, Manuel|Colmenero, Jordi|Arroyo, Vicente|Brenner, David A|Gines, Pere|Bataller, Ramon
PMID: 19929904
Journal: Expert Opin Investig Drugs. 2010 Feb;19(2):265-74.
Title: Targeted therapy of hepatocellular cancer.
Author: Wysocki, Piotr Jan
PMID: 20074016
Journal: Cancer. 2010 Mar 1;116(5):1315-25.
Title: AZD6244 (ARRY-142886) enhances the antitumor activity of rapamycin in mouse models of human hepatocellular carcinoma.
Author: Huynh, Hung
PMID: 20101735
Journal: Virol J. 2010 Feb 20;7:45.
Title: Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.
Author: Li, Weihua|Miao, Xiaohui|Qi, Zhongtian|Zeng, Wenting|Liang, Jianxin|Liang, Zengwei
PMID: 20170530
Journal: Mol Aspects Med. 2010 Apr;31(2):179-93.
Title: Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Author: Frau, Maddalena|Biasi, Fiorella|Feo, Francesco|Pascale, Rosa M
PMID: 20176048
Journal: Am J Transl Res. 2010 Jan 23;2(1):105-18.
Title: Molecular genetics of hepatocellular neoplasia.
Author: Jain, Shilpa|Singhal, Shashideep|Lee, Peng|Xu, Ruliang
PMID: 20182587
Journal: Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1106-10.
Title: Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.
Author: Ozenne, Violaine|Paradis, Valerie|Pernot, Simon|Castelnau, Corinne|Vullierme, Marie-Pierre|Bouattour, Mohamed|Valla, Dominique|Farges, Olivier|Degos, Francoise
PMID: 20300004
Journal: Cancer Sci. 2010 Jun;101(6):1501-10.
Title: Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.
Author: Deng, Ying-Bing|Nagae, Genta|Midorikawa, Yutaka|Yagi, Koichi|Tsutsumi, Shuichi|Yamamoto, Shogo|Hasegawa, Kiyoshi|Kokudo, Norihiro|Aburatani, Hiroyuki|Kaneda, Atsushi
PMID: 20345479
Journal: J Agric Food Chem. 2010 May 12;58(9):5806-14.
Title: Polyphenol-rich extracts from Solanum nigrum attenuated PKC alpha-mediated migration and invasion of hepatocellular carcinoma cells.
Author: Yang, Mon-Yuan|Hsu, Li-Sung|Peng, Chiung-Huei|Shi, Yuan-Shong|Wu, Cheng-Hsun|Wang, Chau-Jong
PMID: 20349911
Journal: Biochem Pharmacol. 2010 Sep 1;80(5):550-60.
Title: Molecularly targeted therapy in hepatocellular carcinoma.
Author: Huynh, Hung
PMID: 20371362
Journal: J Biol Inorg Chem. 2010 Sep;15(7):1087-97.
Title: Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species.
Author: Wang, Qin|Liu, Tong-Tong|Fu, Ying|Wang, Kui|Yang, Xiao-Gai
PMID: 20443032
Journal: J Biomed Sci. 2010 May 6;17:35.
Title: PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
Author: Chiang, Chao-Wei|Huang, Yi|Leong, Ka-Wai|Chen, Lih-Chyang|Chen, Hua-Chien|Chen, Shu-Jen|Chou, Chen-Kung
PMID: 20444294
Journal: Mol Cancer. 2010 Jun 12;9:146.
Title: Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
Author: Colak, Dilek|Chishti, Muhammad A|Al-Bakheet, Al-Bandary|Al-Qahtani, Ahmed|Shoukri, Mohamed M|Goyns, Malcolm H|Ozand, Pinar T|Quackenbush, John|Park, Ben H|Kaya, Namik
PMID: 20540791
Journal: Biol Chem. 2010 Jul;391(7):791-801.
Title: miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27(Kip1)- and MEK/ERK-mediated cell cycle regulation.
Author: Dai, Rongyang|Li, Juan|Liu, Youping|Yan, Dongmei|Chen, Shaokun|Duan, Chunyan|Liu, Xiaoyan|He, Tao|Li, Hong
PMID: 20624000
Journal: Biochemistry. 2010 Sep 14;49(36):7811-20.
Title: 3'-Sulfo-Le(x) is important for regulation of integrin subunit alphaV.
Author: Zhang, Chun-Yi|Hu, Ping|Fu, Da|Wu, Wei|Jia, Cheng-You|Zhu, Xu Chao|Wu, Xing Zhong
PMID: 20695481
Journal: J Hepatol. 2010 Nov;53(5):872-9.
Title: PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection.
Author: Xu, Yong-Feng|Yi, Yong|Qiu, Shuang-Jian|Gao, Qiang|Li, Yi-Wei|Dai, Chen-Xin|Cai, Ming-Yan|Ju, Min-Jie|Zhou, Jian|Zhang, Bo-Heng|Fan, Jia
PMID: 20739083
Journal: Neurosci Lett. 2010 Nov 5;484(3):210-4.
Title: Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells.
Author: Dong, Lin|Qi, Nan|Ge, Rui-Min|Cao, Cui-Li|Lan, Feng|Shen, Li
PMID: 20800650
Journal: Cytotechnology. 2010 Oct;62(5):449-60.
Title: Perifosine induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cell lines by blockade of Akt phosphorylation.
Author: Fei, Hong-Rong|Chen, Geng|Wang, Jian-Mei|Wang, Feng-Ze
PMID: 20842425
Journal: Eur J Pharmacol. 2010 Dec 15;649(1-3):74-83.
Title: C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Author: Nishanth, Reddy P|Ramakrishna, B S|Jyotsna, Radhika G|Roy, Karnati R|Reddy, Gorla V|Reddy, Pratap K|Reddanna, Pallu
PMID: 20858479
Journal: Cell Mol Biol (Noisy-le-grand). 2010 Sep 11;56 Suppl:OL1366-72.
Title: Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk /MAPK signaling pathway.
Author: Qin, X|Liu, C|Zhou, Y|Wang, G
PMID: 20937224
Journal: Anticancer Res. 2010 Dec;30(12):4951-8.
Title: PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
Author: Gedaly, Roberto|Angulo, Paul|Hundley, Jonathan|Daily, Michael F|Chen, Changguo|Koch, Alvaro|Evers, B Mark
PMID: 21187475
Journal: Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):909-14.
Title: [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
Author: Yan, Dong-mei|Dai, Rong-yang|Duan, Chun-yan|Chen, Shao-kun|Liu, You-ping|Chen, Chuan-ning|Li, Hong
PMID: 21205476
Journal: Oncol Res. 2010;19(2):67-76.
Title: Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
Author: Lee, Kyung Hee|Choi, Eun Young|Kim, Min Kyoung|Lee, Si Hyung|Jang, Byung Ik|Kim, Tae Nyeun|Kim, Se Won|Kim, Sang Woon|Song, Sun Kyo|Kim, Jae-Ryong|Jung, Bo Chan
PMID: 21302807
Journal: Exp Toxicol Pathol. 2011 Jan;63(1-2):167-73.
Title: Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
Author: Parekh, Palak|Motiwale, Leena|Naik, Nishigandha|Rao, K V K
PMID: 20133117
Journal: Cancer Gene Ther. 2011 Jan;18(1):20-5.
Title: Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism.
Author: Wu, J-B|Fu, H-Q|Huang, L-Z|Liu, A-W|Zhang, J-X
PMID: 20885449
Journal: Semin Cancer Biol. 2011 Feb;21(1):10-20.
Title: Mitogen-activated protein kinases in hepatocellular carcinoma development.
Author: Min, Lihua|He, Baokun|Hui, Lijian
PMID: 20969960
Journal: Cancer Prev Res (Phila). 2011 Jan;4(1):128-36.
Title: Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
Author: Shimizu, Masahito|Sakai, Hiroyasu|Shirakami, Yohei|Iwasa, Junpei|Yasuda, Yoichi|Kubota, Masaya|Takai, Koji|Tsurumi, Hisashi|Tanaka, Takuji|Moriwaki, Hisataka
PMID: 21071580
Journal: Int J Cancer. 2011 Sep 15;129(6):1519-31.
Title: Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma.
Author: Liu, Chaoyang|Gong, Ke|Mao, Xin|Li, Wenhua
PMID: 21128229
Journal: J Hepatol. 2011 May;54(5):939-47.
Title: Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Author: Um, Tae-Hee|Kim, Haeryoung|Oh, Bong-Kyeong|Kim, Myoung Soo|Kim, Kyung Sik|Jung, Guhung|Park, Young Nyun
PMID: 21145824
Journal: J Biol Chem. 2011 Feb 18;286(7):5913-20.
Title: Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.
Author: Jiang, Hua|Wang, Huamao|Tan, Zhonghua|Hu, Suwen|Wang, Hai|Shi, Bizhi|Yang, Lin|Li, Peiyong|Gu, Jianren|Wang, Hongyang|Li, Zonghai
PMID: 21163950
Journal: Cancer Biol Ther. 2011 Mar 1;11(5):524-34. Epub 2011 Mar 1.
Title: Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.
Author: Beljanski, Vladimir|Lewis, Clayton S|Smith, Charles D
PMID: 21258214
Journal: Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):48-51.
Title: [Relative analysis of OPN and its related signal molecules in hepatocellular carcinoma].
Author: Zhang, Lan|Li, Hai-yu|Yin, Xiao-lu|Xu, Yan-ping|Chen, Yi|Xie, Xiao-ying|Shen, Yue-fang|Ye, Qing-hai|Ren, Zheng-gang
PMID: 21272459
Journal: Hepatology. 2011 Feb;53(2):577-86.
Title: Effect of sorafenib on murine liver regeneration.
Author: Hora, Caroline|Romanque, Pamela|Dufour, Jean-Francois F
PMID: 21274878
Journal: Biochem Pharmacol. 2011 Apr 1;81(7):917-24.
Title: The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-beta-induced apoptosis of liver tumor cells.
Author: Sancho, Patricia|Fabregat, Isabel
PMID: 21276422
Journal: Cancer Prev Res (Phila). 2011 Mar;4(3):396-403.
Title: Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Author: Shimizu, Masahito|Sakai, Hiroyasu|Shirakami, Yohei|Yasuda, Yoichi|Kubota, Masaya|Terakura, Daishi|Baba, Atsushi|Ohno, Tomohiko|Hara, Yukihiko|Tanaka, Takuji|Moriwaki, Hisataka
PMID: 21372039
Journal: Hepatology. 2011 Jun;53(6):1932-42.
Title: RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
Author: Wang, Suihai|Huang, Xiang|Li, Yue|Lao, Haimiao|Zhang, Ying|Dong, Huimin|Xu, Weiwen|Li, Ji-Liang|Li, Ming
PMID: 21391225
Journal: Clin Sci (Lond). 2011 Aug;121(4):159-68.
Title: Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.
Author: Santamato, Angela|Fransvea, Emilia|Dituri, Francesco|Caligiuri, Alessandra|Quaranta, Michele|Niimi, Tomoaki|Pinzani, Massimo|Antonaci, Salvatore|Giannelli, Gianluigi
PMID: 21413933
Journal: Apoptosis. 2011 Jul;16(7):683-95.
Title: Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment.
Author: Zhang, Chris Z Y|Zhang, H T|Chen, George G|Lai, Paul B S
PMID: 21468663
Journal: BMC Cancer. 2011 Apr 22;11:150.
Title: Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Author: Xiao, Chun-Li|Tao, Zhong-Hua|Guo, Lin|Li, Wei-Wei|Wan, Jin-Liang|Sun, Hui-Chuan|Wang, Lu|Tang, Zhao-You|Fan, Jia|Wu, Wei-Zhong
PMID: 21513518
Journal: Mol Med Rep. 2011 Jul-Aug;4(4):719-22.
Title: Blockade of IGF-IR exerts anticancer effects in hepatocellular carcinoma.
Author: Yao, Wei-Feng|Liu, Jun-Wei|Sheng, Guo-Liang|Huang, Dong-Sheng
PMID: 21567089
Journal: Biochem Biophys Res Commun. 2011 Jun 17;409(4):752-7.
Title: ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways.
Author: Yang, Lifang|Ling, Yong|Zhang, Zhenzhen|Zhao, Qian|Tang, Jianxin|Ji, Hui|Zhang, Yihua
PMID: 21621522
Journal: Yakugaku Zasshi. 2011;131(6):993-1000.
Title: Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism.
Author: Wang, Ze-Jian|Song, Li|Guo, Lin-Chen|Yin, Min|Sun, Yong Ning
PMID: 21628989
Journal: J Agric Food Chem. 2011 Jul 13;59(13):7104-13.
Title: Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation.
Author: Huang, Guan-Jhong|Deng, Jeng-Shyan|Huang, Shyh-Shyun|Hu, Miao-Lin
PMID: 21630638
Journal: J Gen Virol. 2011 Oct;92(Pt 10):2237-48.
Title: Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assembly.
Author: Pei, Rongjuan|Chen, Honghe|Lu, Lu|Zhu, Wandi|Beckebaum, Susanne|Cicinnati, Vito|Lu, Mengji|Chen, Xinwen
PMID: 21653755
Journal: Cancer Gene Ther. 2011 Jul;18(7):520-30.
Title: DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma.
Author: Singhal, G|Akhter, M Z|Stern, D F|Gupta, S D|Ahuja, A|Sharma, U|Jagannathan, N R|Rajeswari, M R
PMID: 21660063
Journal: Biochem Biophys Res Commun. 2011 Jul 15;410(4):803-8.
Title: Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism.
Author: Ma, Xiao-Ni|Liu, Xiao-Yun|Yang, Yue-Feng|Xiao, Feng-Jun|Li, Qing-Fang|Yan, Jun|Zhang, Qun-Wei|Wang, Li-Sheng|Li, Xue-Yan|Wang, Hua
PMID: 21703232
Journal: J Pineal Res. 2011 Nov;51(4):463-71.
Title: Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.
Author: Carbajo-Pescador, Sara|Garcia-Palomo, Andres|Martin-Renedo, Javier|Piva, Maiara|Gonzalez-Gallego, Javier|Mauriz, Jose L
PMID: 21718361
Journal: Dis Model Mech. 2011 Nov;4(6):801-13.
Title: A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Author: Nguyen, Anh Tuan|Emelyanov, Alexander|Koh, Chor Hui Vivien|Spitsbergen, Jan M|Lam, Siew Hong|Mathavan, Sinnakaruppan|Parinov, Serguei|Gong, Zhiyuan
PMID: 21729876
Journal: J Cell Biochem. 2011 Nov;112(11):3430-9.
Title: Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
Author: Matsushima-Nishiwaki, Rie|Adachi, Seiji|Yoshioka, Takashi|Yasuda, Eisuke|Yamagishi, Yasumasa|Matsuura, Junya|Muko, Masato|Iwamura, Rutsu|Noda, Takahiro|Toyoda, Hidenori|Kaneoka, Yuji|Okano, Yukio|Kumada, Takashi|Kozawa, Osamu
PMID: 21769911
Journal: J Agric Food Chem. 2011 Aug 24;59(16):9032-8.
Title: Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways.
Author: Ma, Chia-Yu|Ji, Wei-Ting|Chueh, Fu-Shin|Yang, Jai-Sing|Chen, Po-Yuan|Yu, Chien-Chih|Chung, Jing-Gung
PMID: 21770460
Journal: Alcohol Clin Exp Res. 2011 Dec;35(12):2216-25.
Title: Alcohol induces liver neoplasia in a novel alcohol-preferring rat model.
Author: Yip-Schneider, Michele T|Doyle, Courtney J|McKillop, Iain H|Wentz, Sabrina C|Brandon-Warner, Elizabeth|Matos, Jesus M|Sandrasegaran, Kumaresan|Saxena, Romil|Hennig, Matthew E|Wu, Huangbing|Waters, Joshua A|Klein, Patrick J|Froehlich, Janice C|Schmidt, C M
PMID: 21790668
Journal: Med Chem. 2011 Sep;7(5):432-42.
Title: Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
Author: Achari, Chandrani|Reddy, Gorla V|Reddy, T C M|Reddanna, Pallu
PMID: 21801152
Journal: Exp Mol Pathol. 2011 Dec;91(3):653-9.
Title: The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.
Author: French, S W|Bardag-Gorce, F|French, B A|Li, J|Oliva, J
PMID: 21820428
Journal: PLoS One. 2011;6(8):e21980.
Title: Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.
Author: Zhao, Xiangxuan|Ogunwobi, Olorunseun O|Liu, Chen
PMID: 21829603
Journal: Clin Exp Metastasis. 2011 Dec;28(8):851-63.
Title: Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.
Author: Hu, Chi-Tan|Wu, Jia-Ru|Cheng, Chuan-Chu|Wang, Sindy|Wang, Hsiao-Ting|Lee, Ming-Che|Wang, Ling-Jung|Pan, Siou-Mei|Chang, Tsu-Yao|Wu, Wen-Sheng
PMID: 21842414
Journal: Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):358-62.
Title: [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Author: Wu, Xiao-hui|Wang, Shun-xiang|Yang, Yong-jiang|Li, Jian-kun|Xu, Zhuo|Tang, Rui-feng
PMID: 21875465
Journal: Immunol Lett. 2011 Dec 30;141(1):74-82.
Title: Effective inhibition of a Strongylocentrotus nudus eggs polysaccharide against hepatocellular carcinoma is mediated via immunoregulation in vivo.
Author: Wang, Mengyu|Wang, Hui|Tang, Ying|Kang, Di|Gao, Yu|Ke, Mengyun|Dou, Jie|Xi, Tao|Zhou, Changlin
PMID: 21893096
Journal: J Immunol. 2011 Nov 1;187(9):4844-60.
Title: Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2.
Author: Yu, Yi|Gong, Rui|Mu, Yongxin|Chen, Yanni|Zhu, Chengliang|Sun, Zhichen|Chen, Mingzhou|Liu, Yingle|Zhu, Ying|Wu, Jianguo
PMID: 21957142
Journal: For Immunopathol Dis Therap. 2011;2(2):195-204.
Title: Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.
Author: Walker, Evan J|Rosenberg, Stephen A|Wands, Jack R|Kim, Miran
PMID: 21984963
Journal: Cancer Cell Int. 2011 Nov 17;11:40.
Title: Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro.
Author: Hoffmann, Katrin|Xiao, Zhi|Franz, Clemens|Mohr, Elvira|Serba, Susanne|Buchler, Markus W|Schemmer, Peter
PMID: 22088142
Journal: Anticancer Res. 2011 Nov;31(11):3883-90.
Title: Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Author: Hoffmann, Katrin|Shibo, Lin|Xiao, Zhi|Longerich, Thomas|Buchler, Markus W|Schemmer, Peter
PMID: 22110214
Journal: J Korean Med Sci. 2011 Dec;26(12):1563-8.
Title: Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways.
Author: Kim, Heesue|Lim, Ho Yeong
PMID: 22147992
Journal: PLoS One. 2011;6(12):e28977.
Title: Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells.
Author: Hung, Jui-Hsiang|Teng, Yen-Ni|Wang, Lily Hui-Ching|Su, Ih-Jen|Wang, Clay C C|Huang, Wenya|Lee, Kuan-Han|Lu, Kuan-Ying|Wang, Lyu-Han
PMID: 22216150
Journal: J Cell Mol Med. 2012 Mar;16(3):496-506.
Title: Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-alpha in human hepatocellular carcinoma cells.
Author: Wang, Yaohui|Wang, Weimin|Wang, Lingyan|Wang, Xiangdong|Xia, Jinglin
PMID: 21545687
Journal: Mol Biol Rep. 2012 Feb;39(2):1683-9.
Title: Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.
Author: Gao, Yang|Li, Hua-Xing|Xu, Li-Tao|Wang, Peng|Xu, Li-Yan|Cohen, Lorenzo|Yang, Pei-Ying|Gu, Ke|Meng, Zhi-Qiang
PMID: 21617941
Journal: J Hepatol. 2012 Feb;56(2):419-25.
Title: Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish.
Author: Li, Zhen|Huang, Xiaoqian|Zhan, Huiqing|Zeng, Zhiqiang|Li, Caixia|Spitsbergen, Jan M|Meierjohann, Svenja|Schartl, Manfred|Gong, Zhiyuan
PMID: 21888874
Journal: Dis Model Mech. 2012 Jan;5(1):63-72.
Title: An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
Author: Nguyen, Anh Tuan|Emelyanov, Alexander|Koh, Chor Hui Vivien|Spitsbergen, Jan M|Parinov, Serguei|Gong, Zhiyuan
PMID: 21903676
Journal: Exp Mol Pathol. 2012 Feb;92(1):74-81.
Title: BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
Author: Maegdefrau, Ulrike|Bosserhoff, Anja-Katrin
PMID: 22024355
Journal: J Surg Res. 2012 Aug;176(2):542-8.
Title: PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
Author: Gedaly, Roberto|Angulo, Paul|Hundley, Jonathan|Daily, Michael F|Chen, Changguo|Evers, B Mark
PMID: 22261591
Journal: Eur J Pharmacol. 2012 Mar 15;679(1-3):24-33.
Title: Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.
Author: Yoon, Ji-Hae|Choi, Yeo-Jin|Lee, Seong-Gene
PMID: 22314224
Journal: Int J Mol Med. 2012 May;29(5):855-63.
Title: Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
Author: Yan, Meng-Yi|Chien, Su-Yu|Kuo, Shou-Jen|Chen, Dar-Ren|Su, Chin-Cheng
PMID: 22322382
Journal: Phytomedicine. 2012 May 15;19(7):603-8.
Title: Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells.
Author: Lou, Lianqing|Ye, Weiwei|Chen, Yongxin|Wu, Shuang|Jin, Linzheng|He, Jinke|Tao, Xingfei|Zhu, Jinghong|Chen, Xiangyi|Deng, Anmei|Wang, Jinhe
PMID: 22349030
Journal: J Hepatol. 2012 Jul;57(1):77-83.
Title: Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway.
Author: Takeishi, Kazuki|Taketomi, Akinobu|Shirabe, Ken|Toshima, Takeo|Motomura, Takashi|Ikegami, Toru|Yoshizumi, Tomoharu|Sakane, Fumio|Maehara, Yoshihiko
PMID: 22425622
Journal: PLoS One. 2012;7(3):e33379.
Title: Activation of PI3K/AKT and MAPK pathway through a PDGFRbeta-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma.
Author: Li, Quan-Lin|Gu, Fang-Ming|Wang, Zheng|Jiang, Jia-Hao|Yao, Li-Qing|Tan, Chang-Jun|Huang, Xiao-Yong|Ke, Ai-Wu|Dai, Zhi|Fan, Jia|Zhou, Jian
PMID: 22428038
Journal: Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):177-84.
Title: Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma.
Author: Song, Kang|Gao, Qiang|Zhou, Jian|Qiu, Shuang-Jian|Huang, Xiao-Wu|Wang, Xiao-Ying|Fan, Jia
PMID: 22484587
Journal: Int J Biochem Cell Biol. 2012 Aug;44(8):1351-60.
Title: In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
Author: Fang, Evandro Fei|Zhang, Chris Zhi Yi|Zhang, Lin|Fong, Wing Ping|Ng, Tzi Bun
PMID: 22554586
Journal: Apoptosis. 2012 Aug;17(8):784-96.
Title: Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress.
Author: Kim, Kiyoon|Kim, Hunsung|Jeong, Kwon|Jung, Min Hyung|Hahn, Bum-Soo|Yoon, Kyung-Sik|Jin, Byung Kwan|Jahng, Geon-Ho|Kang, Insug|Ha, Joohun|Choe, Wonchae
PMID: 22555451
Journal: Cancer Lett. 2012 Oct 28;323(2):215-22.
Title: Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand.
Author: Ohno, Tomohiko|Shirakami, Yohei|Shimizu, Masahito|Kubota, Masaya|Sakai, Hiroyasu|Yasuda, Yoichi|Kochi, Takahiro|Tsurumi, Hisashi|Moriwaki, Hisataka
PMID: 22579649
Journal: Free Radic Biol Med. 2012 Jul 1;53(1):1-11.
Title: Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells.
Author: Shearn, Colin T|Reigan, Philip|Petersen, Dennis R
PMID: 22580126
Journal: EMBO Mol Med. 2012 Aug;4(8):743-60.
Title: DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
Author: Hager, Martin H|Morley, Samantha|Bielenberg, Diane R|Gao, Sizhen|Morello, Matteo|Holcomb, Ilona N|Liu, Wennuan|Mouneimne, Ghassan|Demichelis, Francesca|Kim, Jayoung|Solomon, Keith R|Adam, Rosalyn M|Isaacs, William B|Higgs, Henry N|Vessella, Robert L|Di Vi
PMID: 22593025
Journal: Br J Cancer. 2012 Jun 5;106(12):1997-2003.
Title: Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Author: Hagiwara, S|Kudo, M|Nagai, T|Inoue, T|Ueshima, K|Nishida, N|Watanabe, T|Sakurai, T
PMID: 22596232
Journal: Chin Med J (Engl). 2012 Mar;125(6):1095-103.
Title: Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1alpha.
Author: Zhu, Hong|Luo, Shun-feng|Wang, Ji|Li, Xin|Wang, Hui|Pu, Wang-yang|Zhang, Hong|Zhuang, Zhi-xiang
PMID: 22613537
Journal: Oncol Rep. 2012 Aug;28(2):511-8.
Title: DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
Author: El-Sitt, Sally|Khalil, Bassem D|Hanna, Samer|El-Sabban, Marwan|Fakhreddine, Najla|El-Sibai, Mirvat
PMID: 22614672
Journal: Braz J Med Biol Res. 2012 Aug;45(8):721-9. Epub 2012 May 24.
Title: Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation.
Author: Ionta, M|Rosa, M C|Almeida, R B|Freitas, V M|Rezende-Teixeira, P|Machado-Santelli, G M
PMID: 22618858
Journal: Biochem Biophys Res Commun. 2012 Jun 15;422(4):687-92.
Title: Combined anti-tumor effects of IFN-alpha and sorafenib on hepatocellular carcinoma in vitro and in vivo.
Author: Wang, Lijing|Jia, Dongwei|Duan, Fangfang|Sun, Zhichao|Liu, Xiaojuan|Zhou, Lei|Sun, Linlin|Ren, Shifang|Ruan, Yuanyuan|Gu, Jianxin
PMID: 22634008
Journal: J Hepatol. 2012 Sep;57(3):592-9.
Title: Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Author: Sieghart, Wolfgang|Pinter, Matthias|Dauser, Bernhard|Rohr-Udilova, Natalya|Piguet, Anne-Christine|Prager, Gerald|Hayden, Hubert|Dienes, Hans-Peter|Dufour, Jean-Francois|Peck-Radosavljevic, Markus
PMID: 22634341
Journal: Int J Oncol. 2012 Sep;41(3):969-78.
Title: Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
Author: Liang, Rong-Rui|Zhang, Shu|Qi, Jun-An|Wang, Zhi-Dong|Li, Jun|Liu, Pei-Jun|Huang, Chen|Le, Xiao-Feng|Yang, Jun|Li, Zong-Fang
PMID: 22684543
Journal: Gastroenterology. 2012 Sep;143(3):787-798.e13.
Title: Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.
Author: Martinez-Lopez, Nuria|Garcia-Rodriguez, Juan L|Varela-Rey, Marta|Gutierrez, Virginia|Fernandez-Ramos, David|Beraza, Naiara|Aransay, Ana M|Schlangen, Karin|Lozano, Juan Jose|Aspichueta, Patricia|Luka, Zigmund|Wagner, Conrad|Evert, Matthias|Calvisi, Diego F
PMID: 22687285
Journal: Anticancer Res. 2012 Jul;32(7):2531-6.
Title: The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.
Author: Gedaly, Roberto|Angulo, Paul|Chen, Changguo|Creasy, Kate Townsend|Spear, Brett T|Hundley, Jonathan|Daily, Michael F|Shah, Malay|Evers, B Mark
PMID: 22753710
Journal: PLoS One. 2012;7(6):e39870.
Title: Histone deacetylase inhibitors facilitate dihydroartemisinin-induced apoptosis in liver cancer in vitro and in vivo.
Author: Zhang, Chris Zhiyi|Pan, Yinghua|Cao, Yun|Lai, Paul B S|Liu, Lili|Chen, George Gong|Yun, Jingping
PMID: 22761917
Journal: Asian Pac J Cancer Prev. 2012;13(4):1183-6.
Title: Effect of insulin-like growth factor-1 on bone morphogenetic protein-2 expression in hepatic carcinoma SMMC7721 cells through the p38 MAPK signaling pathway.
Author: Xu, Guan-Jun|Cai, Sheng|Wu, Jian-Bing
PMID: 22799302
Journal: Asian Pac J Cancer Prev. 2012;13(4):1457-61.
Title: HGFK1 is associated with a better prognosis and reverses inhibition by gefitinib in NSCLC cases.
Author: Zhou, Xiao-Hui|Tang, Li-Na|Yue, Lu|Min, Da-Liu|Yang, Yi|Huang, Jian-An|Shen, Zan
PMID: 22799348
Journal: Mar Drugs. 2012 Jun;10(6):1345-59.
Title: SD118-xanthocillin X (1), a novel marine agent extracted from Penicillium commune, induces autophagy through the inhibition of the MEK/ERK pathway.
Author: Zhao, Ying|Chen, Huan|Shang, Zhuo|Jiao, Binghua|Yuan, Bin|Sun, Weizhang|Wang, Bingui|Miao, Mingyong|Huang, Caiguo
PMID: 22822377
Journal: J Biol Chem. 2012 Oct 12;287(42):35576-88.
Title: Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.
Author: Gong, Ke|Chen, Chao|Zhan, Yao|Chen, Yan|Huang, Zebo|Li, Wenhua
PMID: 22927446
Journal: Int J Biochem Cell Biol. 2012 Dec;44(12):2212-22.
Title: CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability.
Author: Liu, Wen-Hsin|Chen, Yeh-Long|Chang, Long-Sen
PMID: 22964005
Journal: Anticancer Res. 2012 Nov;32(11):4865-70.
Title: Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma.
Author: Shao, Yu-Yun|Chen, Chi-Long|Ho, Ming-Chih|Huang, Chien-Chung|Tu, Hui-Ching|Hsu, Chih-Hung|Cheng, Ann-Lii
PMID: 23155253
Journal: PLoS One. 2012;7(12):e51916.
Title: The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway.
Author: Lin, Chan-Chan|Zhou, Jing-Ping|Liu, Yun-Peng|Liu, Jing-Jing|Yang, Xiao-Ning|Jazag, Amarsanaa|Zhang, Zhi-Ping|Guleng, Bayasi|Ren, Jian-Lin
PMID: 23300578
Journal: Biochim Biophys Acta. 2012 Aug;1826(1):215-37.
Title: Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison.
Author: Calvisi, Diego F|Frau, Maddalena|Tomasi, Maria L|Feo, Francesco|Pascale, Rosa M
PMID: 23393659
Journal: Age (Dordr). 2013 Jun;35(3):719-32.
Title: Induction of cell proliferation in old rat liver can reset certain gene expression levels characteristic of old liver to those associated with young liver.
Author: Chishti, Muhammad A|Kaya, Namik|Binbakheet, Al-Bandary|Al-Mohanna, Falah|Goyns, Malcolm H|Colak, Dilek
PMID: 22477361
Journal: Gut. 2013 Mar;62(3):440-51.
Title: HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.
Author: Xiao, Qianyi|Qu, Kai|Wang, Chenji|Kong, Yahui|Liu, Chao|Jiang, Deke|Saiyin, Hexige|Jia, Fan|Ni, Canrong|Chen, Taoyang|Zhang, Yuanyuan|Zhang, Pingzhao|Qin, Wenxin|Sun, Qingwen|Wang, Hongyang|Yi, Qing|Liu, Jun|Huang, Haojie|Yu, Long
PMID: 22490522
Journal: J Nutr Biochem. 2013 Feb;24(2):496-504.
Title: The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
Author: Androutsopoulos, Vasilis P|Spandidos, Demetrios A
PMID: 22749133
Journal: J Cell Physiol. 2013 Feb;228(2):292-7.
Title: Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery.
Author: Carr, Brian I|Cavallini, Aldo|Lippolis, Catia|D'Alessandro, Rosalba|Messa, Caterina|Refolo, Maria G|Tafaro, Angela
PMID: 22777740
Journal: Curr Cancer Drug Targets. 2013 Mar;13(3):300-12.
Title: Targeting tyrosine kinase receptors in hepatocellular carcinoma.
Author: Muntane, Jordi|De la Rosa, Angel J|Docobo, Fernando|Garcia-Carbonero, Rocio|Padillo, Francisco J
PMID: 23016985
Journal: Carcinogenesis. 2013 Jan;34(1):38-47.
Title: MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
Author: Guegan, Jean-Philippe|Ezan, Frederic|Theret, Nathalie|Langouet, Sophie|Baffet, Georges
PMID: 23042098
Journal: Oncogene. 2013 Oct 10;32(41):4873-82.
Title: Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
Author: Suh, Y|Yoon, C-H|Kim, R-K|Lim, E-J|Oh, Y S|Hwang, S-G|An, S|Yoon, G|Gye, M C|Yi, J-M|Kim, M-J|Lee, S-J
PMID: 23160379
Journal: Int J Oncol. 2013 Feb;42(2):556-64.
Title: Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
Author: Tanahashi, Toshiyuki|Osada, Shinji|Yamada, Atsuko|Kato, Junko|Yawata, Kazunori|Mori, Ryutaro|Imai, Hisashi|Sasaki, Yoshiyuki|Saito, Shiro|Tanaka, Yoshihiro|Nonaka, Kenichi|Yoshida, Kazuhiro
PMID: 23229794
Journal: Cell Oncol (Dordr). 2013 Apr;36(2):121-9.
Title: Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells.
Author: Shu, Guoshun|Xie, Biao|Ren, Feng|Liu, Dong-cai|Zhou, Jiapeng|Li, Qinglong|Chen, Jinhui|Yuan, Lianwen|Zhou, Jianping
PMID: 23248036
Journal: Oncogene. 2013 Oct 10;32(41):4871-2.
Title: Claudin-1 as a promoter of EMT in hepatocellular carcinoma.
Author: Stebbing, J|Filipovic, A|Giamas, G
PMID: 23318416
Journal: Cancer Cell Int. 2013 Jan 15;13(1):3.
Title: MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma.
Author: Lin, Shibo|Hoffmann, Katrin|Xiao, Zhi|Jin, Nan|Galli, Uwe|Mohr, Elvira|Buchler, Markus W|Schemmer, Peter
PMID: 23320839
Journal: J Clin Invest. 2013 Feb;123(2):630-45.
Title: Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.
Author: Xu, Xiaojie|Fan, Zhongyi|Kang, Lei|Han, Juqiang|Jiang, Chengying|Zheng, Xiaofei|Zhu, Ziman|Jiao, Huabo|Lin, Jing|Jiang, Kai|Ding, Lihua|Zhang, Hao|Cheng, Long|Fu, Hanjiang|Song, Yi|Jiang, Ying|Liu, Jiahong|Wang, Rongfu|Du, Nan|Ye, Qinong
PMID: 23321675
Journal: PLoS One. 2013;8(1):e53992.
Title: Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.
Author: Ochoa-Callejero, Laura|Perez-Martinez, Laura|Rubio-Mediavilla, Susana|Oteo, Jose A|Martinez, Alfredo|Blanco, Jose R
PMID: 23326556
Journal: Cell Death Dis. 2013 Feb 7;4:e489.
Title: The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells.
Author: Cheng, P|Ni, Z|Dai, X|Wang, B|Ding, W|Rae Smith, A|Xu, L|Wu, D|He, F|Lian, J
PMID: 23392177
Journal: Mol Cell Proteomics. 2013 May;12(5):1335-49.
Title: Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma.
Author: Liu, Chia-Hung|Chen, Tzu-Chi|Chau, Gar-Yang|Jan, Yi-Hua|Chen, Chun-Houh|Hsu, Chun-Nan|Lin, Kuan-Ting|Juang, Yue-Li|Lu, Pei-Jung|Cheng, Hui-Chuan|Chen, Ming-Huang|Chang, Chia-Fen|Ting, Yu-Shan|Kao, Cheng-Yan|Hsiao, Michael|Huang, Chi-Ying F
PMID: 23397142
Journal: Hepatology. 2013 Jul;58(1):205-17.
Title: MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.
Author: Yang, Hao|Fang, Feng|Chang, Ruimin|Yang, Lianyue
PMID: 23401231
Journal: Carcinogenesis. 2013 Jun;34(6):1323-30.
Title: Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Author: Wang, Xin|Bai, Hua|Zhang, Xiaodi|Liu, Jiangzheng|Cao, Peipei|Liao, Nai|Zhang, Wei|Wang, Zhao|Hai, Chunxu
PMID: 23404993
Journal: PLoS One. 2013;8(2):e55945.
Title: Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.
Author: Zhang, Qiang-Bo|Sun, Hui-Chuan|Zhang, Ke-Zhi|Jia, Qing-An|Bu, Yang|Wang, Miao|Chai, Zong-Tao|Zhang, Quan-Bao|Wang, Wen-Quan|Kong, Ling-Qun|Zhu, Xiao-dong|Lu, Lu|Wu, Wei-Zhong|Wang, Lu|Tang, Zhao-You
PMID: 23409093
Journal: J Agric Food Chem. 2013 Mar 20;61(11):2811-9.
Title: P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.
Author: Chen, Li-Ching|Lee, Wen-Sen
PMID: 23448150
Journal: Ann Surg Oncol. 2013 Dec;20 Suppl 3:S517-26.
Title: PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Author: Katsura, Yoshiteru|Wada, Hiroshi|Murakami, Masahiro|Akita, Hirofumi|Hama, Naoki|Kawamoto, Koichi|Kobayashi, Shogo|Marubashi, Shigeru|Eguchi, Hidetoshi|Tanemura, Masahiro|Umeshita, Koji|Doki, Yuichiro|Mori, Masaki|Nagano, Hiroaki
PMID: 23508585
Journal: Phytomedicine. 2013 Jun 15;20(8-9):743-52.
Title: Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
Author: Shi, Ming-Der|Liao, Yi-Chen|Shih, Yuan-Wei|Tsai, Li-Yu
PMID: 23537747
Journal: Biochem Biophys Res Commun. 2013 Apr 26;434(1):35-41.
Title: The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells.
Author: Zhang, Caixia|He, Hongwei|Zhang, Hao|Yu, Dongke|Zhao, Wuli|Chen, Yi|Shao, Rongguang
PMID: 23545258
Journal: J Cancer Res Clin Oncol. 2013 Jul;139(7):1169-78.
Title: Microarray analyses reveal liver metastasis-related genes in metastatic colorectal cancer cell model.
Author: Chen, Qiang|Chen, Lei|Zhao, Ren|Yang, Xiao-dong|Imran, Khan|Xing, Chun-gen
PMID: 23563852
Journal: Metallomics. 2013 Jun;5(7):813-20.
Title: Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
Author: Liu, Jing-Cheng|Yu, You|Wang, Gang|Wang, Kui|Yang, Xiao-Gai
PMID: 23576171
Journal: Cancer Sci. 2013 Jul;104(7):844-55.
Title: Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.
Author: Svejda, Bernhard|Kidd, Mark|Timberlake, Andrew|Harry, Kathy|Kazberouk, Alexander|Schimmack, Simon|Lawrence, Ben|Pfragner, Roswitha|Modlin, Irvin M
PMID: 23578138
Journal: J Hepatol. 2013 Oct;59(4):830-41.
Title: Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Author: Frau, Maddalena|Feo, Francesco|Pascale, Rosa M
PMID: 23665184
Journal: BMC Cancer. 2013 May 30;13:267.
Title: Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.
Author: Chang, Alex Y|Wang, Miao
PMID: 23721490
Journal: Oncol Rep. 2013 Aug;30(2):986-92.
Title: MDA-7/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines.
Author: Huo, Wei|Li, Zhi-Min|Zhu, Xiao-Min|Bao, Yong-Ming|An, Li-Jia
PMID: 23722307
Journal: Cell Cycle. 2013 Jul 1;12(13):1999-2010.
Title: Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: implications for the treatment of human liver cancer.
Author: Wang, Chunmei|Cigliano, Antonio|Delogu, Salvatore|Armbruster, Julia|Dombrowski, Frank|Evert, Matthias|Chen, Xin|Calvisi, Diego F
PMID: 23759595
Journal: PLoS One. 2013 Jun 7;8(6):e65256.
Title: A feedback inhibition between miRNA-127 and TGFbeta/c-Jun cascade in HCC cell migration via MMP13.
Author: Yang, Zhihong|Zhang, Yuxia|Wang, Li
PMID: 23762330
Journal: Dig Dis Sci. 2013 Aug;58(8):2223-36.
Title: Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Author: Wang, Lili|Zhu, Rong|Huang, Zhiquan|Li, Haigang|Zhu, Hongguang
PMID: 23828139
Journal: Eur J Surg Oncol. 2013 Sep;39(9):974-80.
Title: Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib.
Author: Chen, D|Zhao, P|Li, S Q|Xiao, W K|Yin, X Y|Peng, B G|Liang, L J
PMID: 23845703
Journal: Pharm Biol. 2013 Dec;51(12):1508-14.
Title: Cleome arabica leaf extract has anticancer properties in human cancer cells.
Author: Tigrine, Chafia|Bulzomi, Pamela|Leone, Stefano|Bouriche, Hamama|Kameli, Abdelkarim|Marino, Maria
PMID: 23862683
Journal: PLoS One. 2013 Jul 17;8(7):e68981.
Title: Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells.
Author: Zhang, Yu-Qin|Xiao, Chuan-Xing|Lin, Bi-Yun|Shi, Ying|Liu, Yun-Peng|Liu, Jing-Jing|Guleng, Bayasi|Ren, Jian-Lin
PMID: 23874836
Journal: BMC Cancer. 2013 Jul 29;13:363.
Title: Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma.
Author: Deng, Lifen|Ren, Zhenggang|Jia, Qingan|Wu, Weizhong|Shen, Hujia|Wang, Yanhong
PMID: 23895220
Journal: Bioorg Med Chem. 2013 Sep 15;21(18):5694-706.
Title: Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor.
Author: Jin, Feng|Gao, Dan|Wu, Qin|Liu, Feng|Chen, Yuzong|Tan, Chunyan|Jiang, Yuyang
PMID: 23932071
Journal: Int J Biochem Cell Biol. 2013 Nov;45(11):2501-11.
Title: Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
Author: Castro-Sanchez, Luis|Agra, Noelia|Llorente Izquierdo, Cristina|Motino, Omar|Casado, Marta|Bosca, Lisardo|Martin-Sanz, Paloma
PMID: 23954207
Journal: Toxicol Appl Pharmacol. 2013 Nov 1;272(3):568-78.
Title: Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1.
Author: Hernandez-Breijo, Borja|Monserrat, Jorge|Roman, Irene D|Gonzalez-Rodriguez, Agueda|Fernandez-Moreno, Ma Dolores|Lobo, M Val T|Valverde, Angela M|Gisbert, Javier P|Guijarro, Luis G
PMID: 23958494
Journal: Cancer Biol Ther. 2013 Nov;14(11):1059-67.
Title: Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
Author: Ai, Xi|Wu, Yanhui|Zhang, Wei|Zhang, Zhanguo|Jin, Guannan|Zhao, Jianping|Yu, Jingjing|Lin, Youzhi|Zhang, Wanguang|Liang, Huifang|Datta, Pran K|Zhang, Mingzhi|Zhang, Bixiang|Chen, Xiaoping
PMID: 24025354
Journal: PLoS One. 2013 Sep 6;8(9):e72927.
Title: Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
Author: Chen, Kunlun|Zhang, Shu|Ji, Yuanyuan|Li, Jun|An, Peng|Ren, Hongtao|Liang, Rongrui|Yang, Jun|Li, Zongfang
PMID: 24039823
Journal: BMC Cancer. 2013 Oct 8;13:465.
Title: Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.
Author: Baba, Atsushi|Shimizu, Masahito|Ohno, Tomohiko|Shirakami, Yohei|Kubota, Masaya|Kochi, Takahiro|Terakura, Daishi|Tsurumi, Hisashi|Moriwaki, Hisataka
PMID: 24103747
Journal: J Clin Endocrinol Metab. 2013 Dec;98(12):E1909-17.
Title: Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Author: Yang, Qi|Ji, Meiju|Guan, Haixia|Shi, Bingyin|Hou, Peng
PMID: 24106286
Journal: BMC Cancer. 2013 Oct 10;13:468.
Title: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
Author: Yamaguchi, Fuminori|Hirata, Yuko|Akram, Hossain|Kamitori, Kazuyo|Dong, Youyi|Sui, Li|Tokuda, Masaaki
PMID: 24112473
Journal: PLoS One. 2013 Oct 9;8(10):e76951.
Title: Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.
Author: Lu, Jeng-Wei|Yang, Wan-Yu|Tsai, Su-Mei|Lin, Yueh-Min|Chang, Pen-Heng|Chen, Jim-Ray|Wang, Horng-Dar|Wu, Jen-Leih|Jin, Shiow-Lian Catherine|Yuh, Chiou-Hwa
PMID: 24130815
Journal: Acta Pharmacol Sin. 2013 Dec;34(12):1554-9.
Title: Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro.
Author: Wen, Wei-wei|Xie, Shao|Xin, Xian-liang|Geng, Mei-yu|Ding, Jian|Chen, Yi
PMID: 24141568
Journal: J Transl Med. 2013 Oct 29;11:273.
Title: Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.
Author: Dong, Shuying|Kong, Jian|Kong, Fandong|Kong, Jinge|Gao, Jun|Ke, Shan|Wang, Shaohong|Ding, Xuemei|Sun, Wenbing|Zheng, Lemin
PMID: 24168056
Journal: Mol Cancer Res. 2013 Nov;11(11):1437-47.
Title: ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Author: Li, Xiaoran|Bian, Ying|Takizawa, Yuri|Hashimoto, Tomio|Ikoma, Toshiyuki|Tanaka, Junzo|Kitamura, Naomi|Inagaki, Yutaka|Komada, Masayuki|Tanaka, Toshiaki
PMID: 24177224
Journal: Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;Suppl 59:OL1876-81.
Title: MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Author: Zhao, L Y|Zhang, J|Guo, B|Yang, J|Han, J|Zhao, X G|Wang, X F|Liu, L Y|Li, Z F|Song, T S|Huang, C
PMID: 24199952
Journal: Eur J Med Res. 2013 Dec 4;18:52.
Title: RNA interference targeting human integrin alpha6 suppresses the metastasis potential of hepatocellular carcinoma cells.
Author: Lv, Guannan|Lv, Tianjing|Qiao, Shifeng|Li, Wei|Gao, Weiran|Zhao, Xiaohui|Wang, Jikun
PMID: 24304619
Journal: Zhonghua Gan Zang Bing Za Zhi. 2013 Nov;21(11):845-9.
Title: [Anti-proliferation effect of sorafenib in combination with 5-FU for hepatocellular carcinoma in vitro: antagonistic performance and mechanism].
Author: Deng, Li-fen|Wang, Yan-hong|Jia, Qing-an|Ren, Zheng-gang|Shen, Hu-jia|Sun, Xiao-jing|Li, Jing-huan
PMID: 24331695
Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):39-43.
Title: Valproate activates ERK signaling pathway in primary human hepatocytes.
Author: Bitman, Michal|Vrzal, Radim|Dvorak, Zdenek|Pavek, Petr
PMID: 23073524
Journal: Oncogene. 2014 May 22;33(21):2717-27.
Title: Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
Author: Chew, T W|Liu, X J|Liu, L|Spitsbergen, J M|Gong, Z|Low, B C
PMID: 23812423
Journal: Hepatology. 2014 Mar;59(3):947-57.
Title: Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis.
Author: Chen, Wan-Ting|Tseng, Chun-Chih|Pfaffenbach, Kyle|Kanel, Gary|Luo, Biquan|Stiles, Bangyan L|Lee, Amy S
PMID: 24027047
Journal: Carcinogenesis. 2014 Feb;35(2):282-91.
Title: SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin alphavbeta6.
Author: Wang, Ben|Wang, Wenke|Niu, Weibo|Liu, Enyu|Liu, Xiangjuan|Wang, Jiayong|Peng, Cheng|Liu, Song|Xu, Ling|Wang, Lei|Niu, Jun
PMID: 24085800
Journal: Scand J Gastroenterol. 2014 Jan;49(1):99-108.
Title: The effect of hepatic progenitor cells on experimental hepatocellular carcinoma in the regenerating liver.
Author: Shi, Ji-Hua|Scholz, Hanne|Huitfeldt, Henrik S|Line, Pal-Dag
PMID: 24188385
Journal: J Cell Mol Med. 2014 Feb;18(2):218-30.
Title: The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
Author: Huang, Peixin|Xu, Xiaojing|Wang, Lingyan|Zhu, Bijun|Wang, Xiangdong|Xia, Jingling
PMID: 24268047
Journal: J Cell Mol Med. 2014 Jan;18(1):49-58.
Title: Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
Author: He, Lu|Zhou, Xinke|Qu, Chen|Hu, Lijuan|Tang, Yunqiang|Zhang, Qiong|Liang, Min|Hong, Jian
PMID: 24305552
Journal: Metallomics. 2014 Mar;6(3):518-31.
Title: Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
Author: Yang, Licong|Zhang, Jingnan|Wang, Chuan|Qin, Xiuying|Yu, Qianqian|Zhou, Yanhui|Liu, Jie
PMID: 24336978
Journal: Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5.
Title: Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis.
Author: Nakagawa, Hayato|Hikiba, Yohko|Hirata, Yoshihiro|Font-Burgada, Joan|Sakamoto, Kei|Hayakawa, Yoku|Taniguchi, Koji|Umemura, Atsushi|Kinoshita, Hiroto|Sakitani, Kosuke|Nishikawa, Yuji|Hirano, Kenji|Ikenoue, Tsuneo|Ijichi, Hideaki|Dhar, Debanjan|Shibata, Wata
PMID: 24395807
Journal: BMC Cancer. 2014 Jan 27;14:43.
Title: Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro.
Author: Carr, Brian I|Cavallini, Aldo|D'Alessandro, Rosalba|Refolo, Maria Grazia|Lippolis, Catia|Mazzocca, Antonio|Messa, Caterina
PMID: 24468103
Journal: Hepatology. 2014 Jun;59(6):2238-50.
Title: Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
Author: Bera, Rabindranath|Chiou, Chih-Yung|Yu, Ming-Chin|Peng, Jei-Ming|He, Chung-Ru|Hsu, Chih-Yun|Huang, Hsiao-Ling|Ho, Uda Y|Lin, Shi-Ming|Lin, Yu-Jr|Hsieh, Sen-Yung
PMID: 24470239
Journal: Molecules. 2014 Jan 27;19(2):1592-602.
Title: Resveratrol-4-O-D-(2'-galloyl)-glucopyranoside isolated from Polygonum cuspidatum exhibits anti-hepatocellular carcinoma viability by inducing apoptosis via the JNK and ERK pathway.
Author: Xie, Qichao|Yang, Yupeng|Wang, Zhiyi|Chen, Fanglin|Zhang, Anmei|Liu, Chengcheng
PMID: 24473215
Journal: Cell Signal. 2014 May;26(5):1030-9.
Title: Upregulation of HIF-2alpha induced by sorafenib contributes to the resistance by activating the TGF-alpha/EGFR pathway in hepatocellular carcinoma cells.
Author: Zhao, Dali|Zhai, Bo|He, Changjun|Tan, Gang|Jiang, Xian|Pan, Shangha|Dong, Xuesong|Wei, Zheng|Ma, Lixin|Qiao, Haiquan|Jiang, Hongchi|Sun, Xueying
PMID: 24486412
Journal: Clin Cancer Res. 2014 Mar 1;20(5):1274-1287.
Title: Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo.
Author: Chen, Chun-Han|Chen, Mei-Chuan|Wang, Jing-Chi|Tsai, An-Chi|Chen, Ching-Shih|Liou, Jing-Ping|Pan, Shiow-Lin|Teng, Che-Ming
PMID: 24520095
Journal: Mol Pharm. 2014 Apr 7;11(4):1282-93.
Title: Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway.
Author: Zhang, Yibo|Zheng, Shanyuan|Zheng, Jun-Sheng|Wong, Ka-Hing|Huang, Zhi|Ngai, Sai-Ming|Zheng, Wenjie|Wong, Yum-Shing|Chen, Tianfeng
PMID: 24555485
Journal: Oncol Rep. 2014 Apr;31(4):1669-76.
Title: Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Author: Zheng, Ying|Wang, Xuemei|Wang, Haidong|Yan, Wei|Zhang, Quan|Chang, Xin
PMID: 24573150
Journal: Clin Cancer Res. 2014 May 1;20(9):2410-23.
Title: BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
Author: Breunig, Christian|Mueller, Bernadett J|Umansky, Ludmila|Wahl, Kristin|Hoffmann, Katrin|Lehner, Frank|Manns, Michael P|Bantel, Heike|Falk, Christine S
PMID: 24573550
Journal: Int J Mol Sci. 2014 Feb 26;15(3):3507-18.
Title: HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways.
Author: Wang, Heng-Yi|Yang, Sheng-Li|Liang, Hui-Fang|Li, Chang-Hai
PMID: 24577313
Journal: Cell Signal. 2014 Jun;26(6):1347-54.
Title: MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.
Author: Zhou, Peng|Huang, Gang|Zhao, Yuanyin|Zhong, Dan|Xu, Zhizhen|Zeng, Yijun|Zhang, Yan|Li, Song|He, Fengtian
PMID: 24631531
Journal: Clin Cancer Res. 2014 May 15;20(10):2793-804.
Title: A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
Author: Tabernero, Josep|Elez, Maria Elena|Herranz, Maria|Rico, Isabel|Prudkin, Ludmila|Andreu, Jordi|Mateos, Jose|Carreras, Maria Josep|Han, May|Gifford, James|Credi, Marc|Yin, Wei|Agarwal, Shefali|Komarnitsky, Philip|Baselga, Jose
PMID: 24634378
Journal: Oncol Rep. 2014 May;31(5):2377-84.
Title: Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.
Author: Huang, Guihong|Tang, Bo|Tang, Kun|Dong, Xiaomin|Deng, Jungang|Liao, Luqin|Liao, Zengzhen|Yang, Hua|He, Songqing
PMID: 24676882
Journal: Int J Clin Exp Pathol. 2014 Feb 15;7(3):1085-92. eCollection 2014.
Title: RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cells.
Author: Li, Guang-Ming|Wang, Yu-Gang|Pan, Qin|Wang, Jun|Fan, Jian-Gao|Sun, Chao
PMID: 24696725
Journal: Chin Med J (Engl). 2014;127(7):1211-7.
Title: Higher intratumor than peritumor expression of DUSP6/MKP-3 is associated with recurrence after curative resection of hepatocellular carcinoma.
Author: Yang, Bo|Tan, Yunshan|Sun, Huichuan|Fan, Jia|Tang, Zhaoyou|Ji, Yuan
PMID: 24709168
Journal: Protein Cell. 2014 Jul;5(7):532-43.
Title: FXYD6: a novel therapeutic target toward hepatocellular carcinoma.
Author: Gao, Qian|Chen, Xiongfei|Duan, Hongxia|Wang, Zhaoqing|Feng, Jing|Yang, Dongling|Song, Lina|Zhou, Ningxin|Yan, Xiyun
PMID: 24715268
Journal: Asian Pac J Cancer Prev. 2014;15(6):2619-23.
Title: EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
Author: Yan, Feng|Bai, Li-Ping|Gao, Hua|Zhu, Chang-Ming|Lin, Li|Kang, Xiang-Peng
PMID: 24761873
Journal: Mol Cancer. 2014 Apr 30;13:98.
Title: The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.
Author: Wang, Bin|Ni, Zhenhong|Dai, Xufang|Qin, Liyan|Li, Xinzhe|Xu, Liang|Lian, Jiqin|He, Fengtian
PMID: 24779770
Journal: Biochimie. 2014 Aug;103:118-25.
Title: CCT128930 induces cell cycle arrest, DNA damage, and autophagy independent of Akt inhibition.
Author: Wang, Feng-Ze|Chang, Zheng-Yao|Fei, Hong-Rong|Yang, Ming-Feng|Yang, Xiao-Yi|Sun, Bao-Liang
PMID: 24793486
Journal: Oncotarget. 2014 May 15;5(9):2853-63.
Title: Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
Author: Fan, Cundong|Zheng, Wenjie|Fu, Xiaoyan|Li, Xiaoling|Wong, Yum-Shing|Chen, Tianfeng
PMID: 24797310
Journal: Int J Oncol. 2014 Jul;45(1):177-88.
Title: Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-kappaB signaling.
Author: Hsu, Fei-Ting|Liu, Yu-Chang|Chiang, I-Tsang|Liu, Ren-Shyan|Wang, Hsin-Ell|Lin, Wuu-Jyh|Hwang, Jeng-Jong
PMID: 24807012
Journal: Oncol Rep. 2014 Jul;32(1):411-8.
Title: Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
Author: Zheng, Datong|Hu, Zhenzhen|He, Fan|Gao, Caijie|Xu, Lijian|Zou, Han|Wu, Zhiwei|Jiang, Xiuqin|Wang, Jianjun
PMID: 24807674
Journal: Int J Oncol. 2014 Aug;45(2):629-40.
Title: MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.
Author: Lin, Zhen-Hai|Wang, Liying|Zhang, Ju-Bo|Liu, Yanfeng|Li, Xiao-Qiang|Guo, Lei|Zhang, Bo|Zhu, Wen-Wei|Ye, Qing-Hai
PMID: 24859810
Journal: BMC Cancer. 2014 May 21;14:351.
Title: Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.
Author: D'Alessandro, Rosalba|Refolo, Maria G|Lippolis, Catia|Giannuzzi, Grazia|Carella, Nicola|Messa, Caterina|Cavallini, Aldo|Carr, Brian I
PMID: 24885890
Journal: Eur J Pharmacol. 2014 Sep 5;738:142-52.
Title: Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma.
Author: Gong, Ke|Zhang, Zhenxing|Chen, Yicheng|Shu, Hong-Bing|Li, Wenhua
PMID: 24886888
Journal: Mol Med Rep. 2014 Aug;10(2):839-47.
Title: Activated deltaopioid receptors inhibit hydrogen peroxideinduced apoptosis in liver cancer cells through the PKC/ERK signaling pathway.
Author: Jia, Kaiqi|Sun, Deguang|Ling, Sunbin|Tian, Yu|Yang, Xuejun|Sui, Jidong|Tang, Bo|Wang, Liming
PMID: 24912447
Journal: Biomaterials. 2014 Aug;35(26):7479-87.
Title: Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
Author: Gopalan, Began|Narayanan, Karthikeyan|Ke, Zhiyuan|Lu, Ting|Zhang, Yugen|Zhuo, Lang
PMID: 24912819
Journal: FEBS Open Bio. 2014 Apr 1;4:353-61.
Title: Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFbeta signaling.
Author: Santhekadur, Prasanna K|Akiel, Maaged|Emdad, Luni|Gredler, Rachel|Srivastava, Jyoti|Rajasekaran, Devaraja|Robertson, Chadia L|Mukhopadhyay, Nitai D|Fisher, Paul B|Sarkar, Devanand
PMID: 24918049
Journal: Oncol Lett. 2014 Jul;8(1):17-24.
Title: High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
Author: Hua, Yong-Qiang|Chen, Zhen|Meng, Zhi-Qiang|Chen, Hao|Shen, Jian-Gang|Wang, Kun|Peng, Wang|Shen, Ye-Hua|Liu, Lu-Ming
PMID: 24959213
Journal: Mol Cancer. 2014 Jul 1;13:162.
Title: Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling.
Author: Chen, Cheng-Yi|Chung, I-Hsiao|Tsai, Ming-Ming|Tseng, Yi-Hsin|Chi, Hsiang-Cheng|Tsai, Chung-Ying|Lin, Yang-Hsiang|Wang, You-Ching|Chen, Chie-Pein|Wu, Tzu-I|Yeh, Chau-Ting|Tai, Dar-In|Lin, Kwang-Huei
PMID: 24980078
Journal: J Transl Med. 2014 Jul 4;12:190.
Title: Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
Author: Wu, Jiao|Hao, Zhi-Wei|Zhao, You-Xu|Yang, Xiang-Min|Tang, Hao|Zhang, Xin|Song, Fei|Sun, Xiu-Xuan|Wang, Bin|Nan, Gang|Chen, Zhi-Nan|Bian, Huijie
PMID: 24996644
Journal: Zhongguo Zhong Yao Za Zhi. 2014 Apr;39(7):1276-9.
Title: [Role of ERK/FoxO3a signal axis in inhibitory effect of vitexin 1 (VB-1) in HepG2 cell proliferation].
Author: Zheng, Xing-Xing|Zhang, Ren-Shuo|Zhou, Ying-Jun|Wang, Jian-Gang
PMID: 25011268
Journal: Int J Biol Sci. 2014 Jun 10;10(7):664-76.
Title: Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.
Author: Xu, Wei-Hua|Zhang, Jian-Bin|Dang, Zheng|Li, Xiao|Zhou, Ti|Liu, Jie|Wang, De-Sheng|Song, Wen-Jie|Dou, Ke-Feng
PMID: 25013376
Journal: Oncotarget. 2014 Jul 30;5(14):5570-80.
Title: Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
Author: Huang, Xiao-Hui|Jian, Wei-Hua|Wu, Zhao-Feng|Zhao, Jie|Wang, Hua|Li, Wen|Xia, Jin-Tang
PMID: 25015194
Journal: J Biol Chem. 2014 Aug 29;289(35):24665-79.
Title: A mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-dependent transcriptional program controls activation of the early growth response 1 (EGR1) gene during amino acid limitation.
Author: Shan, Jixiu|Balasubramanian, Mukundh N|Donelan, William|Fu, Lingchen|Hayner, Jaclyn|Lopez, Maria-Cecilia|Baker, Henry V|Kilberg, Michael S
PMID: 25028509
Journal: Oncotarget. 2014 Jul 30;5(14):5819-31.
Title: Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.
Author: Wei, Wei|Wu, Song|Wang, Xiaolin|Sun, Chris Kin-Wai|Yang, Xiaoyang|Yan, Xinrui|Chua, Mei-Sze|So, Samuel
PMID: 25051375
Journal: PLoS One. 2014 Jul 31;9(7):e103828.
Title: Endoplasmic reticulum stress activates the hepatic activator protein 1 complex via mitogen activated protein kinase-dependent signaling pathways.
Author: Olivares, Shantel|Green, Richard M|Henkel, Anne S
PMID: 25077945
Journal: BMC Cancer. 2014 Aug 1;14:556.
Title: Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR/G-protein signaling.
Author: Tsai, Cheng-Fang|Hsieh, Tsung-Hua|Lee, Jau-Nan|Hsu, Chia-Yi|Wang, Yu-Chih|Lai, Feng-Jie|Kuo, Kung-Kai|Wu, Hua-Lin|Tsai, Eing-Mei|Kuo, Po-Lin
PMID: 25081364
Journal: Tumour Biol. 2014 Nov;35(11):11005-11.
Title: Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma.
Author: Wang, Jiajun|Su, Hongying|Han, Xiangjun|Xu, Ke
PMID: 25091573
Journal: Cancer Res. 2014 Aug 15;74(16):4364-77.
Title: AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.
Author: Srivastava, Jyoti|Robertson, Chadia L|Rajasekaran, Devaraja|Gredler, Rachel|Siddiq, Ayesha|Emdad, Luni|Mukhopadhyay, Nitai D|Ghosh, Shobha|Hylemon, Phillip B|Gil, Gregorio|Shah, Khalid|Bhere, Deepak|Subler, Mark A|Windle, Jolene J|Fisher, Paul B|Sarkar, D
PMID: 25125681
Journal: Am J Physiol Gastrointest Liver Physiol. 2014 Oct 1;307(7):G749-59.
Title: PDGF receptor-alpha promotes TGF-beta signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-beta receptors.
Author: Liu, Chunsheng|Li, Jiachu|Xiang, Xiaoyu|Guo, Luyang|Tu, Kangsheng|Liu, Qinghua|Shah, Vijay H|Kang, Ningling
PMID: 25169976
Journal: Cancer Res. 2014 Nov 1;74(21):6184-93.
Title: Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
Author: Robertson, Chadia L|Srivastava, Jyoti|Siddiq, Ayesha|Gredler, Rachel|Emdad, Luni|Rajasekaran, Devaraja|Akiel, Maaged|Shen, Xue-Ning|Guo, Chunqing|Giashuddin, Shah|Wang, Xiang-Yang|Ghosh, Shobha|Subler, Mark A|Windle, Jolene J|Fisher, Paul B|Sarkar, Devana
PMID: 25193383
Journal: Yao Xue Xue Bao. 2014 Jun;49(6):861-8.
Title: [Anti-tumor activity and mechanism of T03 in vitro and in vivo].
Author: Tang, Ke|Yang, Han-Ze|Li, Yan|Tian, Kang|Li, Chao|Zhou, Wan-Qi|Niu, Fei|Feng, Zhi-Qiang|Chen, Xiao-Guang
PMID: 25212033
Journal: Nat Med. 2014 Oct;20(10):1138-46.
Title: In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.
Author: Rudalska, Ramona|Dauch, Daniel|Longerich, Thomas|McJunkin, Katherine|Wuestefeld, Torsten|Kang, Tae-Won|Hohmeyer, Anja|Pesic, Marina|Leibold, Josef|von Thun, Anne|Schirmacher, Peter|Zuber, Johannes|Weiss, Karl-Heinz|Powers, Scott|Malek, Nisar P|Eilers, Mar
PMID: 25216638
Journal: Mol Cancer. 2014 Sep 14;13:216.
Title: Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinoma.
Author: Xu, Gang|Yang, Fang|Ding, Cui-Ling|Zhao, Lan-Juan|Ren, Hao|Zhao, Ping|Wang, Wen|Qi, Zhong-Tian
PMID: 25217841
Journal: Biochem Biophys Res Commun. 2014 Sep 26;452(3):801-7.
Title: Activation of RAS/ERK alone is insufficient to inhibit RXRalpha function and deplete retinoic acid in hepatocytes.
Author: Wang, Ai-Guo|Song, Ya-Nan|Chen, Jun|Li, Hui-Ling|Dong, Jian-Yi|Cui, Hai-Peng|Yao, Liang|Li, Xue-Feng|Gao, Wen-Ting|Qiu, Ze-Wen|Wang, Fu-Jin|Wang, Jing-Yu
PMID: 25218146
Journal: Neoplasia. 2014 Aug;16(8):617-26.
Title: Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
Author: Chen, Wan-Ting|Ha, Dat|Kanel, Gary|Lee, Amy S
PMID: 25220589
Journal: Oncol Lett. 2014 Nov;8(5):2333-2339.
Title: Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity.
Author: Chen, Siyuan|Wang, Yali|Ruan, Wenwen|Wang, Xiaomin|Pan, Chao
PMID: 25295120
Journal: Oncol Rep. 2014 Dec;32(6):2687-95.
Title: Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
Author: Wu, Hong Ge|Zhang, Wen Jie|Ding, Qian|Peng, Gang|Zou, Zhen Wei|Liu, Ting|Cao, Ru Bo|Fei, Shi Jiang|Li, Peng Cheng|Yang, Kun Yu|Hu, Jian Li|Dai, Xiang Fang|Wu, Gang|Li, Pin Dong
PMID: 25310770
Journal: Environ Toxicol Pharmacol. 2014 Nov;38(3):959-67.
Title: Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Author: Jayasooriya, Rajapaksha Gedara Prasad Tharanga|Choi, Yung Hyun|Hyun, Jin Won|Kim, Gi-Young
PMID: 25461556
Journal: Zhong Yao Cai. 2014 Nov;37(11):1938-46.
Title: [Study on synergistic effect of sodium cantharidinate combined with chemotherapeutic drugs on hepatic carcinoma and its effective mechanism].
Author: Zhao, Ruo-lin|Chen, Mei-juan|Zhao, Feng-ming|Xu, Dong-qing|Zhang, Xu|Zhou, Kun-fu
PMID: 26027111
Journal: J Viral Hepat. 2015 Feb;22(2):201-11.
Title: PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/beta-catenin signalling pathway in hepatocellular carcinoma.
Author: Lv, J|Zhu, P|Yang, Z|Li, M|Zhang, X|Cheng, J|Chen, X|Lu, F
PMID: 24910204
Journal: Int J Cancer. 2015 Feb 15;136(4):E3-13.
Title: Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Author: Mikuriya, Yoshihiro|Tashiro, Hirotaka|Kuroda, Shintaro|Nambu, Junko|Kobayashi, Tsuyoshi|Amano, Hironobu|Tanaka, Yuka|Ohdan, Hideki
PMID: 25053237
Journal: Hepatology. 2015 Jan;61(1):214-26.
Title: FAK is required for c-Met/beta-catenin-driven hepatocarcinogenesis.
Author: Shang, Na|Arteaga, Maribel|Zaidi, Ali|Stauffer, Jimmy|Cotler, Scott J|Zeleznik-Le, Nancy J|Zhang, Jiwang|Qiu, Wei
PMID: 25163657
Journal: Mol Carcinog. 2015 Dec;54(12):1554-66.
Title: The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Author: Zhang, Rui|Cao, Yanhua|Bai, Lan|Zhu, Chengliang|Li, Rui|He, Hui|Liu, Yingle|Wu, Kailang|Liu, Fang|Wu, Jianguo
PMID: 25263696
Journal: Cancer Lett. 2015 Jan 28;356(2 Pt B):470-8.
Title: Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-kappaB signal cascade.
Author: Lu, Lili|Zhang, Qi|Wu, Kailang|Chen, Xi|Zheng, Yi|Zhu, Chengliang|Wu, Jianguo
PMID: 25305454
Journal: Int J Cancer. 2015 Jul 1;137(1):104-15.
Title: Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.
Author: Ciou, Shih-Ci|Chou, Yu-Ting|Liu, Yu-Ling|Nieh, Yu-Chin|Lu, Jeng-Wei|Huang, Shiu-Feng|Chou, Yu-Ting|Cheng, Li-Hao|Lo, Jeng-Fan|Chen, Ming-Jen|Yang, Ming-Chi|Yuh, Chiou-Hwa|Wang, Horng-Dar
PMID: 25429733
Journal: Biochem Biophys Res Commun. 2015 Jan 2;456(1):86-91.
Title: Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
Author: Tong, Yongxi|Huang, Haijun|Pan, Hongying
PMID: 25446102
Journal: Exp Cell Res. 2015 Feb 1;331(1):97-104.
Title: Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma.
Author: Nagel, Carmen|Armeanu-Ebinger, Sorin|Dewerth, Alexander|Warmann, Steven W|Fuchs, Jorg
PMID: 25447203
Journal: Cancer Lett. 2015 Jan 28;356(2 Pt B):713-20.
Title: Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Author: Song, Jin|Ge, Zhouhong|Yang, Xinrong|Luo, Qin|Wang, Cun|You, Haiyan|Ge, Tianxiang|Deng, Yun|Lin, Hechun|Cui, Yongqi|Chu, Wei|Yao, Ming|Zhang, Zhigang|Gu, Jianren|Fan, Jia|Qin, Wenxin
PMID: 25449435
Journal: Biochem Pharmacol. 2015 Jan 1;93(1):110-24.
Title: Oncogenic c-Myc and prothymosin-alpha protect hepatocellular carcinoma cells against sorafenib-induced apoptosis.
Author: Lin, Yi-Te|Lu, Hsing-Pang|Chao, Chuck C-K
PMID: 25451688
Journal: Chem Biol Interact. 2015 Jun 5;234:274-81.
Title: Down-regulation of aldo-keto reductase AKR1B10 gene expression by a phorbol ester via the ERK/c-Jun signaling pathway.
Author: Nishinaka, Toru|Miura, Takeshi|Sakou, Mihoko|Hidaka, Chiemi|Sasaoka, Chisato|Okamura, Asuka|Okamoto, Atsushi|Terada, Tomoyuki
PMID: 25463304
Journal: Ann Surg Oncol. 2015 Sep;22(9):3121-9.
Title: TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Author: Duan, Meng|Wang, Zhi-Chao|Wang, Xiao-Ying|Shi, Jie-Yi|Yang, Liu-Xiao|Ding, Zhen-Bing|Gao, Qiang|Zhou, Jian|Fan, Jia
PMID: 25465376
Journal: J Gen Virol. 2015 Mar;96(Pt 3):614-25.
Title: C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis.
Author: Quetier, Ivan|Brezillon, Nicolas|Revaud, Julien|Ahodantin, James|DaSilva, Lucie|Soussan, Patrick|Kremsdorf, Dina
PMID: 25519169
Journal: Biochim Biophys Acta. 2015 Mar;1853(3):539-48.
Title: MAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells.
Author: Shan, Jixiu|Donelan, William|Hayner, Jaclyn N|Zhang, Fan|Dudenhausen, Elizabeth E|Kilberg, Michael S
PMID: 25523140
Journal: Carcinogenesis. 2015 Mar;36(3):378-89.
Title: Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
Author: Bopp, Anita|Wartlick, Friedrich|Henninger, Christian|Schwarz, Michael|Kaina, Bernd|Fritz, Gerhard
PMID: 25556150
Journal: Mol Med Rep. 2015 May;11(5):3842-7.
Title: Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitor.
Author: Shi, Shanshan|Yuan, Chenxing|Zhuang, Kaizan|Liang, Guikai|Yao, Zhangting|Wang, Duoduo|Weng, Qinjie|Cao, Ji|Luo, Peihua|Zhu, Hong|Ding, Ling|Ma, Shenglin
PMID: 25607114
Journal: PLoS One. 2015 Jan 21;10(1):e0114495.
Title: Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.
Author: Wu, Jia-Ru|Hu, Chi-Tan|You, Ren-In|Ma, Pei-Ling|Pan, Siou-Mei|Lee, Ming-Che|Wu, Wen-Sheng
PMID: 25607934
Journal: J Hepatol. 2015 Jun;62(6):1287-95.
Title: ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Author: Chen, Jianxiang|Xia, Hongping|Zhang, Xiaoqian|Karthik, Sekar|Pratap, Seshachalam Veerabrahma|Ooi, London Lucien|Hong, Wanjin|Hui, Kam M
PMID: 25617497
Journal: Discov Med. 2015 Jan;19(102):7-14.
Title: Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
Author: Ma, Lifang|Ji, Lijuan|Yu, Yongchun|Wang, Jiayi
PMID: 25636956
Journal: Chem Asian J. 2015 Mar;10(3):642-52.
Title: Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.
Author: Liu, Yuedan|Luo, Yi|Li, Xiaoling|Zheng, Wenjie|Chen, Tianfeng
PMID: 25641920
Journal: Cancer Sci. 2015 May;106(5):559-66.
Title: Sirtuin 6 promotes transforming growth factor-beta1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
Author: Feng, Xin-Xia|Luo, Jing|Liu, Mei|Yan, Wei|Zhou, Zhen-Zhen|Xia, Yu-Jia|Tu, Wei|Li, Pei-Yuan|Feng, Zuo-Hua|Tian, De-An
PMID: 25683165
Journal: Biochim Biophys Acta. 2015 May;1853(5):929-39.
Title: Dependence of fibroblast infiltration in tumor stroma on type IV collagen-initiated integrin signal through induction of platelet-derived growth factor.
Author: Chen, Sheng-Yi|Lin, Jo-Shi|Lin, Huan-Ching|Shan, Yan-Shen|Cheng, Yu-Jung|Yang, Bei-Chang
PMID: 25686533
Journal: Med Oncol. 2015 Mar;32(3):75.
Title: The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
Author: Qiu, Wei|Wang, Guangyi|Sun, Xiaodong|Ye, Junfeng|Wei, Feng|Shi, Xiaoju|Lv, Guoyue
PMID: 25698534
Journal: J Cell Physiol. 2015 Sep;230(9):2281-98.
Title: Nexavar/Stivarga and viagra interact to kill tumor cells.
Author: Tavallai, Mehrad|Hamed, Hossein A|Roberts, Jane L|Cruickshanks, Nichola|Chuckalovcak, John|Poklepovic, Andrew|Booth, Laurence|Dent, Paul
PMID: 25704960
Journal: Cancer Prev Res (Phila). 2015 May;8(5):455-63.
Title: Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3beta.
Author: Chen, Xiangmei|Zhang, Ling|Zheng, Sujun|Zhang, Ting|Li, Meng|Zhang, Xiaolei|Zeng, Zhenzhen|McCrae, Malcolm A|Zhao, Jingmin|Zhuang, Hui|Lu, Fengmin
PMID: 25712050
Journal: Anticancer Drugs. 2015 Jun;26(5):540-6.
Title: Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases.
Author: Yan, Yuan|Li, Jie|Han, Jia|Hou, Ni|Song, Ying|Dong, Lei
PMID: 25714249
Journal: Eur J Pharmacol. 2015 May 5;754:105-14.
Title: Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-kappaB signaling pathway in H22 tumor-bearing mice.
Author: Yang, Fangfang|Li, Jingmin|Zhu, Jinhui|Wang, Dong|Chen, Shaoshui|Bai, Xianyong
PMID: 25720342
Journal: FEBS Lett. 2015 Apr 2;589(8):897-903.
Title: Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells.
Author: Liu, Nianli|Chen, Tianran|Wang, Xiaohong|Yang, Darong|Xue, Binbin|Zhu, Haizhen
PMID: 25747387
Journal: Int J Cancer. 2015 Sep 15;137(6):1341-51.
Title: Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.
Author: Liao, Yi-Jen|Fang, Cheng-Chieh|Yen, Chia-Hung|Hsu, Shih-Ming|Wang, Chung-Kwe|Huang, Shiu-Feng|Liang, Yu-Chih|Lin, Ying-Yu|Chu, Yu-Tseng|Arthur Chen, Yi-Ming
PMID: 25754535
Journal: Oncotarget. 2015 Apr 10;6(10):7899-917.
Title: Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Author: Wang, Feng|Ying, Hou-Qun|He, Bang-Shun|Pan, Yu-Qin|Deng, Qi-Wen|Sun, Hui-Ling|Chen, Jie|Liu, Xian|Wang, Shu-Kui
PMID: 25760077
Journal: Cell Signal. 2015 Jul;27(7):1544-55.
Title: PKCepsilon-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2.
Author: Hu, Chi-Tan|Cheng, Chuan-Chu|Wu, Jia-Ru|Pan, Siou-Mei|Wu, Wen-Sheng
PMID: 25778903
Journal: Tumour Biol. 2015 Aug;36(8):6173-9.
Title: Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
Author: Sui, Zhenghui|Zhou, Jiahua|Cheng, Zhangjun|Lu, Penhua
PMID: 25787749
Journal: Oncotarget. 2015 Mar 20;6(8):6406-21.
Title: Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.
Author: Chen, Yong|Liu, Ju Mei|Xiong, Xin Xin|Qiu, Xin Yao|Pan, Feng|Liu, Di|Lan, Shu Jue|Jin, Si|Yu, Shang Bin|Chen, Xiao Qian
PMID: 25788268
Journal: Am J Pathol. 2015 Apr;185(4):1135-44.
Title: Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells.
Author: Peng, Hui|Li, Tony W H|Yang, Heping|Moyer, Mary P|Mato, Jose M|Lu, Shelly C
PMID: 25794709
Journal: Tumour Biol. 2015 Aug;36(8):6507-13.
Title: Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration.
Author: Cui, Anguo|Hua, Hui|Shao, Ting|Song, Peiying|Kong, Qingbin|Luo, Ting|Jiang, Yangfu
PMID: 25820822
Journal: PLoS One. 2015 Mar 30;10(3):e0119512.
Title: Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Author: Tahtouh, Roula|Azzi, Anne-Sophie|Alaaeddine, Nada|Chamat, Soulaima|Bouharoun-Tayoun, Hasnaa|Wardi, Layal|Raad, Issam|Sarkis, Riad|Antoun, Najibe Abou|Hilal, George
PMID: 25822740
Journal: Oncotarget. 2015 Apr 20;6(11):9355-69.
Title: Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development.
Author: Deng, Rong|Zhao, Xian|Qu, YingYing|Chen, Cheng|Zhu, Changhong|Zhang, Hailong|Yuan, Haihua|Jin, Hui|Liu, Xin|Wang, Yanli|Chen, Qin|Huang, Jian|Yu, Jianxiu
PMID: 25823821
Journal: Oncotarget. 2015 Apr 30;6(12):10102-15.
Title: Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
Author: Li, Xiaolei|Tao, Junyan|Cigliano, Antonio|Sini, Marcella|Calderaro, Julien|Azoulay, Daniel|Wang, Chunmei|Liu, Yan|Jiang, Lijie|Evert, Katja|Demartis, Maria I|Ribback, Silvia|Utpatel, Kirsten|Dombrowski, Frank|Evert, Matthias|Calvisi, Diego F|Chen, Xin
PMID: 25826091
Journal: Oncotarget. 2015 May 10;6(13):11627-39.
Title: psi-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Author: Ding, Jin|Wen, Wen|Xiang, Daimin|Yin, Peipei|Liu, Yanfang|Liu, Chang|He, Guoping|Cheng, Zhuo|Yin, Jianpeng|Sheng, Chunquan|Zhang, Wen|Nan, Fajun|Ye, Wencai|Zhang, Xiuli|Wang, Hongyang
PMID: 25890498
Journal: Biochem Biophys Res Commun. 2015 Jun 5;461(3):513-8.
Title: Differences in antiproliferative effect of STAT3 inhibition in HCC cells with versus without HBV expression.
Author: Hong, Yun|Zhou, Lin|Xie, Haiyang|Wang, Weilin|Zheng, Shusen
PMID: 25899746
Journal: J Agric Food Chem. 2015 May 13;63(18):4561-9.
Title: Antcin K, an Active Triterpenoid from the Fruiting Bodies of Basswood-Cultivated Antrodia cinnamomea, Inhibits Metastasis via Suppression of Integrin-Mediated Adhesion, Migration, and Invasion in Human Hepatoma Cells.
Author: Huang, Ya-Ling|Chu, Yung-Lin|Ho, Chi-Tang|Chung, Jing-Gung|Lai, Chiao-I|Su, Yu-Cheng|Kuo, Yueh-Hsiung|Sheen, Lee-Yan
PMID: 25911944
Journal: Nutr Cancer. 2015;67(5):748-60.
Title: Tetrahydro Iso-Alpha Acids and Hexahydro Iso-Alpha Acids from Hops Inhibit Proliferation of Human Hepatocarcinoma Cell Lines and Reduce Diethylnitrosamine Induced Liver Tumor Formation in Rats.
Author: Starkel, Peter|De Saeger, Christine|Delire, Benedicte|Magat, Julie|Jordan, Benedicte|Konda, Veera R|Tripp, Mathew L|Borbath, Ivan
PMID: 25941903
Journal: Oncotarget. 2015 Jun 20;6(17):15209-21.
Title: Accelerated hepatocellular carcinoma development in CUL4B transgenic mice.
Author: Yuan, Jupeng|Jiang, Baichun|Zhang, Aizhen|Qian, Yanyan|Tan, Haining|Gao, Jiangang|Shao, Changshun|Gong, Yaoqin
PMID: 25945838
Journal: Oncotarget. 2015 Aug 7;6(22):19055-69.
Title: Galpha12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4alpha inactivation, which causes c-Met induction.
Author: Yang, Yoon Mee|Lee, Chan Gyu|Koo, Ja Hyun|Kim, Tae Hyun|Lee, Jung Min|An, Jihyun|Kim, Kang Mo|Kim, Sang Geon
PMID: 25965999
Journal: J Hepatol. 2015 Oct;63(4):863-73.
Title: EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
Author: Xia, Hongping|Chen, Jianxiang|Shi, Ming|Gao, Hengjun|Sekar, Karthik|Seshachalam, Veerabrahma Pratap|Ooi, London Lucien P J|Hui, Kam M
PMID: 25980764
Journal: Cell Signal. 2015 Sep;27(9):1694-702.
Title: CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and betaTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
Author: Tang, Xun|Chen, Xianzhen|Xu, Yanfeng|Qiao, Yongxia|Zhang, Xiao|Wang, Yulan|Guan, Yu|Sun, Fenyong|Wang, Jiayi
PMID: 26004137
Journal: Mol Med Rep. 2015 Sep;12(3):3890-3894.
Title: Splicing factor 2/alternative splicing factor contributes to extracellular signalregulated kinase activation in hepatocellular carcinoma cells.
Author: Zhao, Yawei|Zhu, Ting|Zhang, Xueying|Wang, Qingyang|Zhang, Jiyan|Ji, Wenbin|Ma, Yuanfang
PMID: 26018840
Journal: Liver Cancer. 2015 Mar;4(2):115-25.
Title: Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
Author: Siegel, Abby B|El-Khoueiry, Anthony B|Finn, Richard S|Guthrie, Katherine A|Goyal, Abhishek|Venook, Alan P|Blanke, Charles D|Verna, Elizabeth C|Dove, Lorna|Emond, Jean|Kato, Tomoaki|Samstein, Benjamin|Busuttil, Ronald|Remotti, Helen|Coffey, Amy|Brown, Robe
PMID: 26020033
Journal: Dig Dis Sci. 2015 Aug;60(8):2360-72.
Title: TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Author: Liang, Bo|Jia, Chunhong|Huang, Yu|He, Hua|Li, Jialu|Liao, Hui|Liu, Xiao|Liu, Xincheng|Bai, Xiaochun|Yang, Dinghua
PMID: 26025609
Journal: Oncotarget. 2015 Aug 28;6(25):20964-76.
Title: Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.
Author: Chan, Lo-Kong|Chiu, Yung-Tuen|Sze, Karen Man-Fong|Ng, Irene Oi-Lin
PMID: 26035355
Journal: World J Hepatol. 2015 May 18;7(8):1105-11.
Title: Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.
Author: Ampuero, Javier|Romero-Gomez, Manuel
PMID: 26052399
Journal: Clin Cancer Res. 2015 Oct 1;21(19):4420-30.
Title: Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.
Author: Huang, Pinbo|Zhuang, Baoxiong|Zhang, Heyun|Yan, Haiyan|Xiao, Zhiyu|Li, Wenbin|Zhang, Jianlong|Tang, Qibin|Hu, Kaishun|Koeffler, H Phillip|Wang, Jie|Yin, Dong
PMID: 26059188
Journal: Mol Cell Biochem. 2015 Sep;407(1-2):223-37.
Title: Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma.
Author: Iyer, Soumya C|Gopal, Ashidha|Halagowder, Devaraj
PMID: 26104578
Journal: ACS Appl Mater Interfaces. 2015 Jul 15;7(27):14933-45.
Title: Functionalized Multiwalled Carbon Nanotubes as Carriers of Ruthenium Complexes to Antagonize Cancer Multidrug Resistance and Radioresistance.
Author: Wang, Ni|Feng, Yanxian|Zeng, Lilan|Zhao, Zhennan|Chen, Tianfeng
PMID: 26107995
Journal: Food Funct. 2015 Aug;6(8):2588-97.
Title: Effects of thonningianin A in natural foods on apoptosis and cell cycle arrest of HepG-2 human hepatocellular carcinoma cells.
Author: Zhang, Tian-Tian|Yang, Li|Jiang, Jian-Guo
PMID: 26119846
Journal: J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):297-306.
Title: INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON HEPATOCELLULAR CARCINOMA: POSSIBLE ROLE OF APOPTOSIS AND CELL CYCLE ARREST.
Author: Cao, J|Miao, Q|Zhang, J|Miao, S|Bi, L|Zhang, S|Yang, Q|Zhou, X|Zhang, M|Xie, Y|Wang, S
PMID: 26122217
Journal: J Breast Cancer. 2015 Jun;18(2):112-8.
Title: Isocryptotanshinone Induced Apoptosis and Activated MAPK Signaling in Human Breast Cancer MCF-7 Cells.
Author: Zhang, Xuenong|Luo, Weiwei|Zhao, Wenwen|Lu, Jinjian|Chen, Xiuping
PMID: 26155286
Journal: Tumour Biol. 2015 Dec;36(12):9779-88.
Title: MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
Author: Zhang, Wei|Liu, Kai|Liu, Songyang|Ji, Bai|Wang, Yingchao|Liu, Yahui
PMID: 26156803
Journal: Evid Based Complement Alternat Med. 2015;2015:171356.
Title: Huaier Aqueous Extract Induces Hepatocellular Carcinoma Cells Arrest in S Phase via JNK Signaling Pathway.
Author: Zhang, Chengshuo|Zhang, Jialin|Li, Xin|Sun, Ning|Yu, Rui|Zhao, Bochao|Yu, Dongyang|Cheng, Ying|Liu, Yongfeng
PMID: 26229542
Journal: PLoS One. 2015 Jul 31;10(7):e0133264.
Title: HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway.
Author: Chen, Wei-Chun|Tseng, Chin-Kai|Chen, Yen-Hsu|Lin, Chun-Kuang|Hsu, Shih-Hsien|Wang, Shen-Nien|Lee, Jin-Ching
PMID: 26231035
Journal: World J Hepatol. 2015 Jul 28;7(15):1964-70.
Title: Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy.
Author: Chen, Chuan|Wang, Ge
PMID: 26244070
Journal: Cancer Lett. 2015 Nov 1;368(1):126-34.
Title: Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Author: Qian, Liqiang|Liu, Yan|Xu, Yang|Ji, Weidan|Wu, Qiuye|Liu, Yongjing|Gao, Quangen|Su, Changqing
PMID: 26259512
Journal: Oncotarget. 2015 Sep 29;6(29):27252-66.
Title: TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression.
Author: Ho, Victor|Lim, Tong Seng|Lee, Justin|Steinberg, Jeffrey|Szmyd, Radoslaw|Tham, Muly|Yaligar, Jadegoud|Kaldis, Philipp|Abastado, Jean-Pierre|Chew, Valerie
PMID: 26287667
Journal: J Proteomics. 2015 Oct 14;128:262-71.
Title: Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics.
Author: Xing, Xiaohua|Huang, Yao|Wang, Sen|Chi, Minhui|Zeng, Yongyi|Chen, Lihong|Li, Ling|Zeng, Jinhua|Lin, Minjie|Han, Xiao|Liu, Xiaolong|Liu, Jingfeng
PMID: 26300425
Journal: Cell Physiol Biochem. 2015;37(1):361-74.
Title: 8-Methoxypsoralen Induces Intrinsic Apoptosis in HepG2 Cells: Involvement of Reactive Oxygen Species Generation and ERK1/2 Pathway Inhibition.
Author: Yang, Huan|Xiong, Jing|Luo, Wenjing|Yang, Jian|Xi, Tao
PMID: 26316083
Journal: Oncol Rep. 2015 Nov;34(5):2602-8.
Title: Hexane extract from Sargassum serratifolium inhibits the cell proliferation and metastatic ability of human glioblastoma U87MG cells.
Author: Kang, Chang-Won|Park, Min-Seok|Kim, Nan-Hee|Lee, Ji-Hyun|Oh, Chul-Woong|Kim, Hyeung-Rak|Kim, Gun-Do
PMID: 26323587
Journal: J Exp Clin Cancer Res. 2015 Sep 11;34:101.
Title: DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
Author: Xie, Binhui|Lin, Weihao|Ye, Junming|Wang, Xiaonong|Zhang, Bing|Xiong, Shiqiu|Li, Heping|Tan, Guosheng
PMID: 26362312
Journal: Oncotarget. 2015 Oct 20;6(32):33658-74.
Title: GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma.
Author: Gu, Yan-jiao|Li, Hong-dan|Zhao, Liang|Zhao, Song|He, Wu-bin|Rui, Li|Su, Chang|Zheng, Hua-chuan|Su, Rong-jian
PMID: 26378040
Journal: Mar Drugs. 2015 Sep 24;13(10):6064-81.
Title: Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Kappab P65 and Wnt/Beta-Catenin in Vitro.
Author: Li, Jingjing|Dai, Weiqi|Xia, Yujing|Chen, Kan|Li, Sainan|Liu, Tong|Zhang, Rong|Wang, Jianrong|Lu, Wenxia|Zhou, Yuqing|Yin, Qin|Abudumijiti, Huerxidan|Chen, Rongxia|Zheng, Yuanyuan|Wang, Fan|Lu, Jie|Zhou, Yingqun|Guo, Chuanyong
PMID: 26404320
Journal: Oncotarget. 2015 Dec 8;6(39):42040-52.
Title: Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Author: Zhang, Jiangbo|Cheng, Jin|Zeng, Zhenzhen|Wang, Yongfeng|Li, Xiaojun|Xie, Qing|Jia, Junqiao|Yan, Ying|Guo, Zhengyang|Gao, Jian|Yao, Mingjie|Chen, Xiangmei|Lu, Fengmin
PMID: 26547929
Journal: J Exp Clin Cancer Res. 2015 Nov 11;34:138.
Title: Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Author: Li, Xinli|Liu, Chun|Ip, Blanche C|Hu, Kang-Quan|Smith, Donald E|Greenberg, Andrew S|Wang, Xiang-Dong
PMID: 26560698
Journal: World J Gastroenterol. 2015 Nov 14;21(42):12059-70.
Title: Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
Author: Gao, Jian-Jun|Shi, Zhen-Yan|Xia, Ju-Feng|Inagaki, Yoshinori|Tang, Wei
PMID: 26576091
Journal: J Agric Food Chem. 2015 Dec 9;63(48):10388-98.
Title: Curcumin Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular Carcinoma.
Author: Tsai, Cheng-Fang|Hsieh, Tsung-Hua|Lee, Jau-Nan|Hsu, Chia-Yi|Wang, Yu-Chih|Kuo, Kung-Kai|Wu, Hua-Lin|Chiu, Chien-Chih|Tsai, Eing-Mei|Kuo, Po-Lin
PMID: 26585812
Journal: PLoS One. 2015 Dec 4;10(12):e0143830.
Title: Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
Author: Nolting, Svenja|Maurer, Julian|Spottl, Gerald|Aristizabal Prada, Elke Tatjana|Reuther, Clemens|Young, Karen|Korbonits, Marta|Goke, Burkhard|Grossman, Ashley|Auernhammer, Christoph J
PMID: 26636335
Journal: PLoS One. 2015 Dec 11;10(12):e0144433.
Title: Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.
Author: Yu, XiaoTong|Wang, PengYan|Shi, ZhengMing|Dong, Kun|Feng, Ping|Wang, HongXia|Wang, XueJiang
PMID: 26658815
Journal: Food Nutr Res. 2015 Dec 22;59:29884.
Title: Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration.
Author: Liao, Jung Chun|Lee, Kun Tsung|You, Bang Jau|Lee, Chia Lin|Chang, Wen Te|Wu, Yang Chang|Lee, Hong-Zin
PMID: 26699938
Journal: Onco Targets Ther. 2015 Dec 15;8:3731-42.
Title: GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma.
Author: Chen, Junyi|Yang, Pinghua|Yang, Jue|Wen, Zhijian|Zhang, Baohua|Zheng, Xin
PMID: 26719701
Journal: Hepat Oncol. 2015;2(3):303-312.
Title: The role of AEG-1 in the development of liver cancer.
Author: Robertson, Chadia L|Srivastava, Jyoti|Rajasekaran, Devaraja|Gredler, Rachel|Akiel, Maaged A|Jariwala, Nidhi|Siddiq, Ayesha|Emdad, Luni|Fisher, Paul B|Sarkar, Devanand
PMID: 26798451
Journal: Int J Clin Exp Pathol. 2015 Dec 1;8(12):15863-70. eCollection 2015.
Title: Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Author: Huo, Sibo|Yu, Huiqiu|Li, Chusheng|Zhang, Jiayu|Liu, Tongjun
PMID: 26884857
Journal: Cell Death Discov. 2015 Nov 30;1:15051.
Title: Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.
Author: Tsai, M-C|Chen, K-D|Wang, C-C|Huang, K-T|Wu, C-H|Kuo, I-Y|Chen, L-Y|Hu, T-H|Goto, S|Nakano, T|Dorling, A|McVey, J H|Chen, C-L|Lin, C-C
PMID: 27551480
Journal: Tumour Biol. 2016 Feb;37(2):2023-35.
Title: Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Author: Zhang, Mei-Xia|Xu, Xi-Ming|Zhang, Peng|Han, Na-Na|Deng, Jun-Jian|Yu, Ting-Ting|Gan, Yuan-Yuan|He, Xiao-Qin|Long, Zhi-Xiong
PMID: 26337275
Journal: Tumour Biol. 2016 Feb;37(2):2527-35.
Title: Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.
Author: Dang, Zheng|Shangguan, Jianying|Zhang, Chao|Hu, Peng|Ren, Yanshun|Lv, Zhicheng|Xiang, Hongjun|Wang, Xianghui
PMID: 26386721
Journal: Cancer Lett. 2016 Jan 1;370(1):1-9.
Title: Activation of signal transduction pathways during hepatic oncogenesis.
Author: Chung, Waihong|Kim, Miran|de la Monte, Suzanne|Longato, Lisa|Carlson, Rolf|Slagle, Betty L|Dong, Xiaoqun|Wands, Jack R
PMID: 26433160
Journal: Toxicol Mech Methods. 2016;26(1):11-21.
Title: ML-7 amplifies the quinocetone-induced cell death through akt and MAPK-mediated apoptosis on HepG2 cell line.
Author: Zhou, Yan|Zhang, Shen|Deng, Sijun|Dai, Chongshan|Tang, Shusheng|Yang, Xiayun|Li, Daowen|Zhao, Kena|Xiao, Xilong
PMID: 26446980
Journal: Oncotarget. 2016 Jan 19;7(3):2646-59.
Title: pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Author: Li, Jun|Shi, Lehua|Zhang, Xiaofeng|Sun, Bin|Yang, Yefa|Ge, Naijian|Liu, Huiying|Yang, Xia|Chen, Lei|Qian, Haihua|Wu, Mengchao|Yin, Zhengfeng
PMID: 26544731
Journal: Int J Oncol. 2016 Jan;48(1):358-66.
Title: Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression.
Author: Duan, Yan|Wong, Winnie|Chua, Sonja Courtney|Wee, Hwee Lin|Lim, Seng Gee|Chua, Boon Tin|Ho, Han Kiat
PMID: 26573872
Journal: Toxicol In Vitro. 2016 Mar;31:86-92.
Title: Alkaloids derived from flowers of Senna spectabilis, (-)-cassine and (-)-spectaline, have antiproliferative activity on HepG2 cells for inducing cell cycle arrest in G1/S transition through ERK inactivation and downregulation of cyclin D1 expression.
Author: Pereira, Rodrigo Machado|Ferreira-Silva, Guilherme Alvaro|Pivatto, Marcos|Santos, Luciana de Avila|Bolzani, Vanderlan da Silva|Chagas de Paula, Daniela Aparecida|Oliveira, Jaqueline Carvalho de|Viegas Junior, Claudio|Ionta, Marisa
PMID: 26616281
Journal: Cancer Lett. 2016 Feb 1;371(1):107-16.
Title: Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Author: Zhang, Qi|Wei, Liang|Yang, Hongchuan|Yang, Wanqi|Yang, Qingyu|Zhang, Zhuofan|Wu, Kailang|Wu, Jianguo
PMID: 26620707
Journal: Clin Cancer Res. 2016 May 15;22(10):2368-76.
Title: A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.
Author: Adjei, Alex A|Richards, Donald A|El-Khoueiry, Anthony|Braiteh, Fadi|Becerra, Carlos H R|Stephenson, Joe J Jr|Hezel, Aram F|Sherman, Morris|Garbo, Lawrence|Leffingwell, Diane P|Iverson, Cory|Miner, Jeffrey N|Shen, Zancong|Yeh, Li-Tain|Gunawan, Sonny|Wilson
PMID: 26644411
Journal: Cancer Lett. 2016 Feb 28;371(2):171-81.
Title: MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Author: Xu, Yanmin|Huang, Ji|Ma, Leina|Shan, Juanjuan|Shen, Junjie|Yang, Zhi|Liu, Limei|Luo, Yongli|Yao, Chao|Qian, Cheng
PMID: 26655273
Journal: Oncotarget. 2016 Jan 12;7(2):2009-21.
Title: Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis.
Author: Kato, Hiroyuki|Naiki-Ito, Aya|Naiki, Taku|Suzuki, Shugo|Yamashita, Yoriko|Sato, Shinya|Sagawa, Hiroyuki|Kato, Akihisa|Kuno, Toshiya|Takahashi, Satoru
PMID: 26655499
Journal: Life Sci. 2016 Jan 1;144:121-8.
Title: Identification of intracellular pathways through which TGF-beta1 upregulates URG-4/URGCP gene expression in hepatoma cells.
Author: Tokay, Esra|Kockar, Feray
PMID: 26657209
Journal: Tumour Biol. 2016 Jun;37(6):7589-97.
Title: Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
Author: Liu, Yan|Bi, Tingting|Dai, Wei|Wang, Gang|Qian, Liqiang|Gao, Quangen|Shen, Genhai
PMID: 26687645
Journal: Int J Oncol. 2016 Mar;48(3):1125-34.
Title: AP-2alpha inhibits hepatocellular carcinoma cell growth and migration.
Author: Huang, Wenhuan|Chen, Cheng|Liang, Zhongheng|Qiu, Junlu|Li, Xinxin|Hu, Xiang|Xiang, Shuanglin|Ding, Xiaofeng|Zhang, Jian
PMID: 26780928
Journal: Cell Cycle. 2016;15(4):573-83.
Title: A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.
Author: Augello, Giuseppa|Puleio, Roberto|Emma, Maria Rita|Cusimano, Antonella|Loria, Guido R|McCubrey, James A|Montalto, Giuseppe|Cervello, Melchiorre
PMID: 26794644
Journal: Oncotarget. 2016 Mar 1;7(9):9832-43.
Title: RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation.
Author: Bouhlal, Hicham|Ouled-Haddou, Hakim|Debuysscher, Veronique|Singh, Amrathlal Rabbind|Ossart, Christele|Reignier, Aline|Hocini, Hakim|Fouquet, Gregory|Al Baghami, Mohammed|Eugenio, Melanie Simoes|Nguyen-Khac, Eric|Regimbeau, Jean-Marc|Marcq, Ingrid
PMID: 26799423
Journal: Tumour Biol. 2016 Jul;37(7):9691-8.
Title: Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
Author: Zhan, Hao|Jiang, Jiahao|Luo, Chubin|Sun, Qiman|Ke, Aiwu|Sun, Chao|Hu, Jinwu|Hu, Zhiqiang|Hu, Bo|Zhu, Kai|Fan, Jia|Zhou, Jian|Huang, Xiaowu
PMID: 26801674
Journal: Sci Signal. 2016 Feb 2;9(413):ra13.
Title: Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylation.
Author: Iwamoto, Nao|D'Alessandro, Lorenza A|Depner, Sofia|Hahn, Bettina|Kramer, Bernhard A|Lucarelli, Philippe|Vlasov, Artyom|Stepath, Markus|Bohm, Martin E|Deharde, Daniela|Damm, Georg|Seehofer, Daniel|Lehmann, Wolf D|Klingmuller, Ursula|Schilling, Marcel
PMID: 26838549
Journal: BMC Complement Altern Med. 2016 Feb 9;16:58.
Title: Polyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways.
Author: Zhang, Chao|Jia, Xuejing|Bao, Jiaolin|Chen, Shenghui|Wang, Kai|Zhang, Yulin|Li, Peng|Wan, Jian-Bo|Su, Huanxing|Wang, Yitao|Mei, Zhinan|He, Chengwei
PMID: 26861252
Journal: Oncotarget. 2016 Mar 8;7(10):11595-608.
Title: MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
Author: Sun, Wei|Zhang, Zhuochao|Wang, Jianlin|Shang, Runze|Zhou, Liang|Wang, Xing|Duan, Juanli|Ruan, Bai|Gao, Yuan|Dai, Bin|Qu, Shibin|Liu, Wei|Ding, Rui|Wang, Lin|Wang, Desheng|Dou, Kefeng
PMID: 26871477
Journal: World J Gastroenterol. 2016 Feb 14;22(6):2071-80.
Title: Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
Author: Ding, Ning|Che, Li|Li, Xiao-Lei|Liu, Yan|Jiang, Li-Jie|Fan, Biao|Tao, Jun-Yan|Chen, Xin|Ji, Jia-Fu
PMID: 26877611
Journal: Sci Rep. 2016 Feb 16;6:21260.
Title: Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
Author: Liu, Feng|Zhang, Wen|Yang, Fusheng|Feng, Tingting|Zhou, Meng|Yu, Yuan|Yu, Xiuping|Zhao, Weiming|Yi, Fan|Tang, Wei|Lu, Yi
PMID: 26879559
Journal: Phytomedicine. 2016 Jan 15;23(1):42-51.
Title: Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status.
Author: Durmaz, Irem|Guven, Ebru Bilget|Ersahin, Tulin|Ozturk, Mehmet|Calis, Ihsan|Cetin-Atalay, Rengul
PMID: 26902406
Journal: Oncotarget. 2016 Mar 29;7(13):16349-61.
Title: AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
Author: Gao, Mei|Kong, Qingbin|Hua, Hui|Yin, Yancun|Wang, Jiao|Luo, Ting|Jiang, Yangfu
PMID: 26918349
Journal: PLoS One. 2016 Mar 16;11(3):e0151455.
Title: Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.
Author: Shen, Minqian|Shi, Haifei
PMID: 26982332
Journal: Oncotarget. 2016 Apr 19;7(16):22674-86.
Title: MicroRNA-630 suppresses tumor metastasis through the TGF-beta- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
Author: Chen, Wei-Xun|Zhang, Zhan-Guo|Ding, Ze-Yang|Liang, Hui-Fang|Song, Jia|Tan, Xiao-Long|Wu, Jing-Jing|Li, Guang-Zhen|Zeng, Zhuo|Zhang, Bi-Xiang|Chen, Xiao-Ping
PMID: 26993767
Journal: Cell Oncol (Dordr). 2016 Aug;39(4):333-42.
Title: Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
Author: Liu, Junshan|Wei, Xiduan|Wu, Yafeng|Wang, Yanni|Qiu, Yuwen|Shi, Junmin|Zhou, Hongling|Lu, Zibin|Shao, Meng|Yu, Linzhong|Tong, Li
PMID: 27016209
Journal: Pharmaceuticals (Basel). 2016 Mar 24;9(2). pii: ph9020018.
Title: A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.
Author: Tagaram, Hephzibah Rani S|Desai, Dhimant|Li, Guangfu|Liu, Dai|Rountree, C Bart|Gowda, Kavitha|Berg, Arthur|Amin, Shantu|Staveley-O'Carroll, Kevin F|Kimchi, Eric T
PMID: 27023566
Journal: Oncotarget. 2016 May 3;7(18):26027-41.
Title: Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Author: Xu, Ling|Dai, Weiqi|Li, JingJing|He, Lei|Wang, Fan|Xia, Yujing|Chen, Kan|Li, Sainan|Liu, Tong|Lu, Jie|Zhou, Yingqun|Wang, Yugang|Guo, Chuanyong
PMID: 27029030
Journal: Med Oncol. 2016 May;33(5):46.
Title: FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
Author: Liu, Xinyu|Jing, Xiaoqian|Cheng, Xi|Ma, Ding|Jin, Zhijian|Yang, Weiping|Qiu, Weihua
PMID: 27044356
Journal: Onco Targets Ther. 2016 Mar 21;9:1697-706.
Title: Up-regulated expression of phospholipase C, beta1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma.
Author: Li, Junxiang|Zhao, Xuya|Wang, Dazhi|He, Wei|Zhang, Shuai|Cao, Wei|Huang, Yu|Wang, Ling|Zhou, Shi|Luo, Kaijian
PMID: 27051304
Journal: Oncoimmunology. 2015 Aug 24;5(2):e1078055.
Title: Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.
Author: Zhang, Liang|Wang, Huanyu|Yang, Tianshu|Su, Zhifeng|Fang, Dan|Wang, Yafeng|Fang, Jiazhu|Hou, Xinwei|Le, Yingying|Chen, Keqiang|Wang, Ji Ming|Su, Shao Bo|Lin, Qing|Zhou, Qi
PMID: 27057451
Journal: Biochem Biophys Res Commun. 2016 May 27;474(2):330-337.
Title: MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models.
Author: Wang, Kaifeng|Fan, Yaohua|Chen, Gongying|Wang, Zhengrong|Kong, Dexin|Zhang, Peng
PMID: 27107695
Journal: Oncotarget. 2016 Jul 5;7(27):41274-41284.
Title: Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint.
Author: Chen, Jiang|Ji, Tong|Zhao, Jie|Li, Gaofeng|Zhang, Jian|Jin, Renan|Liu, Jinghua|Liu, Xiaolong|Liang, Xiao|Huang, Diyu|Xie, Anyong|Lin, Hui|Cang, Yong|Cai, Xiujun
PMID: 27129180
Journal: Oncotarget. 2016 Jun 14;7(24):36767-36782.
Title: Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
Author: Cui, Shu-Xiang|Shi, Wen-Na|Song, Zhi-Yu|Wang, Shu-Qing|Yu, Xin-Feng|Gao, Zu-Hua|Qu, Xian-Jun
PMID: 27167344
Journal: Oncol Rep. 2016 Jul;36(1):10-22.
Title: Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Author: Xu, Song|Yi, Xiao-Ming|Tang, Chao-Peng|Ge, Jing-Ping|Zhang, Zheng-Yu|Zhou, Wen-Quan
PMID: 27176634
Journal: Am J Cancer Res. 2016 Jan 15;6(2):509-21. eCollection 2016.
Title: Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation.
Author: Li, Jing-Huan|Wang, Ying-Cong|Qin, Cheng-Dong|Yao, Rong-Rong|Zhang, Rui|Wang, Yan|Xie, Xiao-Ying|Zhang, Lan|Wang, Yan-Hong|Ren, Zheng-Gang
PMID: 27186420
Journal: Mol Cancer Ther. 2016 Jun;15(6):1227-37.
Title: Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma.
Author: Du, Zhiqiang|Caenepeel, Sean|Shen, Yuqing|Rex, Karen|Zhang, Yanni|He, Ying|Tang, En-Tzu|Wang, Ouhong|Zhong, Wenge|Zhou, Hui|Huang, Jacqueline|Huang, Eric|Hu, Liaoyuan|Coxon, Angela|Zhang, Mingqiang
PMID: 27196749
Journal: Oncotarget. 2016 Jul 19;7(29):45302-45316.
Title: EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
Author: Wang, Lumin|Sun, Hongfei|Wang, Xiaofei|Hou, Ni|Zhao, Lingyu|Tong, Dongdong|He, Kang|Yang, Yang|Song, Tusheng|Yang, Jun|Huang, Chen
PMID: 27244890
Journal: Cancer Res. 2016 Jul 15;76(14):4205-15.
Title: Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma.
Author: Li, Ke|Shen, Baiyong|Cheng, Xi|Ma, Ding|Jing, Xiaoqian|Liu, Xinyu|Yang, Weiping|Peng, Chenghong|Qiu, Weihua
PMID: 27267910
Journal: Cell Biochem Funct. 2016 Jun;34(4):274-85.
Title: Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Author: Yang, Guang-Yun|Zhang, Ai-Qun|Wang, Jing|Li, Chong-Hui|Wang, Xian-Qiang|Pan, Ke|Zhou, Cheng|Dong, Jia-Hong
PMID: 27273265
Journal: Oncol Rep. 2016 Aug;36(2):961-7.
Title: Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo.
Author: Lin, Wanfu|Zhong, Maofeng|Yin, Huixia|Chen, Yongan|Cao, Qingxin|Wang, Chen|Ling, Changquan
PMID: 27278720
Journal: J Cancer. 2016 Jun 6;7(9):1142-51.
Title: Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin.
Author: Xin, Hong-Wu|Ambe, Chenwi M|Miller, Tyler C|Chen, Jin-Qiu|Wiegand, Gordon W|Anderson, Andrew J|Ray, Satyajit|Mullinax, John E|Hari, Danielle M|Koizumi, Tomotake|Godbout, Jessica D|Goldsmith, Paul K|Stojadinovic, Alexander|Rudloff, Udo|Thorgeirsson, Snorri
PMID: 27326258
Journal: Cell Death Dis. 2016 Jun 23;7(6):e2269.
Title: NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
Author: Emma, M R|Iovanna, J L|Bachvarov, D|Puleio, R|Loria, G R|Augello, G|Candido, S|Libra, M|Gulino, A|Cancila, V|McCubrey, J A|Montalto, G|Cervello, M
PMID: 27336713
Journal: Crit Rev Oncol Hematol. 2016 Sep;105:65-72.
Title: Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology.
Author: Lamarca, Angela|Mendiola, Marta|Barriuso, Jorge
PMID: 27372199
Journal: Biomed Pharmacother. 2016 Oct;83:450-455.
Title: Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Author: Peng, Wei|Fan, Hong
PMID: 27427851
Journal: J Exp Clin Cancer Res. 2016 Jul 18;35(1):114.
Title: Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in hepatoma cells and increases hepatocyte injury.
Author: Dong, Yinying|Shen, Xiaoyun|He, Mingyan|Wu, Zhifeng|Zheng, Qiongdan|Wang, Yaohui|Chen, Yuhan|Wu, Sifan|Cui, Jiefeng|Zeng, Zhaochong
PMID: 27431384
Journal: J Korean Med Sci. 2016 Aug;31(8):1215-23.
Title: OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
Author: Li, Hua|Miao, Qian|Xu, Chun-Wei|Huang, Jian-Hui|Zhou, Yue-Fen|Wu, Mei-Juan
PMID: 27478331
Journal: Oncotarget. 2016 Oct 18;7(42):68044-68056.
Title: Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Author: Han, Bing|Shin, Hye-Jun|Bak, In Seon|Bak, Yesol|Jeong, Ye-Lin|Kwon, Taeho|Park, Young-Ho|Sun, Hu-Nan|Kim, Cheol-Hee|Yu, Dae-Yeul
PMID: 27517622
Journal: Biochem Biophys Res Commun. 2016 Sep 16;478(2):964-9.
Title: Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops.
Author: Ma, Yang|Han, Chen-Chen|Li, Yifan|Wang, Yang|Wei, Wei
PMID: 27521890
Journal: Hepatology. 2016 Nov;64(5):1637-1651.
Title: Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.
Author: Chen, Hsin-An|Kuo, Tsang-Chih|Tseng, Chi-Feng|Ma, Jui-Ti|Yang, Shu-Ting|Yen, Chia-Jui|Yang, Ching-Yao|Sung, Shian-Ying|Su, Jen-Liang
PMID: 27530187
Journal: Oncotarget. 2016 Oct 11;7(41):66635-66646.
Title: Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis.
Author: Ji, Tong|Li, Gaofeng|Chen, Jiang|Zhao, Jie|Li, Xi|Lin, Hui|Cai, Xiujun|Cang, Yong
PMID: 27556180
Journal: Sci Rep. 2016 Sep 15;6:33205.
Title: STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Author: Wang, Zhaowen|Qu, Lei|Deng, Biao|Sun, Xing|Wu, Shaohan|Liao, Jianhua|Fan, Junwei|Peng, Zhihai
PMID: 27628214
Journal: BMC Cancer. 2016 Sep 21;16(1):742.
Title: Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Author: Wang, Yu|Nie, Hao|Zhao, Xin|Qin, Yong|Gong, Xingguo
PMID: 27654866
Journal: Biomed Pharmacother. 2016 Dec;84:237-243.
Title: Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Author: Liu, Yongdong|Sun, Liling|Su, Xingwang|Guo, Sien
PMID: 27662474
Journal: EBioMedicine. 2016 Oct;12:55-67.
Title: The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
Author: Xu, Junjie|Lin, Hui|Li, Gonghui|Sun, Yin|Chen, Jiang|Shi, Liang|Cai, Xiujun|Chang, Chawnshang
PMID: 27688096
Journal: Food Funct. 2016 Oct 12;7(10):4170-4174.
Title: delta and gamma tocotrienols suppress human hepatocellular carcinoma cell proliferation via regulation of Ras-Raf-MEK-ERK pathway-associated upstream signaling.
Author: Burdeos, Gregor Carpentero|Ito, Junya|Eitsuka, Takahiro|Nakagawa, Kiyotaka|Kimura, Fumiko|Miyazawa, Teruo
PMID: 27713963
Journal: Med Oncol. 2016 Nov;33(11):123.
Title: Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
Author: Higashi, Takaaki|Hayashi, Hiromitsu|Kitano, Yuki|Yamamura, Kensuke|Kaida, Takayoshi|Arima, Kota|Taki, Katsunobu|Nakagawa, Shigeki|Okabe, Hirohisa|Nitta, Hidetoshi|Imai, Katsunori|Hashimoto, Daisuke|Chikamoto, Akira|Beppu, Toru|Baba, Hideo
PMID: 27734263
Journal: Oncotarget. 2016 Nov 22;7(47):76984-76994.
Title: Phosphorylation of PPARgamma at Ser84 promotes glycolysis and cell proliferation in hepatocellular carcinoma by targeting PFKFB4.
Author: Shu, Yuxin|Lu, Yan|Pang, Xiaojuan|Zheng, Wei|Huang, Yahong|Li, Jiahong|Ji, Jianguo|Zhang, Can|Shen, Pingping
PMID: 27769068
Journal: Am J Transl Res. 2016 Oct 15;8(10):4250-4264. eCollection 2016.
Title: Glycosylation patterns and PHA-E-associated glycoprotein profiling associated with early hepatic encephalopathy in Chinese hepatocellular carcinoma patients.
Author: Liu, Tian-Hua|Liu, Deng-He|Mo, Cui-Ju|Sun, Lu|Liu, Xiao-Xia|Li, Wei|Zhang, Shu|Liu, Yin-Kun|Guo, Kun
PMID: 27830009
Journal: Oncotarget. 2016 Dec 6;7(49):81223-81240.
Title: Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into beta-arrestin-dependent ERK signaling.
Author: Liu, Hongda|Zhang, Qun|Li, Kangshuai|Gong, Zheng|Liu, Zhaochen|Xu, Yunfei|Swaney, Mary Hannah|Xiao, Kunhong|Chen, Yuxin
PMID: 27835898
Journal: Cancer Cell. 2016 Nov 14;30(5):723-736.
Title: ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.
Author: Sun, Hui-Lung|Cui, Ri|Zhou, JianKang|Teng, Kun-Yu|Hsiao, Yung-Hsuan|Nakanishi, Kotaro|Fassan, Matteo|Luo, Zhenghua|Shi, Guqin|Tili, Esmerina|Kutay, Huban|Lovat, Francesca|Vicentini, Caterina|Huang, Han-Li|Wang, Shih-Wei|Kim, Taewan|Zanesi, Nicola|Jeon, Yo
PMID: 27846390
Journal: Korean J Physiol Pharmacol. 2016 Nov;20(6):595-603.
Title: The p90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line.
Author: Kim, Han Sang|Kim, Su-Jin|Bae, Jinhyung|Wang, Yiyi|Park, Sun Young|Min, Young Sil|Je, Hyun Dong|Sohn, Uy Dong
PMID: 27847436
Journal: Oncoimmunology. 2016 Sep 20;5(10):e1226718.
Title: Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib.
Author: Kalathil, Suresh Gopi|Lugade, Amit Anand|Iyer, Renuka|Miller, Austin|Thanavala, Yasmin
PMID: 27853648
Journal: Sci Rep. 2016 Nov 25;6:37499.
Title: Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
Author: Zuo, Wei-Han|Zeng, Peng|Chen, Xi|Lu, Yan-Jun|Li, An|Wu, Jian-Bin
PMID: 27886213
Journal: World J Gastroenterol. 2016 Dec 7;22(45):10053-10063.
Title: Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression.
Author: Su, Jing-Ran|Kuai, Jing-Hua|Li, Yan-Qing
PMID: 28018113
Journal: Front Pharmacol. 2016 Dec 21;7:490.
Title: Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation.
Author: Chen, Wei-Chun|Tseng, Chin-Kai|Chen, Bing-Hung|Lin, Chun-Kuang|Lee, Jin-Ching
PMID: 28066241
Journal: Semin Cancer Biol. 2017 Feb;42:70-80.
Title: Smyd3-associated regulatory pathways in cancer.
Author: Giakountis, Antonis|Moulos, Panagiotis|Sarris, Michalis E|Hatzis, Pantelis|Talianidis, Iannis
PMID: 27554136
Journal: J Pineal Res. 2017 Jan;62(1).
Title: Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.
Author: Sanchez, Diana I|Gonzalez-Fernandez, Barbara|San-Miguel, Beatriz|de Urbina, Juan Ortiz|Crespo, Irene|Gonzalez-Gallego, Javier|Tunon, Maria J
PMID: 27696512
Journal: Curr Pharm Des. 2017;23(1):170-175.
Title: Targeting Signalling Pathways in Hepatocellular Carcinoma.
Author: Blagotinsek, Kaja|Rozman, Damjana
PMID: 27719638
Journal: Oncogene. 2017 Apr 6;36(14):1978-1990.
Title: Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.
Author: Liao, P-H|Hsu, H-H|Chen, T-S|Chen, M-C|Day, C-H|Tu, C-C|Lin, Y-M|Tsai, F-J|Kuo, W-W|Huang, C-Y
PMID: 27748761
Journal: Appl Microbiol Biotechnol. 2017 Feb;101(4):1535-1546.
Title: C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.
Author: Jiang, Shanshan|Wang, Qian|Feng, Meiqing|Li, Jiyang|Guan, Zhongbin|An, Duopeng|Dong, Mengxue|Peng, Yuzhe|Kuerban, Kudelaidi|Ye, Li
PMID: 27807662
Journal: Chem Biol Interact. 2017 Jan 5;261:118-126.
Title: Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells.
Author: Wei, Jinbin|Huang, Quanfang|Bai, Facheng|Lin, Jun|Nie, Jinlan|Lu, Shengjuan|Lu, Chunyuang|Huang, Renbin|Lu, Zhongpeng|Lin, Xing
PMID: 27899290
Journal: Anticancer Res. 2017 Jan;37(1):87-93.
Title: Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Author: Nass, Norbert|Streit, Sebastian|Wybranski, Christian|Jurgens, Julian|Brauner, Jan|Schulz, Nadine|Powerski, Maciej|Ricke, Jens|Kalinski, Thomas|Dudeck, Oliver|Seidensticker, Max
PMID: 28011478
Journal: Biochem Pharmacol. 2017 Mar 1;127:90-100.
Title: Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
Author: Sun, Wei-Jian|Huang, He|He, Bin|Hu, Dan-Hong|Li, Pi-Hong|Yu, Yao-Jun|Zhou, Xiao-Hu|Lv, Zhen|Zhou, Lei|Hu, Tian-Ye|Yao, Zhi-Chao|Lu, Ming-Dong|Shen, Xian|Zheng, Zhi-Qiang
PMID: 28012958
Journal: Cancer Med. 2017 Feb;6(2):374-381.
Title: Alendronate-anchored PEGylation of ceria nanoparticles promotes human hepatoma cell proliferation via AKT/ERK signaling pathways.
Author: Cheng, Heng|Liao, Zhong-Li|Ning, Lin-Hong|Chen, Hong-Yan|Wei, Shan-Shan|Yang, Xiao-Chao|Guo, Hong
PMID: 28070935
Journal: Hepatology. 2017 Jun;65(6):1948-1962.
Title: Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
Author: Yue, Xihua|Ai, Jing|Xu, Yang|Chen, Yi|Huang, Min|Yang, Xinying|Hu, Bo|Zhang, Haotian|He, Changxi|Yang, Xinrong|Tang, Weiguo|Peng, Xia|Dong, Liwei|Wang, Hongyang|Fan, Jia|Ding, Jian|Geng, Meiyu
PMID: 28073159
Journal: Oncotarget. 2017 Feb 14;8(7):12174-12185.
Title: NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.
Author: Zhao, Jing|Dong, Qiong-Zhu|Zhong, Fan|Cai, Li-Li|Qin, Zhao-Yu|Liu, Yang|Lin, Cheng-Zhao|Qin, Lun-Xiu|He, Fu-Chu
PMID: 28077802
Journal: J Cell Biochem. 2017 Aug;118(8):2357-2370.
Title: ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation.
Author: Kang, Bong Seok|Hwang, Yoon Jin|Dong, Zigang
PMID: 28106280
Journal: Cancer Lett. 2017 Apr 28;392:1-8.
Title: Mathematical modelling unveils the essential role of cellular phosphatases in the inhibition of RAF-MEK-ERK signalling by sorafenib in hepatocellular carcinoma cells.
Author: Saidak, Zuzana|Giacobbi, Anne-Sophie|Louandre, Christophe|Sauzay, Chloe|Mammeri, Youcef|Galmiche, Antoine
PMID: 28161506
Journal: Mol Oncol. 2017 Mar;11(3):320-334.
Title: Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
Author: Han, Peng|Li, Hali|Jiang, Xian|Zhai, Bo|Tan, Gang|Zhao, Dali|Qiao, Haiquan|Liu, Bing|Jiang, Hongchi|Sun, Xueying
PMID: 28164434
Journal: Prostate. 2017 May;77(7):718-728.
Title: Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Author: Huang, Hai|Du, Tao|Zhang, Yiming|Lai, Yiming|Li, Kaiwen|Fan, Xinxing|Zhu, Dingjun|Lin, Tianxin|Xu, Kewei|Huang, Jian|Liu, Leyuan|Guo, Zhenghui
PMID: 28230260
Journal: Discov Med. 2017 Jan;23(124):7-17.
Title: Reduced N-acetylglucosaminyltransferase III expression via Smad3 and Erk signaling in TGF-beta1-induced HCC EMT model.
Author: Mo, Cuiju|Liu, Tianhua|Zhang, Shu|Guo, Kun|Li, Meng|Qin, Xue|Liu, Yinkun
PMID: 28245423
Journal: Sci Rep. 2017 Mar 9;7:44123.
Title: Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.
Author: Chen, Yunching|Liu, Ya-Chi|Sung, Yun-Chieh|Ramjiawan, Rakesh R|Lin, Ts-Ting|Chang, Chih-Chun|Jeng, Kuo-Shyang|Chang, Chiung-Fang|Liu, Chun-Hung|Gao, Dong-Yu|Hsu, Fu-Fei|Duyverman, Annique M|Kitahara, Shuji|Huang, Peigen|Dima, Simona|Popescu, Irinel|Flaher
PMID: 28276530
Journal: J Hepatol. 2017 Aug;67(2):360-369.
Title: Mice lacking liver-specific beta-catenin develop steatohepatitis and fibrosis after iron overload.
Author: Preziosi, Morgan E|Singh, Sucha|Valore, Erika V|Jung, Grace|Popovic, Branimir|Poddar, Minakshi|Nagarajan, Shanmugam|Ganz, Tomas|Monga, Satdarshan P
PMID: 28341391
Journal: Int J Oncol. 2017 Mar 13.
Title: Molecular mechanism of C-reaction protein in promoting migration and invasion of hepatocellular carcinoma cells in vitro.
Author: Shen, Shasha|Gong, Jiaojiao|Yang, Yixuan|Qin, Si|Huang, Lifan|She, Sha|Yang, Min|Ren, Hong|Hu, Huaidong
PMID: 28350119
Journal: Biomed Pharmacother. 2017 Jun;90:222-228.
Title: Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells.
Author: Zhang, Ling|He, Dian|Li, Kun|Liu, Hongli|Wang, Baitao|Zheng, Lifang|Li, Jiazhong
PMID: 28363167
Journal: PLoS Pathog. 2017 Apr 10;13(4):e1006321.
Title: GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
Author: Zhang, Xuewu|Zhu, Chengliang|Wang, Tianci|Jiang, Hui|Ren, Yahui|Zhang, Qi|Wu, Kailang|Liu, Fang|Liu, Yingle|Wu, Jianguo
PMID: 28394926
Journal: BMC Microbiol. 2017 Apr 13;17(1):92.
Title: The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection.
Author: Chen, Hong-Yi|Lin, Mei-Hui|Chen, Chien-Cheng|Shu, Jwu-Ching
PMID: 28407745
Journal: Oncotarget. 2017 Apr 25;8(17):28385-28394.
Title: Identification of DNA-PKcs as a primary resistance factor of TIC10 in hepatocellular carcinoma cells.
Author: Cheng, Long|Liu, Yuan-Yuan|Lu, Pei-Hua|Peng, Yi|Yuan, Qiang|Gu, Xin-Shi|Jin, Yong|Chen, Min-Bin|Bai, Xu-Ming
PMID: 28415690
Journal: Oncotarget. 2017 Jul 18;8(29):47121-47135.
Title: HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Author: Wang, Wei-Min|Xu, Yang|Wang, Yao-Hui|Sun, Hai-Xiang|Sun, Yun-Fan|He, Yi-Feng|Zhu, Qing-Feng|Hu, Bo|Zhang, Xin|Xia, Jing-Lin|Qiu, Shuang-Jian|Zhou, Jian|Yang, Xin-Rong|Fan, Jia
PMID: 28454092
Journal: Pharmacol Res. 2017 Jul;121:145-157.
Title: Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
Author: Xi, Shao-Song|Bai, Xiao-Xu|Gu, Li|Bao, Li-Hui|Yang, Hui-Min|An, Wei|Wang, Xiao-Min|Zhang, Hong
PMID: 28455267
Journal: Oncotarget. 2017 Apr 18;8(16):26515-26531.
Title: The cell polarity protein Scrib functions as a tumor suppressor in liver cancer.
Author: Kapil, Shweta|Sharma, Bal Krishan|Patil, Mallikarjun|Elattar, Sawsan|Yuan, Jinling|Hou, Steven X|Kolhe, Ravindra|Satyanarayana, Ande
PMID: 28460446
Journal: Oncotarget. 2017 Apr 18;8(16):27263-27276.
Title: SHP2 is induced by the HBx-NF-kappaB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Author: Kang, Hyo Jeong|Chung, Dal-Hee|Sung, Chang Ohk|Yoo, Su Hyun|Yu, Eunsil|Kim, Nayoung|Lee, Sy-Hye|Song, Ji-Young|Kim, Chong Jai|Choi, Jene
PMID: 28460481
Journal: Oncol Res. 2017 Nov 2;25(9):1607-1616.
Title: Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-beta1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.
Author: Liu, Ling|Li, Nianfeng|Zhang, Qi|Zhou, Jixiang|Lin, Ling|He, Xinxin
PMID: 28492136
Journal: Exp Mol Pathol. 2017 Jun;102(3):492-499.
Title: Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK/Cyclin D1 pathway.
Author: Li, Zixuan|Qu, Lianyue|Luo, Wenting|Tian, Yulong|Zhai, Huan|Xu, Ke|Zhong, Hongshan
PMID: 28506767
Journal: Mol Cell Proteomics. 2017 Aug;16(8):1475-1490.
Title: Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.
Author: Rong, Zhuona|Fan, Tingting|Li, Huiling|Li, Juan|Wang, Kangwei|Wang, Xinxin|Dong, Jianyi|Chen, Jun|Wang, Fujin|Wang, Jingyu|Wang, Aiguo
PMID: 28512230
Journal: Int J Mol Sci. 2017 May 19;18(5). pii: ijms18051095.
Title: Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades.
Author: Lee, Hanwool|Baek, Seung Ho|Lee, Jong Hyun|Kim, Chulwon|Ko, Jeong-Hyeon|Lee, Seok-Geun|Chinnathambi, Arunachalam|Alharbi, Sulaiman Ali|Yang, Woong Mo|Um, Jae-Young|Sethi, Gautam|Ahn, Kwang Seok
PMID: 28534824
Journal: Oncotarget. 2017 Jul 18;8(29):47412-47424.
Title: Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of Yap.
Author: Liu, Sushun|Miao, Runchen|Zhai, Mimi|Pang, Qing|Deng, Yan|Liu, Sinan|Qu, Kai|Liu, Chang|Zhang, Jingyao
PMID: 28537892
Journal: Parasit Vectors. 2017 May 25;10(1):262.
Title: Clonorchis sinensis granulin: identification, immunolocalization, and function in promoting the metastasis of cholangiocarcinoma and hepatocellular carcinoma.
Author: Wang, Caiqin|Lei, Huali|Tian, Yanli|Shang, Mei|Wu, Yinjuan|Li, Ye|Zhao, Lu|Shi, Mengchen|Tang, Xin|Chen, Tingjin|Lv, Zhiyue|Huang, Yan|Tang, Xiaoping|Yu, Xinbing|Li, Xuerong
PMID: 28545547
Journal: Int J Oncol. 2017 Jul;51(1):128-144.
Title: Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells.
Author: Abeni, Edoardo|Salvi, Alessandro|Marchina, Eleonora|Traversa, Michele|Arici, Bruna|De Petro, Giuseppina
PMID: 28560380
Journal: Life Sci. 2017 Aug 15;183:60-68.
Title: Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Author: Wang, Yan|Dong, Lei|Li, Jing|Luo, Miaosha|Shang, Boxin
PMID: 28583366
Journal: Immunol Lett. 2017 Aug;188:116-123.
Title: ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Author: Xie, Yu-Xiao|Liao, Rui|Pan, Long|Du, Cheng-You
PMID: 28668554
Journal: Cancer Res. 2017 Sep 1;77(17):4602-4612.
Title: TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma.
Author: Ng, Kai-Yu|Chan, Lok-Hei|Chai, Stella|Tong, Man|Guan, Xin-Yuan|Lee, Nikki P|Yuan, Yunfei|Xie, Dan|Lee, Terence K|Dusetti, Nelson J|Carrier, Alice|Ma, Stephanie
PMID: 28674078
Journal: Int J Oncol. 2017 Sep;51(3):791-800.
Title: Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
Author: Xu, Yantian|Zheng, Yuanwen|Liu, Hongyan|Li, Tao
PMID: 28677801
Journal: Sci Rep. 2017 Jul 11;7(1):5134.
Title: Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Author: Wu, Dongdong|Li, Mengling|Tian, Wenke|Wang, Shuaiwei|Cui, Longzhen|Li, Hui|Wang, Huijuan|Ji, Ailing|Li, Yanzhang
PMID: 28698660
Journal: Cancer Sci. 2017 Sep;108(9):1778-1786.
Title: Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment.
Author: Zhang, Rui|Ma, Min|Dong, Gang|Yao, Rong-Rong|Li, Jing-Huan|Zheng, Qiong-Dan|Dong, Yin-Ying|Ma, Hui|Gao, Dong-Mei|Cui, Jie-Feng|Ren, Zheng-Gang|Chen, Rong-Xin
PMID: 28699238
Journal: Environ Toxicol. 2017 Nov;32(11):2360-2370.
Title: beta-mangostin suppresses human hepatocellular carcinoma cell invasion through inhibition of MMP-2 and MMP-9 expression and activating the ERK and JNK pathways.
Author: Huang, Chien-Feng|Teng, Ying-Hock|Lu, Fung-Jou|Hsu, Wen-Hung|Lin, Chia-Liang|Hung, Chia-Chen|Tung, Jai-Nien|Hsieh, Yi-Hsien|Liu, Chung-Jung
PMID: 28722351
Journal: Biomed Pharmacother. 2017 Sep;93:1025-1032.
Title: MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Author: Zhou, Kun|Luo, Xiaoyu|Wang, Yu|Cao, Dachun|Sun, Gang
PMID: 28732393
Journal: Oncol Res. 2017 Jul 21.
Title: MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene-6 (MIG-6).
Author: Li, Hui|Chen, Huicheng|Wang, Haibin|Dong, Yilong|Yin, Min|Zhang, Liang|Wei, Jia
PMID: 28734040
Journal: Oncogene. 2017 Nov 30;36(48):6691-6700.
Title: Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
Author: Ding, D|Huang, H|Jiang, W|Yu, W|Zhu, H|Liu, J|Saiyin, H|Wu, J|Huang, H|Jiang, S|Yu, L
PMID: 28745317
Journal: FASEB J. 2017 Dec;31(12):5530-5542.
Title: Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.
Author: Cheng, Jianghong|Zhong, Yanhong|Chen, Shuai|Sun, Yan|Huang, Lantang|Kang, Yujia|Chen, Baozhen|Chen, Gang|Wang, Fengli|Tian, Yingpu|Liu, Wenjie|Feng, Gen-Sheng|Lu, Zhongxian
PMID: 28842424
Journal: Am J Transl Res. 2017 Aug 15;9(8):3853-3866. eCollection 2017.
Title: The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression.
Author: Cai, Nan|Zhou, Wei|Ye, Lan-Lan|Chen, Jun|Liang, Qiu-Ni|Chang, Gang|Chen, Jia-Jie
PMID: 28861175
Journal: Apoptosis. 2017 Nov;22(11):1404-1418.
Title: 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells.
Author: Ai, Hui-Han|Zhou, Zi-Long|Sun, Lu-Guo|Yang, Mei-Ting|Li, Wei|Yu, Chun-Lei|Song, Zhen-Bo|Huang, Yan-Xin|Wu, Yin|Liu, Lei|Yang, Xiao-Guang|Zhao, Yu-Qing|Bao, Yong-Li|Li, Yu-Xin
PMID: 28864870
Journal: Int J Biochem Cell Biol. 2017 Oct;91(Pt A):53-59.
Title: miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.
Author: Su, Shu-Guang|Yang, Mei|Zhang, Mei-Fang|Peng, Quan-Zhou|Li, Ming-Yue|Liu, Li-Ping|Bao, Shi-Yun
PMID: 28867541
Journal: Sci Rep. 2017 Sep 5;7(1):10499.
Title: Cell Spheroids with Enhanced Aggressiveness to Mimic Human Liver Cancer In Vitro and In Vivo.
Author: Jung, Hong-Ryul|Kang, Hyun Mi|Ryu, Jea-Woon|Kim, Dae-Soo|Noh, Kyung Hee|Kim, Eun-Su|Lee, Ho-Joon|Chung, Kyung-Sook|Cho, Hyun-Soo|Kim, Nam-Soon|Im, Dong-Soo|Lim, Jung Hwa|Jung, Cho-Rok
PMID: 28874716
Journal: Mol Med Rep. 2017 Nov;16(5):6299-6305.
Title: Antitumor activity of 2[(2E)3,7dimethyl2,6octadienyl]6methyl2,5cyclohexadiene1,4dione isolated from the aerial part of Atractylodes macrocephala in hepatocellular carcinoma.
Author: Li, Lei|Zhao, Rui|Li, Ying|Wang, Wen-Hui
PMID: 28901513
Journal: Int J Oncol. 2017 Oct;51(4):1291-1299.
Title: Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Author: Liu, Xiaoni|Xu, Jianji|Wang, Shuang|Yu, Xiaoxiao|Kou, Boxin|Chai, Mengyin|Zang, Yunjin|Chen, Dexi
PMID: 28902369
Journal: Oncotarget. 2017 Jul 5;8(33):55084-55093.
Title: Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.
Author: Xia, Yun-Hong|Lu, Zhen|Zhao, Min|Dai, Wen-Ting|Ding, Lu|Hu, Li-Xia|Jiang, Guo-Lin
PMID: 28903404
Journal: Cancer Res. 2017 Nov 1;77(21):5831-5845.
Title: ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
Author: Yan, Qian|Jiang, Lingxi|Liu, Ming|Yu, Dandan|Zhang, Yu|Li, Yan|Fang, Shuo|Li, Yan|Zhu, Ying-Hui|Yuan, Yun-Fei|Guan, Xin-Yuan
PMID: 28904065
Journal: Sci Rep. 2017 Sep 14;7(1):11563.
Title: Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.
Author: Zhou, Ying|Fukuda, Tomohiko|Hang, Qinglei|Hou, Sicong|Isaji, Tomoya|Kameyama, Akihiko|Gu, Jianguo
PMID: 28912543
Journal: Oncol Lett. 2017 Sep;14(3):2831-2837.
Title: Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.
Author: Bao, Han|Guo, Chun-Guang|Qiu, Peng-Cheng|Zhang, Xin-Lei|Dong, Qi|Wang, Yu-Kun
PMID: 28928822
Journal: Sci Rep. 2017 Sep 28;7(1):12362.
Title: Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior.
Author: Cheng, Xi|Wu, Huo|Jin, Zhi-Jian|Ma, Ding|Yuen, Stanley|Jing, Xiao-Qian|Shi, Min-Min|Shen, Bai-Yong|Peng, Cheng-Hong|Zhao, Ren|Qiu, Wei-Hua
PMID: 28959024
Journal: Cancer Lett. 2017 Dec 28;411:117-129.
Title: BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
Author: Ma, Junli|Zeng, Shan|Zhang, Yan|Deng, Ganlu|Qu, Yanling|Guo, Cao|Yin, Ling|Han, Ying|Cai, Changjing|Li, Yiyi|Wang, Guqi|Bonkovsky, Herbert L|Shen, Hong
PMID: 28987388
Journal: Sci Rep. 2017 Oct 9;7(1):12803.
Title: N-terminal gelsolin fragment potentiates TRAIL mediated death in resistant hepatoma cells.
Author: Meyer, Keith|Kwon, Young-Chan|Ray, Ratna B|Ray, Ranjit
PMID: 28993697
Journal: Cancer Med. 2017 Dec;6(12):2787-2795.
Title: Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.
Author: Liang, Yuelong|Chen, Jiang|Yu, Qingsong|Ji, Tong|Zhang, Bin|Xu, Junjie|Dai, Yi|Xie, Yangyang|Lin, Hui|Liang, Xiao|Cai, Xiujun
PMID: 29030911
Journal: Sci Rep. 2017 Oct 16;7(1):13201.
Title: Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas.
Author: Lee, Hyun Min|Joh, Jae Won|Seo, Se-Ri|Kim, Won-Tae|Kim, Min Kyu|Choi, Hong Seo|Kim, So Young|Jang, Young-Joo|Sinn, Dong Hyun|Choi, Gyu Seong|Kim, Jong Man|Kwon, Choon Hyuck David|Chang, Hee Jin|Kim, Dae Shick|Ryu, Chun Jeih
PMID: 29038587
Journal: Int J Oncol. 2017 Nov;51(5):1449-1459.
Title: Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
Author: Liao, Bo|Zhou, Honghao|Liang, Huifang|Li, Changhai
PMID: 29048612
Journal: Ann Clin Lab Sci. 2017 Sep;47(5):572-580.
Title: Aminoguanidine (AG) Induces Induced both Pro- and Antioxidant Effect in AR42J Cells, a Rat Pancreatic Tumor Cell Line.
Author: Chowdhury, Parimal
PMID: 29066484
Journal: Nutr Cancer. 2017 Nov-Dec;69(8):1272-1280.
Title: Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer.
Author: Miethe, C|Nix, H|Martin, R|Hernandez, A R|Price, R S
PMID: 29068700
Journal: Clin Epigenetics. 2017 Oct 23;9:116.
Title: Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Author: Guo, Yulin|Peng, Yaojun|Gao, Dan|Zhang, Meiying|Yang, Weili|Linghu, Enqiang|Herman, James G|Fuks, Francois|Dong, Guanglong|Guo, Mingzhou
PMID: 29075359
Journal: World J Gastroenterol. 2017 Sep 28;23(36):6639-6649.
Title: Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Author: Gui, Yirui|Khan, Md Gulam Musawwir|Bobbala, Diwakar|Dubois, Claire|Ramanathan, Sheela|Saucier, Caroline|Ilangumaran, Subburaj
PMID: 29085209
Journal: Oncotarget. 2017 Jul 17;8(44):76223-76230.
Title: Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells.
Author: Wang, Yadong|Pan, Teng|Wang, Haiyu|Li, Li|Li, Jiangmin|Zhang, Ding|Yang, Haiyan
PMID: 29100306
Journal: Oncotarget. 2017 Aug 18;8(44):77096-77109.
Title: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish.
Author: Yan, Chuan|Yang, Qiqi|Shen, Han-Ming|Spitsbergen, Jan M|Gong, Zhiyuan
PMID: 29100373
Journal: Oncotarget. 2017 Sep 15;8(44):77915-77927.
Title: Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cells.
Author: Zhuang, Peng-Yuan|Zhang, Ke-Wei|Wang, Jian-Dong|Zhou, Xue-Ping|Liu, Ying-Bin|Quan, Zhi-Wei|Shen, Jun
PMID: 29100435
Journal: Oncotarget. 2017 Jul 6;8(46):80429-80442.
Title: Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.
Author: Cheng, Wei|Huang, Po-Chun|Chao, Hsiao-Mei|Jeng, Yung-Ming|Hsu, Hey-Chi|Pan, Hung-Wei|Hwu, Wuh-Liang|Lee, Yu-May
PMID: 29113314
Journal: Nat Med. 2017 Dec;23(12):1424-1435.
Title: Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Author: Broutier, Laura|Mastrogiovanni, Gianmarco|Verstegen, Monique Ma|Francies, Hayley E|Gavarro, Lena Morrill|Bradshaw, Charles R|Allen, George E|Arnes-Benito, Robert|Sidorova, Olga|Gaspersz, Marcia P|Georgakopoulos, Nikitas|Koo, Bon-Kyoung|Dietmann, Sabine|Da
PMID: 29131160
Journal: Oncotarget. 2016 Oct 18;8(48):83469-83479.
Title: AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-kappaB signaling pathways.
Author: Chow, Raymond Kwok Kei|Tsz-Kwan Sin, Sarah|Liu, Ming|Li, Yan|Man Chan, Tim Hon|Song, Yangyang|Chen, Leilei|Lai-Wan Kwong, Dora|Guan, Xin-Yuan
PMID: 29137357
Journal: Oncotarget. 2017 Sep 23;8(50):87737-87749.
Title: microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.
Author: Liu, Xin|Yang, Liu|Tu, Jianfeng|Cai, Wenwei|Zhang, Meiqi|Shou, Zhangxuan|Yao, Yingmin|Xu, Qiuran
PMID: 29152116
Journal: Oncotarget. 2017 May 9;8(49):84958-84973.
Title: Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.
Author: Wang, Ji Yu|Fang, Meng|Boye, Alex|Wu, Chao|Wu, Jia Jun|Ma, Ying|Hou, Shu|Kan, Yue|Yang, Yan
PMID: 29156696
Journal: Sci Rep. 2017 Dec 20;7(1):17943.
Title: Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice.
Author: Kuppusamy, Panjamurthy|Nagalingam, Arumugam|Muniraj, Nethaji|Saxena, Neeraj K|Sharma, Dipali
PMID: 29263422
Journal: Oncoimmunology. 2017 Oct 26;7(1):e1368603.
Title: The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma.
Author: Lenk, Lennart|Pein, Maren|Will, Olga|Gomez, Beatriz|Viol, Fabrice|Hauser, Charlotte|Egberts, Jan-Hendrik|Gundlach, Jan-Paul|Helm, Ole|Tiwari, Sanjay|Weiskirchen, Ralf|Rose-John, Stefan|Rocken, Christoph|Mikulits, Wolfgang|Wenzel, Patrick|Schneider, Gunter
PMID: 29296518
Journal: J BUON. 2017 Nov-Dec;22(6):1517-1524.
Title: Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-gamma and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
Author: Wang, Hao|Wang, Jun|Shi, Xiaolei|Ding, Yitao
PMID: 29332347
Journal: ACS Omega. 2017 Apr 30;2(4):1489-1504.
Title: Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells.
Author: Fageria, Leena|Pareek, Vikram|Dilip, R Venkataramana|Bhargava, Arpit|Pasha, Sheik Saleem|Laskar, Inamur Rahaman|Saini, Heena|Dash, Subhra|Chowdhury, Rajdeep|Panwar, Jitendra
PMID: 30023637
Journal: Eur J Nutr. 2018 Apr;57(3):1215-1224.
Title: Attenuation of liver cancer development by oral glycerol supplementation in the rat.
Author: Capiglioni, Alejo M|Lorenzetti, Florencia|Quiroga, Ariel D|Parody, Juan P|Ronco, Maria T|Pisani, Gerardo B|Carrillo, Maria C|Ceballos, Maria P|Alvarez, Maria de Lujan
PMID: 28255652
Journal: Int J Hyperthermia. 2018 Sep;34(6):812-823.
Title: Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.
Author: Thompson, Scott M|Jondal, Danielle E|Butters, Kim A|Knudsen, Bruce E|Anderson, Jill L|Stokes, Matthew P|Jia, Xiaoying|Grande, Joseph P|Roberts, Lewis R|Callstrom, Matthew R|Woodrum, David A
PMID: 28954551
Journal: Cell Biol Int. 2018 Feb;42(2):194-204.
Title: OAMDP, a novel podophyllotoxin derivative, induces apoptosis, cell cycle arrest and autophagy in hepatoma HepG2 cells.
Author: Ren, Jie|Liu, Yu|Li, Lixia|Zhao, Yuexin|Li, Zhongyu|Wu, Chao|Chen, Lin|Hu, Kun
PMID: 29052919
Journal: Int J Oncol. 2018 Jan;52(1):189-200.
Title: Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins.
Author: De Araujo, Raimundo F Jr|Pessoa, Jonas B|Cruz, Luis J|Chan, Alan B|De Castro Miguel, Emilio|Cavalcante, Romulo S|Brito, Gerly Anne C|Silva, Heloiza Fernada O|Gasparotto, Luiz H S|Guedes, Paulo M M|Araujo, Aurigena A
PMID: 29115423
Journal: Life Sci. 2018 Jan 1;192:286-292.
Title: Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells.
Author: Im, Eunji|Yeo, Changhwan|Lee, Hyo-Jeong|Lee, Eun-Ok
PMID: 29128513
Journal: Biomed Pharmacother. 2018 Jan;97:1282-1288.
Title: Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Author: Lu, Mingxia|Fei, Zhenghua|Zhang, Ganlu
PMID: 29156516
Journal: Environ Toxicol. 2018 Mar;33(3):261-268.
Title: Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma.
Author: Feng, I-Che|Hsieh, Ming-Ju|Chen, Pei-Ni|Hsieh, Yi-Hsien|Ho, Hsin-Yu|Yang, Shun-Fa|Yeh, Chao-Bin
PMID: 29159945
Journal: Biochem Biophys Res Commun. 2018 Jan 1;495(1):1136-1143.
Title: Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
Author: Zhao, Fengbo|Gong, Xiu|Liu, Aifen|Lv, Xiufang|Hu, Baoying|Zhang, Haijian
PMID: 29175326
Journal: Acta Pharmacol Sin. 2018 Mar;39(3):438-448.
Title: Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.
Author: Zhang, Su-Shan|Ni, Yu-Hao|Zhao, Chen-Ru|Qiao, Zhen|Yu, Hong-Xia|Wang, Lu-Yao|Sun, Jin-Yan|Du, Chen|Zhang, Jia-Hao|Dong, Li-Ying|Wang, KeWei|Gao, Jian-Jun
PMID: 29188798
Journal: J Biomater Appl. 2018 Feb;32(7):945-956.
Title: Localized delivery of chemokine for in vitro manipulation of hepatocellular carcinoma cell behaviors during the epithelial-mesenchymal transition.
Author: Liu, Xi-Qiu|Tang, Rui-Zhi
PMID: 29199892
Journal: Int J Cancer. 2018 Apr 15;142(8):1712-1722.
Title: Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.
Author: Kaji, Kosuke|Nishimura, Norihisa|Seki, Kenichiro|Sato, Shinya|Saikawa, Soichiro|Nakanishi, Keisuke|Furukawa, Masanori|Kawaratani, Hideto|Kitade, Mitsuteru|Moriya, Kei|Namisaki, Tadashi|Yoshiji, Hitoshi
PMID: 29205334
Journal: Oncol Rep. 2018 Feb;39(2):843-850.
Title: Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Author: Yokoi, Kenta|Kobayashi, Akira|Motoyama, Hiroaki|Kitazawa, Masato|Shimizu, Akira|Notake, Tsuyoshi|Yokoyama, Takahide|Matsumura, Tomio|Takeoka, Michiko|Miyagawa, Shin-Ichi
PMID: 29251327
Journal: Int J Biochem Cell Biol. 2018 Mar;96:9-19.
Title: Novel 1,4-naphthoquinone derivatives induce apoptosis via ROS-mediated p38/MAPK, Akt and STAT3 signaling in human hepatoma Hep3B cells.
Author: Liu, Chang|Shen, Gui-Nan|Luo, Ying-Hua|Piao, Xian-Ji|Jiang, Xue-Yuan|Meng, Ling-Qi|Wang, Yue|Zhang, Yi|Wang, Jia-Ru|Wang, Hao|Xu, Wan-Ting|Li, Jin-Qian|Liu, Yang|Wu, Yi-Qin|Sun, Hu-Nan|Han, Ying-Hao|Jin, Mei-Hua|Cui, Yu-Dong|Fang, Nan-Zhu|Jin, Cheng-Hao
PMID: 29326072
Journal: Cancer Res. 2018 May 1;78(9):2219-2232.
Title: Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.
Author: Liu, Yun|Zhang, Xinran|Yang, Baicai|Zhuang, Hao|Guo, Hua|Wei, Wen|Li, Yuan|Chen, Ruibing|Li, Yongmei|Zhang, Ning
PMID: 29330146
Journal: J Exp Clin Cancer Res. 2018 Jan 22;37(1):10.
Title: MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Author: Liu, Mingyu|Hu, Qiaoting|Tu, Mengxian|Wang, Xinyi|Yang, Zike|Yang, Guoxiong|Luo, Rongcheng
PMID: 29357919
Journal: Cancer Sci. 2018 Apr;109(4):1088-1100.
Title: Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
Author: Hou, Helei|Ge, Chao|Sun, Hefen|Li, Hong|Li, Jinjun|Tian, Hua
PMID: 29377347
Journal: World J Hepatol. 2018 Jan 27;10(1):155-165.
Title: Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.
Author: Bhat, Venkat|Srinathan, Sujitha|Pasini, Elisa|Angeli, Marc|Chen, Emily|Baciu, Cristina|Bhat, Mamatha
PMID: 29399289
Journal: Biochem Biophys Res Commun. 2018 Feb 26;497(1):32-38.
Title: GPR182 is a novel marker for sinusoidal endothelial differentiation with distinct GPCR signaling activity in vitro.
Author: Schmid, Christian David|Schledzewski, Kai|Mogler, Carolin|Waldburger, Nina|Kalna, Viktoria|Marx, Alexander|Randi, Anna Maria|Geraud, Cyrill|Goerdt, Sergij|Koch, Philipp-Sebastian
PMID: 29408502
Journal: Gene Expr. 2018 May 18;18(2):135-147.
Title: The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, beta-Catenin-Mutated Mouse Model.
Author: Zhan, Na|Michael, Adeola Adebayo|Wu, Kaiyuan|Zeng, Gang|Bell, Aaron|Tao, Junyan|Monga, Satdarshan P
PMID: 29409568
Journal: Am J Cancer Res. 2018 Jan 1;8(1):154-164. eCollection 2018.
Title: Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma.
Author: Pan, Jie-Xue|Chen, Gang|Li, Jun-Jian|Zhu, Qian-Dong|Li, Jing-Jie|Chen, Zong-Jing|Yu, Zheng-Ping|Ye, Long-Yun
PMID: 29416928
Journal: Oncotarget. 2017 Dec 11;9(3):3605-3618.
Title: Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.
Author: Dietrich, Peter|Freese, Kim|Mahli, Abdo|Thasler, Wolfgang Erwin|Hellerbrand, Claus|Bosserhoff, Anja Katrin
PMID: 29423069
Journal: Int J Mol Med. 2018 May;41(5):2893-2900.
Title: Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals.
Author: Zhong, Jingtao|Yu, Xiaoming|Dong, Xiaofeng|Lu, Hong|Zhou, Wuyuan|Li, Lei|Li, Zhongchao|Sun, Pengfei|Shi, Xuetao
PMID: 29436591
Journal: Cancer Med. 2018 Mar;7(3):869-882.
Title: PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma.
Author: Jiang, Hai|Zhu, Yue|Zhou, Zhenyu|Xu, Junyang|Jin, Shaowen|Xu, Kang|Zhang, Heyun|Sun, Qing|Wang, Jie|Xu, Junyao
PMID: 29441724
Journal: Cell Death Differ. 2018 Sep;25(9):1612-1624.
Title: Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.
Author: Li, Jiao|Pu, Wenchen|Sun, Hui-Lung|Zhou, Jian-Kang|Fan, Xin|Zheng, Yuanyuan|He, Juan|Liu, Xuesha|Xia, Zhichu|Liu, Lunxu|Wei, Yu-Quan|Peng, Yong
PMID: 29445125
Journal: Theranostics. 2018 Jan 1;8(4):894-905.
Title: Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Author: Sung, Yun-Chieh|Liu, Ya-Chi|Chao, Po-Han|Chang, Chih-Chun|Jin, Pei-Ru|Lin, Ts-Ting|Lin, Ja-An|Cheng, Hui-Teng|Wang, Jane|Lai, Charles P|Chen, Ling-Hsuan|Wu, Anthony Y|Ho, Ting-Lun|Chiang, Tsaiyu|Gao, Dong-Yu|Duda, Dan G|Chen, Yunching
PMID: 29463989
Journal: Steroids. 2018 Jun;134:78-87.
Title: The ER-alpha36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells.
Author: You, Hui|Meng, Kun|Wang, Zhao-Yi
PMID: 29481815
Journal: Phytomedicine. 2018 Feb 1;40:98-105.
Title: Early LC3 lipidation induced by d-limonene does not rely on mTOR inhibition, ERK activation and ROS production and it is associated with reduced clonogenic capacity of SH-SY5Y neuroblastoma cells.
Author: Berliocchi, Laura|Chiappini, Carlotta|Adornetto, Annagrazia|Gentile, Debora|Cerri, Silvia|Russo, Rossella|Bagetta, Giacinto|Corasaniti, Maria Tiziana
PMID: 29496180
Journal: J Hepatol. 2018 Jul;69(1):79-88.
Title: Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic beta-Catenin, PIK3CA and MET.
Author: Liu, Jacey J|Li, Yanjie|Chen, Wendy S|Liang, Yan|Wang, Gaowei|Zong, Min|Kaneko, Kota|Xu, Ruiyun|Karin, Michael|Feng, Gen-Sheng
PMID: 29505847
Journal: J Exp Clin Cancer Res. 2018 Mar 5;37(1):45.
Title: Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Author: Wang, Ji-Long|Yang, Meng-Yuan|Xiao, Shuai|Sun, Bo|Li, Yi-Ming|Yang, Lian-Yue
PMID: 29506567
Journal: Life Sci. 2018 Apr 15;199:48-59.
Title: Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways.
Author: Rodenak-Kladniew, Boris|Castro, Agustina|Starkel, Peter|De Saeger, Christine|Garcia de Bravo, Margarita|Crespo, Rosana
PMID: 29510199
Journal: World J Gastroenterol. 2018 Mar 14;24(10):1120-1133.
Title: Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Author: Sun, Liang|Li, Pi-Bao|Yao, Yan-Fen|Xiu, Ai-Yuan|Peng, Zhi|Bai, Yu-Huan|Gao, Yan-Jing
PMID: 29563756
Journal: Anticancer Drugs. 2018 Jul;29(6):513-519.
Title: Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinoma.
Author: Yu, Zhen|Zhao, Ronglei
PMID: 29570100
Journal: Med Sci Monit. 2018 Mar 26;24:1759-1767.
Title: MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.
Author: Wang, Xujing|Wang, Yongkun|Zhang, Qiqi|Zhuang, Huiren|Chen, Bo
PMID: 29576605
Journal: Anticancer Res. 2018 Apr;38(4):2119-2125.
Title: Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.
Author: Tsai, Jai-Jen|Hsu, Fei-Ting|Pan, Po-Jung|Chen, Chia-Wen|Kuo, Yu-Cheng
PMID: 29599330
Journal: Biomed Pharmacother. 2018 May;101:910-919.
Title: Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway.
Author: Fang, Yu|Liu, Guoxing|Xie, Chengzhi|Qian, Ke|Lei, Xiaohua|Liu, Qiang|Liu, Gao|Cao, Zhenyu|Fu, Jie|Du, Huihui|Liu, Sushun|Huang, Shengfu|Hu, Jixiong|Xu, Xundi
PMID: 29635900
Journal: Biomed Pharmacother. 2018 Jul;103:272-283.
Title: Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARgamma.
Author: Han, Mei|Gao, Hui|Ju, Ping|Gao, Ming-Quan|Yuan, Yin-Ping|Chen, Xue-Hong|Liu, Kai-Li|Han, Yan-Tao|Han, Zhi-Wu
PMID: 29656183
Journal: Cell Death Dis. 2018 May 1;9(5):482.
Title: The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
Author: Li, Wenjuan|Cui, Kaisa|Prochownik, Edward V|Li, Youjun
PMID: 29706623
Journal: Genomics Proteomics Bioinformatics. 2018 Apr;16(2):120-126.
Title: The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.
Author: Wu, Ke|He, Juan|Pu, Wenchen|Peng, Yong
PMID: 29723684
Journal: Cell Death Dis. 2018 May 1;9(5):513.
Title: HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Author: Chen, Lu|Guo, Piao|He, Yuchao|Chen, Ziye|Chen, Liwei|Luo, Yi|Qi, Lisha|Liu, Yuanyuan|Wu, Qiang|Cui, Yunlong|Fang, Feng|Zhang, Xiaofang|Song, Tianqiang|Guo, Hua
PMID: 29725020
Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2018 Apr 20;38(4):477-482.
Title: [Glycyrrhetinic acid selectively inhibits proliferation of hepatocellular carcinoma cells in vitro].
Author: Zhang, Yun-Qi|Cai, Yun|Liu, Yuan|Zhao, Bo-Xin|Li, Guo-Feng
PMID: 29735451
Journal: Cell Death Dis. 2018 May 1;9(5):549.
Title: MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1alpha-mediated Warburg effect.
Author: Chen, Zhiqiang|Zuo, Xueliang|Zhang, Yao|Han, Guoyong|Zhang, Long|Wu, Jindao|Wang, Xuehao
PMID: 29748591
Journal: Mol Carcinog. 2018 Sep;57(9):1201-1212.
Title: A novel mechanism of the M1-M2 methionine adenosyltransferase switch-mediated hepatocellular carcinoma metastasis.
Author: Wang, Ruizhi|Jin, Yi|Yao, Xue-Hua|Fan, Wenzhe|Zhang, Jiang|Cao, Yihai|Li, Jiaping
PMID: 29749642
Journal: Cell Physiol Biochem. 2018;47(1):39-53.
Title: Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
Author: Ji, Yuanyuan|Wang, Zhidong|Chen, Haiyan|Zhang, Lei|Zhuo, Fei|Yang, Qingqing
PMID: 29763915
Journal: Oncotarget. 2018 Apr 20;9(30):21429-21443.
Title: MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma.
Author: Ranjan, Atul|Iyer, Swathi V|Ward, Christopher|Link, Tim|Diaz, Francisco J|Dhar, Animesh|Tawfik, Ossama W|Weinman, Steven A|Azuma, Yoshiaki|Izumi, Tadahide|Iwakuma, Tomoo
PMID: 29765550
Journal: Eur J Pharmacol. 2018 Aug 5;832:39-49.
Title: Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Author: Mao, Jie|Yang, Hongbao|Cui, Tingting|Pan, Pan|Kabir, Nadia|Chen, Duo|Ma, Jinyan|Chen, Xingyi|Chen, Yijun|Yang, Yong
PMID: 29782854
Journal: Biosci Trends. 2018 Jul 17;12(3):291-297.
Title: Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway.
Author: Qi, Fanghua|Wang, Jinjing|Zhao, Lin|Cai, Pingping|Tang, Wei|Wang, Zhixue
PMID: 29794405
Journal: Biochem Biophys Res Commun. 2018 Jul 12;502(2):194-201.
Title: Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma.
Author: Ding, Kai|Liao, Yannian|Gong, Dinghao|Zhao, Xin|Ji, Wu
PMID: 29800569
Journal: Bioorg Chem. 2018 Sep;79:355-362.
Title: Pyran-2-one derivatives from Croton crassifolius as potent apoptosis inducers in HepG2 cells via p53-mediated Ras/Raf/ERK pathway.
Author: Tian, Jin-Long|Yao, Guo-Dong|Zhang, Ying-Ying|Lin, Bin|Zhang, Yan|Li, Ling-Zhi|Huang, Xiao-Xiao|Song, Shao-Jiang
PMID: 29852310
Journal: J Cancer Res Clin Oncol. 2018 Aug;144(8):1487-1501.
Title: Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.
Author: Kim, Jin Sun|Choi, Gwang Hyeon|Jung, Yusun|Kim, Kang Mo|Jang, Se-Jin|Yu, Eun Sil|Lee, Han Chu
PMID: 29858683
Journal: Oxid Med Cell Longev. 2018 May 10;2018:5287971.
Title: Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition.
Author: He, Qiang|Li, Hui|Meng, Fanzhi|Sun, Xiangjun|Feng, Xu|Chen, Jiang|Li, Libo|Liu, Jinghua
PMID: 29861830
Journal: J Exp Clin Cancer Res. 2018 Jun 4;37(1):113.
Title: Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1alpha/VEGFA signalling in hepatocellular carcinoma.
Author: Lin, Jinduan|Cao, Shunwang|Wang, Yu|Hu, Yanwei|Liu, Hongwei|Li, Jiehua|Chen, Jing|Li, Pan|Liu, Jumei|Wang, Qian|Zheng, Lei
PMID: 29866133
Journal: Mar Drugs. 2018 Jun 7;16(6). pii: md16060200.
Title: Tachypleus tridentatus Lectin Enhances Oncolytic Vaccinia Virus Replication to Suppress In Vivo Hepatocellular Carcinoma Growth.
Author: Li, Gongchu|Cheng, Jianhong|Mei, Shengsheng|Wu, Tao|Ye, Ting
PMID: 29880736
Journal: Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3386-3393.
Title: Correlation between HSD17B4 expression in rat liver cancer tissues and inflammation or proliferation.
Author: Pan, L-C|Xiao, H-Y|Yin, W-J|Lin, Z
PMID: 29917219
Journal: J Exp Clin Cancer Res. 2018 Jun 28;37(1):128.
Title: Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Author: Chen, Xueran|Zhang, Shangrong|Wang, Zhen|Wang, Fengsong|Cao, Xinwang|Wu, Quan|Zhao, Chenggang|Ma, Huihui|Ye, Fang|Wang, Hongzhi|Fang, Zhiyou
PMID: 29954442
Journal: Environ Toxicol. 2018 Sep;33(9):946-954.
Title: Coronarin D induces apoptotic cell death through the JNK pathway in human hepatocellular carcinoma.
Author: Lin, Hui-Wen|Hsieh, Ming-Ju|Yeh, Chao-Bin|Hsueh, Kuan-Chun|Hsieh, Yi-Hsien|Yang, Shun-Fa
PMID: 29968959
Journal: Integr Cancer Ther. 2018 Jul 1:1534735418785999.
Title: Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft.
Author: Yu, XiaoXiao|Lin, Xue-Jun|Wang, Shuang|Liu, XiuHong|Li, WeiHua|Kou, Bu-Xin|Chai, MengYin|Chen, DeXi|Liu, XiaoNi|Wang, XiaoJun
PMID: 29978739
Journal: Biochem Pharmacol. 2018 Sep;155:305-315.
Title: HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis.
Author: Benkheil, Mohammed|Paeshuyse, Jan|Neyts, Johan|Van Haele, Matthias|Roskams, Tania|Liekens, Sandra
PMID: 30012461
Journal: Sci Rep. 2018 Jul 19;8(1):10923.
Title: Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells.
Author: Wang, Jing|Sun, Peng|Chen, Yijun|Yao, Hequan|Wang, Shuzhen
PMID: 30026540
Journal: Hepatology. 2018 Jul 20.
Title: A CCDC50 splice variant is modulated by SRSF3 and promotes hepatocellular carcinoma via the Ras signaling pathway.
Author: Hong, Wang|Zhang, Chris Zhiyi|Lu, Shi-Xun|Zhang, Mei-Fang|Liu, Li-Li|Luo, Rong-Zhen|Yang, Xia|Wang, Chun-Hua|Chen, Shi-Lu|He, Yang-Fan|Xie, Dan|Xu, Rui-Hua|Yun, Jing-Ping
PMID: 30028541
Journal: J Hepatol. 2018 Jul 18. pii: S0168-8278(18)32184-6.
Title: Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
Author: Wang, Cun|Jin, Haojie|Gao, Dongmei|Lieftink, Cor|Evers, Bastiaan|Jin, Guangzhi|Xue, Zheng|Wang, Liqin|Beijersbergen, Roderick L|Qin, Wenxin|Bernards, Rene
PMID: 30030148
Journal: Transl Gastroenterol Hepatol. 2018 Jun 29;3:36.
Title: Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma.
Author: Pascale, Rosa M|Feo, Claudio F|Calvisi, Diego F|Feo, Francesco
PMID: 30050996
Journal: Int J Mol Med. 2018 Nov;42(5):2551-2559.
Title: Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK.
Author: Lee, Seulki|Cho, Young Youn|Cho, Eun Ju|Yu, Su Jong|Lee, Jeong-Hoon|Yoon, Jung-Hwan|Kim, Yoon Jun
PMID: 30106087
Journal: Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):336-344.
Title: MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Author: Cheng, Jun|Wu, Li-Ming|Deng, Xue-Song|Wu, Jian|Lv, Zhen|Zhao, Hang-Fen|Yang, Zhang|Ni, Yong
PMID: 30108016
Journal: Biomed Pharmacother. 2018 Nov;107:824-833.
Title: LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Author: Bao, Jie|Chen, Xiaoqi|Hou, Yuge|Kang, Gailing|Li, Qiaoli|Xu, Yun
PMID: 30142544
Journal: Biochem Biophys Res Commun. 2018 Sep 18;503(4):3093-3099.
Title: Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
Author: He, Chao|Wu, Tingting|Hao, Yongqiang
PMID: 30146257
Journal: Mol Carcinog. 2018 Sep 4.
Title: Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade.
Author: Qiu, Zhenpeng|Zhang, Cong|Zhou, Junxuan|Hu, Junjie|Sheng, Lei|Li, Xin|Chen, Liang|Li, Xiang|Deng, Xukun|Zheng, Guohua
PMID: 30182439
Journal: Toxicol In Vitro. 2018 Sep 6;53:222-232.
Title: Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells.
Author: Wudtiwai, Benjawan|Pitchakarn, Pornsiri|Banjerdpongchai, Ratana
PMID: 30195041
Journal: Lab Invest. 2018 Sep 11. pii: 10.1038/s41374-018-0127-3.
Title: The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis.
Author: Wang, Zhuo|Li, Jia'an|Xiao, Wen'ang|Long, Jiafu|Zhang, Hongmin
PMID: 30206312
Journal: Oncoimmunology. 2018 Apr 9;7(8):e1450713.
Title: delta-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation.
Author: Huang, Fei|Chen, Junying|Lan, Ruilong|Wang, Zeng|Chen, Ruiqing|Lin, Jingan|Zhang, Lurong|Fu, Lengxi
PMID: 30221043
Journal: Stem Cells Int. 2018 Aug 27;2018:8058979.
Title: Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats.
Author: Alzahrani, Faisal A|El-Magd, Mohammed A|Abdelfattah-Hassan, Ahmed|Saleh, Ayman A|Saadeldin, Islam M|El-Shetry, Eman S|Badawy, Abdelnaser A|Alkarim, Saleh
PMID: 30224923
Journal: BMC Cancer. 2018 Sep 18;18(1):901.
Title: Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment.
Author: Zhang, Rui|Ma, Min|Lin, Xia-Hui|Liu, Hua-Hua|Chen, Jie|Chen, Jun|Gao, Dong-Mei|Cui, Jie-Feng|Ren, Zheng-Gang|Chen, Rong-Xin
PMID: 30227844
Journal: J Exp Clin Cancer Res. 2018 Sep 19;37(1):231.
Title: HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Author: Li, Qing|Wang, Cong|Wang, Yufeng|Sun, Liankang|Liu, Zhikui|Wang, Liang|Song, Tao|Yao, Yingmin|Liu, Qingguang|Tu, Kangsheng
PMID: 30231922
Journal: Theranostics. 2018 Sep 9;8(17):4649-4663.
Title: Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
Author: Liu, Zhikui|Wang, Yufeng|Dou, Changwei|Xu, Meng|Sun, Liankang|Wang, Liang|Yao, Bowen|Li, Qing|Yang, Wei|Tu, Kangsheng|Liu, Qingguang
PMID: 30279729
Journal: Clin Exp Med. 2018 Oct 10. pii: 10.1007/s10238-018-0528-z.
Title: mTOR and ERK regulate VKORC1 expression in both hepatoma cells and hepatocytes which influence blood coagulation.
Author: Liu, Yaofu|Li, Huiling|Dong, Jianyi|Ma, Lei|Liao, Aijun|Rong, Zhuona|Zhou, Zhi|Cao, Liang|Wang, Fujin|Wang, Jingyu|Wang, Aiguo
PMID: 30306378
Journal: J Cell Physiol. 2018 Oct 14.
Title: LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Author: Wang, Jianchu|Luo, Zongjiang|Yao, Tianwei|Li, Wenchuan|Pu, Jian
PMID: 30317590
Journal: Zhonghua Gan Zang Bing Za Zhi. 2018 Aug 20;26(8):601-606.
Title: [Mechanism of angiotensin II (Ang II) on the proliferation of human hepatoma cell line HepG2 cells].
Author: Qi, R|Lei, C G|Bai, Y X|Xing, X
PMID: 30317792
Journal: Cell Rep. 2018 Oct 16;25(3):690-701.e8.
Title: PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
Author: Chan, Lok Hei|Zhou, Lei|Ng, Kai Yu|Wong, Tin Lok|Lee, Terence K|Sharma, Rakesh|Loong, Jane H|Ching, Yick Pang|Yuan, Yun-Fei|Xie, Dan|Lo, Chung Mau|Man, Kwan|Artegiani, Benedetta|Clevers, Hans|Yan, Helen H|Leung, Suet Yi|Richard, Stephane|Guan, Xin-Yuan|Hu
PMID: 30332648
Journal: Biofactors. 2018 Sep;44(5):453-464.
Title: SPARC acts as a mediator of TGF-beta1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
Author: Sun, Weichao|Feng, Jianguo|Yi, Qian|Xu, Xichao|Chen, Ying|Tang, Liling
PMID: 30346081
Journal: Mol Carcinog. 2018 Oct 26.
Title: lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Author: Zhuang, Runzhou|Zhang, Xuanyu|Lu, Di|Wang, Jianguo|Zhuo, Jianyong|Wei, Xuyong|Ling, Qi|Xie, Haiyang|Zheng, Shusen|Xu, Xiao
PMID: 30362626
Journal: Oncol Rep. 2018 Oct 25.
Title: PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
Author: Tang, Bo|Liang, Wenjin|Liao, Yong|Li, Zeming|Wang, Yan|Yan, Chao
PMID: 30365128
Journal: Int J Mol Sci. 2018 Oct 31;19(11). pii: ijms19113419.
Title: Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
Author: Guo, Xing-Xian|Li, Xiao-Peng|Zhou, Peng|Li, Dan-Yang|Lyu, Xiao-Ting|Chen, Yi|Lyu, Yan-Wei|Tian, Kuan|Yuan, De-Zhi|Ran, Jian-Hua|Chen, Di-Long|Jiang, Rong|Li, Jing
PMID: 30384473